Publications – 2025

  • Chawla LS, Murray PT, Goldstein SL, Cunningham A, Hebbar S, Wunderink RG, Chertow GM. Inhibition of Calcium Release-Activated Calcium (CRAC) channels to Treat Acute Kidney Injury: Design and Rationale of the KOURAGE study. Am J Nephrol. 2025 Jun 9:1-19. doi: 10.1159/000546863.
  • Branch KRH, Lam CSP, Islam S, Del Prato S, Lopes RD, Pratley R, Rosenstock J, Sattar N, Gerstein HC. Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial. Diabetes Care. 2025 Jun 9:dc242629. doi: 10.2337/dc24-2629.
  • Inciardi RM, Vaduganathan M, Claggett B, AbouEzzeddine OF, Borlaug BA, Desai AS, Jhund PS, Lam CSP, Minamisawa M, Lewis EF, Redfield MM, Shah SJ, Fontana M, Pfeffer MA, McMurray JJV, Solomon SD. Application of a transthyretin amyloid cardiomyopathy score to heart failure with mildly reduced or preserved ejection fraction. Eur J Heart Fail. 2025 Jun 9. doi: 10.1002/ejhf.3698.
  • Pecoits-Filho R, Wong MMY, Moorthy M, Banerjee D, Behera S, Calice-Silva V, Chothia MY, Colbert GB, Gulati M, Herzog CA, Jouhra F, Lerma EV, Malik C, Patel KV, Rakisheva A, Rosano GMC, Satish P, Wu HHL, Wang AY. Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: a call to action from the cardio-kidney community. ESC Heart Fail. 2025 Jun 9. doi: 10.1002/ehf2.15262.
  • Tuttle KR, Reynolds CL, Kornowske LM, Jones CR, Alicic RZ, Daratha KB, Neumiller JJ, Greenbaum C, Pavkov ME, Xu F, Duru OK, Nicholas SB, Norris KC, CURE-CKD Consortium. Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real-world cohort study. Lancet Reg Health Am. 2025 May 15;47:101130. doi: 10.1016/j.lana.2025.101130. eCollection 2025 Jul.
  • Di Vece D, Connors JM, Barco S. Reply to “Reevaluating thromboprophylaxis in COVID-19 outpatients: the case for a targeted, risk-based approach”. Res Pract Thromb Haemost. 2025 Apr 17;9(3):102861. doi: 10.1016/j.rpth.2025.102861. eCollection 2025 Mar.
  • Mazhar F, Fu EL, Faucon AL, Hjemdahl P, Mathisen J, Faqir Muhammad I, Plunde O, Perkovic V, Tuttle KR, Carrero JJ. Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease. Am J Kidney Dis. 2025 Jun 6:S0272-6386(25)00875-3. doi: 10.1053/j.ajkd.2025.04.011.
  • Gibson CM, Escano AK, McKenzie JJ, Wijesinghe DS, Donohoe KL. Enhancing student knowledge and confidence through two sequential total parenteral nutrition active learning approaches. Curr Pharm Teach Learn. 2025 Jun 6;17(9):102396. doi: 10.1016/j.cptl.2025.102396.
  • Henkin S, Wood MJ, Naderi S, Gornik HL, Kadian-Dodov D, Grodzinsky A, Chi G, Gibson CM, Leon KK, Kim ESH. Persistent Left Ventricular Dysfunction After Spontaneous Coronary Artery Dissection: A Report of the iSCAD Registry. JACC Adv. 2025 Jun 6;4(7):101854. doi: 10.1016/j.jacadv.2025.101854.
  • Skaarup KG, Johansen ND, Brandi L, Lindhardt MK, Bech JN, Svensson M, Kristensen T, Thuesen AD, Knudsen MG, Kampman JD, Hornnum M, Orts B, Modin D, Lassen MCH, Janstrup KH, Claggett BL, Vaduganathan M, Bhatt AS, Van Spall HGC, Jensen JUS, Zannad F, Solomon SD, Moller A, Borg R, Birn H, Hansen D, Biering-Sorensen T. A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients with Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial. Circulation. 2025 Jun 7. doi: 10.1161/CIRCULATIONAHA.125.075403.
  • Wong WK, Takeuchi F, Kuan LL, Nicholls SJ, Peter K, Chew DP. The presence or absence of standard modifiable cardiovascular risk factors in patients with myocardial infarction impacts long-term but not 30-day mortality: a UK Biobank prospective cohort study. Eur J Prev Cardiol. 2025 Jun 6:zwaf274. doi: 10.1093/eurjpc/zwaf274.
  • Rohatgi A, Anand SS, Gadgil M, Gujral UP, Jain SS, Javed Z, Jha M, Joshi PH, Manubolu VS, Nasir K, Natarajan P, Pagidipati N, Palaniappan L, Patel AP, Satish P, Shah NS, Sharma G, Trivedi MH, Virani SS, Gulati M, Patel J. South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population – An American society for preventive cardiology clinical practice statement. Am J Prev Cardiol. 2025 Apr 22;22:101000. doi: 10.1016/j.ajpc.2025.101000. eCollection 2025 Jun.
  • Caron E, Marcaccio CL, St John E, Li S, Song Y, Yeh RW, Schermerhorn ML, Secemsky EA. Exploring Socioeconomic Disparities in Outcomes and Follow-up After Endovascular Treatment of Abdominal Aortic Aneurysms among Medicare Beneficiaries. J Vasc Surg. 2025 Jun 3:S0741-5214(25)01132-2. doi: 10.1016/j.jvs.2025.05.051.
  • Gragnano F, De Sio V, Angiolillo DJ, Calabro P. Oral anticoagulation alone in atrial fibrillation and stable coronary artery disease: evidence silences doubt. J Cardiovasc Med (Hagerstown). 2025 Jun 1;26(6):266-268. doi: 10.2459/JCM.0000000000001732. Epub 2025 May 1.
  • Herzig MS, Kim JM, Stangenberg L, Schermerhorn ML, Li S, Song Y, Secemsky EA. Changing Clinical Indications for Femoropopliteal Revascularization From 2016 to 2023. JACC Cardiovasc Interv. 2025 May 27:S1936-8798(25)01185-9. doi: 10.1016/j.jcin.2025.04.019.
  • Watson NW, Earle WB, Kandzari DE, Kirtane AJ, Mahfoud F, Cluett JL, Krawisz AK, Juraschek SP, Secemsky EA. National Estimates of Patient Eligibility for Renal Denervation Therapy. JACC Cardiovasc Interv. 2025 May 19:S1936-8798(25)01191-4. doi: 10.1016/j.jcin.2025.04.025.
  • Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Bohm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G. Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure. Eur J Heart Fail. 2025 Jun 5. doi: 10.1002/ejhf.3719.
  • Dastmalchi LN, Gulati M. Age at Menarche and Cardiovascular Risk: A Moving Target of Risk Assessment in Women. Eur J Prev Cardiol. 2025 Jun 5:zwaf318. doi: 10.1093/eurjpc/zwaf318.
  • Furtado RHM, Rochitte CE, Nicolau JC, Echeverria LE, Arias-Mendoza A, Bahit MC, Padilla F, Lopes RD. American College of Cardiology/American Heart Association Acute Coronary Syndrome Guidelines: A Latin American Perspective. J Am Coll Cardiol. 2025 Jun 10;85(22):2122-2125. doi: 10.1016/j.jacc.2025.04.037.
  • Coughlan JJ, Al Lamee R, Byrne RA. ACS Guidelines: Bridging the Transatlantic Divide. J Am Coll Cardiol. 2025 Jun 10;85(22):2118-2121. doi: 10.1016/j.jacc.2025.04.050.
  • Beltrame JF, Nicholls SJ. The 2025 ACC/AHA Guideline for Acute Coronary Syndromes: A View From Down Under. J Am Coll Cardiol. 2025 Jun 10;85(22):2111-2113. doi: 10.1016/j.jacc.2025.04.009.
  • Brandts J, Ray KK. Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline: What It Is and What It Might Have Been. J Am Coll Cardiol. 2025 Jun 10;85(22):2107-2110. doi: 10.1016/j.jacc.2025.04.024.
  • Ko DT, Al-Lamee RK, Bikdeli B, Cohen DJ, Januzzi JL, Sawano M, Spatz ES, Chan You S. Perspective on the Choice and Duration of Dual Antiplatelet Therapy Recommendations in the 2025 Acute Coronary Syndrome Management Guideline. J Am Coll Cardiol. 2025 Jun 10;85(22):2079-2082. doi: 10.1016/j.jacc.2025.04.045.
  • Bikdeli B, Ujueta F, Rashedi S, Talasaz AH, Kadakia KT, Lopes RD, White HD, Steg PG, Piazza G, Al-Lamee RK, Cohen DJ, Mehran R, Krumholz HM. Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations. J Am Coll Cardiol. 2025 Jun 10;85(22):2074-2078. doi: 10.1016/j.jacc.2025.04.002.
  • Lam CSP, Spatz ES. Shared Decision Making in the 2025 ACS Guideline. J Am Coll Cardiol. 2025 Jun 10;85(22):2071-2073. doi: 10.1016/j.jacc.2025.04.031.
  • Rao SV. The 2025 American College of Cardiology/American Heart Association Acute Coronary Syndrome Guideline: A Personal Perspective. J Am Coll Cardiol. 2025 Jun 10;85(22):2068-2070. doi: 10.1016/j.jacc.2025.04.035.
  • Isath A, Mehra MR. Thin Blood and Thinner Margins in Anticoagulation with Left Ventricular Assist Devices: Living on the Razor’s Edge. J Heart Lung Transplant. 2025 Jun 2:S1053-2498(25)02016-9. doi: 10.1016/j.healun.2025.05.016.
  • Khan MS, Rashid AM, Van Spall HGC, Girerd N, Chew NWS, Volk ML, Butler J, Sanyal AJ, Zannad F. Exclusion of Liver Disease and Underutilization of Liver-Specific Endpoints in Heart Failure Trials. JACC Heart Fail. 2025 Jun 3;13(7):102490. doi: 10.1016/j.jchf.2025.03.036.
  • Castagna F, Mehra MR, Nabzdyk CGS, Givertz MM. Vasoplegia Syndrome After Cardiac Surgery: Insights Into Mechanisms and Treatment. JACC Heart Fail. 2025 Jun 3;13(7):102482. doi: 10.1016/j.jchf.2025.02.028.
  • Hoffman BU, Ben-Yehuda O. TAVR for Asymptomatic Severe Aortic Stenosis. N Engl J Med. 2025 Jun 5;392(21):2176-2177. doi: 10.1056/NEJMc2502177.
  • Siracuse JJ, Kaufman JA, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Powell RJ, Venermo M, Doros G, Faries P, Strong MB, Dake MD. Antiproliferative endovascular drug technology is associated with fewer major reinterventions after femoropopliteal interventions for chronic limb-threatening ischemia. J Vasc Surg. 2025 May 29:S0741-5214(25)00989-9. doi: 10.1016/j.jvs.2025.04.029.
  • Hou W, Tuttle KR, Shen W, Reikes A, Watanabe JH. Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape. J Diabetes. 2025 Jun;17(6):e70108. doi: 10.1111/1753-0407.70108.
  • Prochaska MT, Portela GT, Brooks MM, Fergusson DA, Hebert PC, Polonsky TS, Caixeta A, Cooper HA, Crozier I, Daneault B, Kim S, Bainey KR, de Barros E Silva P, Goldfarb M, Gupta R, Rao SV, Fonteles Ritt LE, Simon T, Carson JL. Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 3:e250654. doi: 10.1001/jamainternmed.2025.0654.
  • Fathieh S, Tang O, Gray MP, Zanchin C, Vernon ST, Genetzakis E, Tran C, Sullivan DR, Nicholls SJ, Celermajer DS, Psaltis PJ, Grieve SM, Figtree GA. Evaluating the Role of Lipoprotein(a) in Enhancing Risk Stratification for the Presence and Extent of Subclinical Coronary Artery Disease Burden – A BioHEART-CT Study. Eur J Prev Cardiol. 2025 Jun 3:zwaf323. doi: 10.1093/eurjpc/zwaf323.
  • Pandey A, Thomas T, Ji Y, Kroger B, Carlsgaard P, Irion CI, Kalkan F, Segar M, Subramanian V, Bayes-Genis A, Son A, Young KA, Trowbridge JJ, Premnath N, Jiang N, Daou D, Hu W, Ware SA, Tong D, Chung SS. TET2-Mutant Clonal Hematopoiesis Promotes Heart Failure With Preserved Ejection Fraction. Circulation. 2025 Jun 3;151(22):1622-1625. doi: 10.1161/CIRCULATIONAHA.124.072909. Epub 2025 Jun 2.
  • Wahood W, Takahashi EA, Lookstein R, Secemsky EA, DeMartino RR, Beckman J, Conte MS, Misra S. Perioperative Events Following Open Versus Endovascular Revascularization for Chronic Limb-Threatening Ischemia: An NSQIP Analysis. J Soc Cardiovasc Angiogr Interv. 2025 Apr 1;4(5):102579. doi: 10.1016/j.jscai.2025.102579. eCollection 2025 May.
  • Gertz ZM, Pibarot P, Zhou Z, Schonning MJ, Redfors B, Li Y, Kar S, Lim DS, Weissman NJ, Cohen DJ, Lindenfeld J, Abraham WT, Mack MJ, Asch FM, Stone GW. Forward Flow in Patients With Heart Failure and Functional Mitral Regurgitation: The COAPT Trial. J Soc Cardiovasc Angiogr Interv. 2025 Mar 26;4(5):102609. doi: 10.1016/j.jscai.2025.102609. eCollection 2025 May.
  • Wang TKM, Nicholls SJ, St John J, Wolski K, Nissen SE. Differential cardiovascular impact of omega-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial. Atherosclerosis. 2025 May 28:120228. doi: 10.1016/j.atherosclerosis.2025.120228.
  • Kunadian V, Pompei G, Dasgupta I, Swift P, Adamson D, Banerjee A, Guzik TJ, Hildick-Smith D, Garbi M, Laskar N, Anderson L, Zakeri R, Ahmed F, Rosen SD, Bannister C, Roberts E, Quail MA, Coats L, Page SP, Wicks E, Moorjani N, Loubani M, Probert H, Cowie A, Thakkar R, Moore J, Deshpande A, Augustine DX, Paton MF, Captur G, Singh A, Morgan H, Brown O, Ting FF, Hogan S, Sanders K, Ashton JR, Malkin R, Brown S, Arnold A, Rodas M, Zhecheva V, Ng GA. Strategies to enhance recruitment of female participants to cardiovascular research: a joint British Cardiovascular Societies’ consensus document in collaboration with the British Heart Foundation Clinical Research Collaborative. Heart. 2025 Jun 1:heartjnl-2024-325545. doi: 10.1136/heartjnl-2024-325545.
  • Kaur G, Gulati M. Where are the women? Fixing the broken pipeline in cardiovascular research. Heart. 2025 Jun 1:heartjnl-2025-325979. doi: 10.1136/heartjnl-2025-325979.
  • Taub PR, Greene SJ, Fudim M. The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment. Heart Fail Rev. 2025 May 31. doi: 10.1007/s10741-025-10520-3.
  • Dani SS, Makwana B, Khadke S, Kumar A, Jhund P, Nasir K, Sattar N, Al-Kindi S, Fonarow G, Butler J, Bhatt DL, Kosiborod MN, Nohria A, Ganatra S. An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists. JACC Adv. 2025 May;4(5):101740. doi: 10.1016/j.jacadv.2025.101740.
  • Piccoli GB, Ahmed SB, Fakhouri F, Garovic VD, Hladunewich MA, Jesudason S, Prakash J, Webster AC, Zakharova E, Cheung M, King JM, Jadoul M, Winkelmayer WC, Wyatt CM, Conference Participants. Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2025 May 27:S0085-2538(25)00246-7. doi: 10.1016/j.kint.2025.02.021.
  • Vidal-Cales P, Bujak K, Rinaldi R, Salazar-Rodriguez A, Ortega-Paz L, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, Jimenez-Quevedo P, Diletti R, Bordes P, Campo G, Silvestro A, Maristany J, Flores X, Miguel-Castro A, Iniguez A, Ielasi A, Tespili M, Lenzen M, Gonzalo N, Tebaldi M, Biscaglia S, Romaguera R, Gomez-Hospital JA, Serruys PW, Sabate M, Brugaletta S. [[Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial]]. REC Interv Cardiol. 2025 Jan 29;7(2):99-108. doi: 10.24875/RECIC.M24000491. eCollection 2025 Apr-Jun.
  • Barkas F, Brandts J, De Bacquer D, Jennings C, De Backer GG, Kotseva K, Ryden L, Lip GYH, Santos RD, Libby P, Erlund I, Ganly S, Vihervaara T, Adamska A, Abreu A, Almahmeed W, Ambari AM, Ge J, Hasan-Ali H, Huo Y, Jankowski P, Jimenez RM, Li Y, Mahmood Zuhdi AS, Makubi A, Mbakwem AC, Mbau L, Navarro Estrada JL, Ogah OS, Ogola EN, Quintero-Baiz A, Sani MU, Sosa Liprandi MI, Tan JWC, Urina Triana MA, Yeo TJ, Wood D, McEvoy JW, Ray KK, INTERASPIRE Investigators. Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies. J Am Coll Cardiol. 2025 Jun 3;85(21):2028-2042. doi: 10.1016/j.jacc.2025.04.010.
  • Erlinge D, Tsimikas S, Maeng M, Maehara A, Larsen AI, Engstrom T, Kjoller-Hansen L, Matsumura M, Ben-Yehuda O, Botker HE, Frobert O, Persson J, Wiseth R, Jensen LO, Nordrehaug JE, Trovik T, Jensen U, Bleie O, Omerovic E, James SK, Rylance R, Sharma T, Ali ZA, Stone GW. Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy. J Am Coll Cardiol. 2025 Jun 3;85(21):2011-2024. doi: 10.1016/j.jacc.2025.04.013.
  • Baudry G, Li G, Wang R, Newton RAV, Monzo L, Girerd N, Mocumbi A, Zannad F, Van Spall HGC. Global heart failure epidemiology versus enrolment in pivotal trials: A formidable mismatch. Eur J Heart Fail. 2025 May 28. doi: 10.1002/ejhf.3707.
  • Wanner C, Zhao MH, Amin AN, De Nicola L, Sauer AJ, Allum AM, Aranda U, Nam YS, Butler J. Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review. Adv Ther. 2025 May 28. doi: 10.1007/s12325-025-03228-1.
  • Neves JS, Vale C, Leite AR, Leite-Moreira A, Zannad F, Butler J, Packer M, Ferreira JP. GLP-1 Receptor Agonists in Heart Failure With Reduced Ejection Fraction: Meta-Analysis of Randomized Clinical Trials. JACC Heart Fail. 2025 May 28;13(7):102489. doi: 10.1016/j.jchf.2025.03.035.
  • Cioffi GM, Lamelas P, Shenouda M, Halperin J, Goffredo F, McGrath BP, Vega Servin NS, Mehta SR, Jolly SS, Schwalm JD, Natarajan MK, Valettas N, Velianou JL, Tsang MB, Pinilla-Echeverri N, Sibbald MG, Sheth TN. OCT-based diagnosis, management, and predictors of recurrent stent failure: a cohort study. Front Cardiovasc Med. 2025 May 13;12:1565676. doi: 10.3389/fcvm.2025.1565676. eCollection 2025.
  • Balinisteanu A, Rimbas RC, Nicula AI, Piroiu D, Dumitru A, Ene A, Vinereanu D. Multimodality Imaging Leading the Way to a Prompt Diagnosis and Management of Transthyretin Amyloidosis. J Clin Med. 2025 May 19;14(10):3547. doi: 10.3390/jcm14103547.
  • Kumbhani DJ, Pandey A. From Passive to Proactive: A Call to Action on Valve Disease Screening. Circulation. 2025 May 27;151(21):1508-1511. doi: 10.1161/CIRCULATIONAHA.125.074928. Epub 2025 May 27.
  • Di Giovanni G, Fujino M, Kataoka Y, Butters J, Hucko T, Puri R, Nissen SE, Nelson AJ, Psaltis PJ, Nicholls SJ. Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis. Eur J Prev Cardiol. 2025 Apr 8:zwaf211. doi: 10.1093/eurjpc/zwaf211.
  • Aroda VR, Perreault L. Overweight and Obesity – Capturing the Whole Picture. N Engl J Med. 2025 May 25. doi: 10.1056/NEJMe2505819.
  • Greene SJ, Kaltenbach LA, Fonarow GC, Chiswell K, Kittipibul V, Haywood HB, Khan MS, Hammill BG, Butler J, Hernandez AF, Felker GM. Clinical and financial implications of inpatient and outpatient management of worsening heart failure. Eur J Heart Fail. 2025 May 26. doi: 10.1002/ejhf.3702.
  • Moore HJ, Wu WC, Heidenreich PA, Rossignol P, Patel SS, Lu F, Lam PH, Ahmed AA, Faselis C, Butler J, Palant CE, Pitt B, Weir MR, Deedwania P, Atkins D, Raman VK, Rangaswami J, Vargas JD, Zhang S, Morgan CJ, Sheriff HM, Zeng-Treitler Q, Fonarow GC, Ahmed A. Higher Risk of Kidney Failure Associated with Angiotensin Receptor Blockers Versus ACE Inhibitors in Patients with Heart Failure. Am J Med. 2025 May 24:S0002-9343(25)00314-6. doi: 10.1016/j.amjmed.2025.05.024.
  • Balinisteanu A, Duchenne J, Puvrez A, Wouters L, Bezy S, Youssef A, Minten L, Bekhuis Y, Van Langenhoven L, Papangelopoulou K, Cieplucha A, Cattapan I, Tostes P, Bogaert J, Vinereanu D, Thomas JD, Badano L, Voigt JU. Vendor Differences in 2D-Speckle Tracking Global Longitudinal Strain: An Update on a Ten-Year Standardization Effort. Eur Heart J Cardiovasc Imaging. 2025 May 26:jeaf155. doi: 10.1093/ehjci/jeaf155.
  • Hentati F, Carroll BJ, Murphy TP, Murphy MR, Secemsky EA. Identifying predictors of durable treatment response among patients with claudication: A secondary analysis of the CLEVER trial. Vasc Med. 2025 May 26:1358863X251333932. doi: 10.1177/1358863X251333932.
  • Polymeris AA, Lioutas VA, Foster LD, Incontri D, Heistand E, Marchal J, Lazar A, Fischer U, Engelter S, Seiffge DJ, Yeatts SD, Selim M. Early neurological improvement with deferoxamine after intracerebral hemorrhage: a post hoc analysis of the i-DEF trial. Int J Stroke. 2025 May 26:17474930251348088. doi: 10.1177/17474930251348088.
  • Yokose C, McCormick N, Lu N, Jiang B, Tan K, Chigurupati S, Rai S, Challener G, Avina-Zubieta JA, Cipolletta E, Abhishek A, Gaffo A, Januzzi JL, Zhang Y, Choi HK. Comparative Cardiovascular Safety of NSAID versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients with Gout: Target Trial Emulations. Arthritis Rheumatol. 2025 May 26. doi: 10.1002/art.43259.
  • Mahowald MK, Ortega-Paz L, Laudani C, Angiolillo DJ. Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection. J Thromb Thrombolysis. 2025 May 26. doi: 10.1007/s11239-025-03114-1.
  • Iqbal S, Seth N, Shahraki T, Filippidis A, Selim M, Thomas AJ, Wen Y, Spincemaille P, Wang Y, Soman S. Clinical Performance of Quantitative Susceptibility Mapping in Cerebral Microbleed Detection Relative to 2D GRE. Clin Neuroradiol. 2025 May 23. doi: 10.1007/s00062-025-01529-0.
  • Sposato LA, Ayan D, Ahmed M, Fridman S, Mandzia JL, Elrayes M, Lodol F, Khaw AV, Mai LM, Bogiatzi C, Casserly C, Fraser JA, Chan R, Florendo Cumbermack A, Markovic N, Yu Y, Debicki D, Fleming L, Beauchamp B, Lambourn L, Mayich M, Milroy L, Sharma M, Pandey S, Bagur R. Extended CT angiography versus standard CT angiography for the detection of cardioaortic thrombus in patients with ischaemic stroke and transient ischaemic attack (DAYLIGHT): a prospective, randomised, open-label, blinded end-point trial. Lancet Neurol. 2025 Jun;24(6):489-499. doi: 10.1016/S1474-4422(25)00111-5.
  • Mnatzaganian CL, Gibson CM, Kipper L, Williams CR, Cat TB. The Preceptors’ Toolkit for Working with Struggling Pharmacy Students. Pharmacy (Basel). 2025 May 2;13(3):66. doi: 10.3390/pharmacy13030066.
  • Bongiovanni D, Landi A, Frigoli E, Heg D, Chalkou K, Bartunek J, Delorme L, Dewilde W, Hildick-Smith D, Leibundgut G, Leonardi S, Lesiak M, Kala P, Kedev S, Roffi M, Stankovic G, Tonino PAL, Velchev V, Vranckx P, Windecker S, Smits PC, Valgimigli M. Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR Patient. J Am Coll Cardiol. 2025 May 7:S0735-1097(25)06483-6. doi: 10.1016/j.jacc.2025.05.010.
  • Giao DM, Poluha AM, Secemsky EA, Krawisz AK. Endovascular renal denervation for the treatment of hypertension. Vasc Med. 2025 May 23:1358863X251322179. doi: 10.1177/1358863X251322179.
  • O’Reilly C, Craig JC, Cho Y, Crowe S, Gill JS, Hemmelgarn B, Howell M, Hughes A, Ju A, Manera K, Manns B, Pecoits-Filho R, Sautenet B, Scholes-Robertson N, Teixeira-Pinto A, Tugwell P, Van Biesen W, Viecelli AK, Wang AY, Winkelmayer WC, Wong G, Guha C, Jaure A. The Standardized Outcomes in Nephrology (SONG) initiative: a decade of harmonizing patient voices and research in kidney disease. Kidney Int. 2025 Jun;107(6):955-958. doi: 10.1016/j.kint.2025.02.016.
  • Charytan DM, Winkelmayer WC, Granger CB, Middleton JP, Herzog CA, Chertow GM, Eudicone JM, Whitson JD, Tumlin JA, ADAPT Investigators. Corrigendum to “Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.” Kidney International 2025;107:169-179. Kidney Int. 2025 Jun;107(6):1123. doi: 10.1016/j.kint.2025.03.009.
  • White HD, O’Brien SM, Boden WE, Fremes SE, Bangalore S, Reynolds HR, Stone GW, Ali ZA, Parakh N, Lopez-Sendon JL, Wang Y, Chen YQ, Mark DB, Chaitman BR, Spertus JA, Maron DJ, Hochman JS, ISCHEMIA Research Group. Use of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention and Associated Outcomes in the ISCHEMIA Trial. Am Heart J. 2025 May 20:S0002-8703(25)00165-6. doi: 10.1016/j.ahj.2025.05.009.
  • Rizvi SK, Dhruve R, Keshvani N, Hendren N, Chadha DS, Ramakrishnan S, Nandekar A, Dasgupta U, Segar MW, Vaduganathan M, Butler J, Bhograj C, Pandey A, Greene SJ. Remote Optimization of Guideline-Directed Medical Therapy Using Home Monitoring in Heart Failure: The GOALS-HF Study. J Card Fail. 2025 May 16:S1071-9164(25)00208-8. doi: 10.1016/j.cardfail.2025.05.005.
  • Tasdighi E, Dardari Z, Whelton SP, Patel J, Kanaya AM, Budoff MJ, Javaid A, Kulkarni S, Ma TW, Butler J, Shah NS, Blaha MJ, Agarwala A. Sex-Specific Coronary Artery Calcium Percentiles Across South Asian Adults: Combined Analyses From MASALA and DILWALE. JACC Adv. 2025 May 14:101779. doi: 10.1016/j.jacadv.2025.101779.
  • Nanna MG, Wojdyla D, Peterson ED, Navar AM, Williamson JD, Colantonio LD, Wang SY, Jamil Y, Bertoni AG, Nahid M, Damluji AA, Goyal P, Chaudhry SI, Gill TM, Alexander KP. Development and Validation of Models to Estimate the Incident Risk of Cognitive Impairment and Atherosclerotic Cardiovascular Disease in Older Adults. J Am Heart Assoc. 2025 Jun 3;14(11):e038949. doi: 10.1161/JAHA.124.038949. Epub 2025 May 22.
  • Polymeris AA, Lioutas VA, Marchina S, Seiffge DJ, Roh DJ, Poyraz FC, Selim MH, i-DEF Investigators. Hemoglobin and Perihematomal Edema After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial. Neurocrit Care. 2025 May 21. doi: 10.1007/s12028-025-02284-3.
  • Kelshiker MA, Bachtiger P, Mansell J, Kramer DB, Nakhare S, Almonte MT, Alrumayh A, Petri CF, Peters A, Costelloe C, Falaschetti E, Barton C, Al-Lamee R, Majeed A, Plymen CM, Peters NS. Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER): design and rationale for a decentralised, real-world cluster-randomised controlled trial and implementation study. BMJ Open. 2025 May 21;15(5):e098030. doi: 10.1136/bmjopen-2024-098030.
  • Petch J, Tabja Bortesi JP, Sheth T, Natarajan M, Pinilla-Echeverri N, Di S, Bangdiwala SI, Mosleh K, Ibrahim O, Bainey KR, Dobranowski J, Becerra MP, Sonier K, Schwalm JD. Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography for Low-Risk Patients Screened With Artificial Intelligence: Protocol for the CarDIA-AI Randomized Controlled Trial. JMIR Res Protoc. 2025 May 21;14:e71726. doi: 10.2196/71726.
  • Pabon MA, Vardeny O, Vaduganathan M, Desai AS, Claggett BL, Kulac IJ, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Saldarriaga CI, Petrie MC, Merkely B, Borentain M, Mueller K, Viswanathan P, Amarante F, Morris A, McMurray JJV, Solomon SD. Finerenone in Heart Failure With Improved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025 May 21:e251101. doi: 10.1001/jamacardio.2025.1101.
  • Revoori R, McEvoy JW, McCarthy CP. Regulatory Approval vs Guideline Endorsement of Novel BP-Lowering Treatments. JAMA Cardiol. 2025 May 21. doi: 10.1001/jamacardio.2025.1365.
  • Goto S, Yamasawa D, Goto S. Regional Heterogeneity in the Risk of Thrombosis and Bleeding in Patients With Peripheral Artery Disease. JACC Asia. 2025 May 7:S2772-3747(25)00195-4. doi: 10.1016/j.jacasi.2025.03.007.
  • Nicholls SJ, Nelson AJ. Current perspectives on Lp(a) lowering therapies: Who may benefit? Kardiol Pol. 2025 May 21. doi: 10.33963/v.phj.106327.
  • Xu X, Yang X, Zhang J, Wang Y, Selim M, Zheng Y, Shen R, Sun L, Huang Q, Wang W, Xu W, Guan Y, Liu J, Deng Y, Xie F, Li B, Alzheimer’s Disease Neuroimaging Initiative (ADNI). Choroid plexus free-water correlates with glymphatic function in Alzheimer’s disease. Alzheimers Dement. 2025 May;21(5):e70239. doi: 10.1002/alz.70239.
  • Fiolet ATL, Lin A, Kwiecinski J, Tutein Nolthenius J, McElhinney P, Grodecki K, Kietselaer B, Opstal TS, Cornel JH, Knol RJ, Schaap J, Aarts RAHM, Tutein Nolthenius AMFA, Nidorf SM, Velthuis BK, Dey D, Mosterd A. Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial. Heart. 2025 May 29:heartjnl-2024-325527. doi: 10.1136/heartjnl-2024-325527.
  • Taub PR, Gutierrez A, Wewers D, Garcia Cantu E, Cao H, Deck C, Lesogor A, Ott D, Mena-Madrazo J, Zang X, Wright RS. Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD: The VICTORION-Mono Randomized Clinical Trial. J Am Coll Cardiol. 2025 May 5:S0735-1097(25)06392-2. doi: 10.1016/j.jacc.2025.04.049.
  • Dastmalchi LN, Gulati M, Thurston RC, Lau E, Sarma A, Marfori CQ, Gaffey AE, Faubion S, Laddu D, Shufelt CL, Sharma G. Improving Cardiovascular Clinical Competencies for the Menopausal Transition: A Focus on Cardiometabolic Health in Midlife. JACC Adv. 2025 May 15:101791. doi: 10.1016/j.jacadv.2025.101791.
  • Baudry G, Girerd N, Duarte K, Monzo L, Delmas C, Van Spall HGC, Kimmoun A, Levy B. Sex-Related Prognosis of VA-ECMO-Treated Cardiogenic Shock: A Post-Hoc Analysis of the HYPO-ECMO Trial. Circ Heart Fail. 2025 May 20. doi: 10.1161/CIRCHEARTFAILURE.124.012702.
  • Ormiston CK, Pazargadi A, Rosander A, Ceballos G, Villarreal F, Taub PR. Enhancement of Statin Effects on Lipid Lowering and Reduction of Cardiovascular Risk Score by (-)-Epicatechin in Proof-of-Concept Pilot Study. Clin Transl Sci. 2025 May;18(5):e70236. doi: 10.1111/cts.70236.
  • Baron SJ, Chou JC, Shah T, Vest AR  paragraph sign, Abbott JD, Alasnag M dagger, Aurigemma C dagger, Barbato E dagger, Bellumkonda L, Bortnick AE double dagger, Chieffo A dagger, van Geuns RJ dagger, Grines CL, Halvorsen S  section sign, Hassager C  section sign, Kapur NK, Naidu SS, Ng VG, Saw J, Lansky AJ. SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women. EuroIntervention. 2025 May 20:EIJ-D-24-01126. doi: 10.4244/EIJ-D-24-01126.
  • Nicholas SB, Kornowske LM, Jones CR, Daratha KB, Alicic RZ, Reynolds CL, Neumiller JJ, Bensink ME, Gong W, Norris KC, Tuttle KR. Population Risk Predictors of Major Adverse Kidney Events in Patients with Focal Segmental Glomerulosclerosis from the CURE-CKD Registry. Res Sq [Preprint]. 2025 May 6:rs.3.rs-5844460. doi: 10.21203/rs.3.rs-5844460/v1.
  • O’Reilly RL, Harraka P, Burke J, Belluoccio D, Yeh P, Howlett K, Behrouzfar K, Rewse A, Tsimiklis H, Giles GG, Hopper JL, Bubb KJ, Nicholls SJ, Milne RL, Southey MC. Smart Nonuniformity: Calibration of Sequencing Depth of a Targeted Gene Panel to Simultaneously Detect Somatic and Germline Variants. J Mol Diagn. 2025 May 15:S1525-1578(25)00117-5. doi: 10.1016/j.jmoldx.2025.04.007.
  • Maron MS, Gimeno JR, Veselka J, Barriales-Villa R, Claggett BL, Coats CJ, Hegde SM, Januzzi JL, Kulac IJ, Masri A, Nassif ME, Spertus JA, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Wohltman A, Olivotto I, SEQUOIA-HCM Investigators. Efficacy of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy and Mild Symptoms: Results from the SEQUIOA-HCM Trial. Eur Heart J. 2025 May 17:ehaf364. doi: 10.1093/eurheartj/ehaf364.
  • Cunningham JW, Claggett BL, Vaduganathan M, Desai AS, Jhund PS, Lam CSP, Senni M, Shah S, Voors A, Zannad F, Pitt B, Amarante F, Lay-Flurrie J, Rohwedder K, Goea L, Berger M, McMurray JJV, Solomon SD. Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial. Eur J Heart Fail. 2025 May 16. doi: 10.1002/ejhf.3694.
  • Chimura M, Yang M, Henderson AD, Jhund PS, Docherty KF, Claggett BL, Desai AS, Filippatos G, Gajos G, Mueller K, Glasauer A, Rohwedder K, Viswanathan P, Lam CSP, Sato N, Senni M, Voors AA, Zannad F, Yilmaz MB, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV,  on behalf of the FINEARTS-HF Committees and Investigators. Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial. Eur J Heart Fail. 2025 May 16. doi: 10.1002/ejhf.3682.
  • Gitto M, Baber U, Sartori S, Vogel B, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dudek D, Oliva A, Escaned J, Feng Y, Gibson CM, Han YL, Di Muro FM, Shlofmitz RA, Huber K, Steg PG, Sharma S, Sardella G, Kastrati A, Kaul U, Kornowski R, Kunadian V, Stefanini GG, Mehta SR, Dangas G, Mehran R. Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial. EuroIntervention. 2025 May 16;21(10):550-559. doi: 10.4244/EIJ-D-24-00973.
  • Januzzi JLJ, Sattar N, Vaduganathan M, Magaret CA, Rhyne RF, Liu Y, Masson S, Butler J, Hansen MK. A validated multivariable machine learning model to predict cardio-kidney risk in diabetic kidney disease. Cardiovasc Diabetol. 2025 May 15;24(1):213. doi: 10.1186/s12933-025-02779-5.
  • Abdelaziz A, Elshahat A, Gadelmawla AF, Desouky M, Hafez AH, Abdelaziz M, Hammad N, Eldosoky D, Bhatia K, Filtz A, Lorenzatti D, Kuno T, Virani SS, Gulati M, Shapiro MD, Lavie CJ, Slipczuk L. Sex Differences in the Impact of Exercise Volume on Subclinical Coronary Atherosclerosis: A Meta-Analysis. JACC Adv. 2025 May 14;4(6 Pt 1):101786. doi: 10.1016/j.jacadv.2025.101786.
  • Galli M, Angiolillo DJ. Direct oral anticoagulants in stroke prevention of atrial fibrillation patients: can we rely on them in all clinical scenarios? Future Cardiol. 2025 May 15:1-3. doi: 10.1080/14796678.2025.2506915.
  • Higashi RT, Thakur B, Repasky EC, Casillas A, Steitz BD, Hogan TP, Lehmann CU, Peterson ED, Navar AM, Turer RW. Digital Health Technology Use Among Spanish Speakers in the US: A Scoping Review. JAMA Netw Open. 2025 May 1;8(5):e2510386. doi: 10.1001/jamanetworkopen.2025.10386.
  • Mohammadnia N, Wesselink BE, Bax WA, Nidorf SM, Mosterd A, Fiolet ATL, Cetinyurek-Yavuz A, Thompson PL, Bangdiwala SI, Eikelboom JW, Cornel JH, El Messaoudi S. Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial. J Am Heart Assoc. 2025 May 20;14(10):e038687. doi: 10.1161/JAHA.124.038687. Epub 2025 May 15.
  • Khan SU, Pandey A, Nasir K. Individual Variability in the Cardiometabolic Response to Tirzepatide: Moving Beyond the Average. J Am Coll Cardiol. 2025 May 20;85(19):1873-1875. doi: 10.1016/j.jacc.2025.04.004.
  • Galli M, Terracina S, Schiera E, De Corci S, Sangiorgi D, Mancone M, Frati L, Sciarretta S, Angiolillo DJ, Pulcinelli FM. Sex-Related Variations in Platelet Reactivity in Presence or Absence of Antiplatelet Therapy. Eur Heart J Cardiovasc Pharmacother. 2025 May 14:pvaf034. doi: 10.1093/ehjcvp/pvaf034.
  • Patel L, Segar MW, Usman MS, Dhruve R, Keshvani N, Postalian A, Mentias A, Rubin CD, Patel KV, Kumbhani DJ, Banerjee S, Pandey A. Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials. J Am Geriatr Soc. 2025 May 14. doi: 10.1111/jgs.19508.
  • Greene SJ, Gaggin HK, Bash LD, Lautsch D, Song Y, Zhou M, Signorovitch J, Stevenson AS, Blaustein RO, Butler J. Cardiologist-Reported Reasons for Not Titrating Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction. J Card Fail. 2025 May 11:S1071-9164(25)00206-4. doi: 10.1016/j.cardfail.2025.04.010.
  • Chertow GM, Eckardt KU, Sarnak MJ, Winkelmayer WC, Agarwal R, Minga T, Luo W, Burke SK. Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States. J Am Soc Nephrol. 2025 May 13. doi: 10.1681/ASN.0000000708.
  • Goel SS, Guha A, Lindenfeld J, Abraham WT, Kar S, Kapadia SR, Little SH, Lim DS, Reardon MJ, Kleiman NS, Aiyer J, Kotinkaduwa L, Mack M, Stone GW. Impact of Natriuretic Peptide and Prior Hospitalization in Patients With Severe Mitral Regurgitation: COAPT Trial. Circ Cardiovasc Interv. 2025 May 13:e015192. doi: 10.1161/CIRCINTERVENTIONS.125.015192.
  • Lalani C, Sharma RK, Sevilla-Cazes J, Kennedy K, Butala NM, Secemsky EA, Pinto D, Poulin MF, Laham R, Kolte D, Cohen DJ, Yeh RW. Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the CathPCI Registry. Am J Cardiol. 2025 May 10;251:18-24. doi: 10.1016/j.amjcard.2025.05.006.
  • Sattar N, Weerakkody GJ, McGuire DK, Kosiborod MN, Lee MMY, Welsh P, Pearson ER, Wiese RJ, Duffin K, Wilson J, Pavo N, Hulsmann M, Pavo I. The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4. Circulation. 2025 May 13;151(19):1430-1432. doi: 10.1161/CIRCULATIONAHA.124.072889. Epub 2025 May 12.
  • Clark AJ, Flores BM, Saade MC, Vu KQ, Pence IJ, Berg A, Parikh SM. Pediatric acute kidney injury is associated with impairment in nicotinamide adenine dinucleotide (NAD+) metabolism. Pediatr Nephrol. 2025 May 12. doi: 10.1007/s00467-025-06791-5.
  • Tang AB, Lewsey SC, Yancy CW, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Thomas K, Fonarow GC. Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead. Circ Heart Fail. 2025 May 12:e012936. doi: 10.1161/CIRCHEARTFAILURE.125.012936.
  • Roger G, Packard CJ, Masana L, Laufs U, Catapano AL, Steg PG. Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia. Heart. 2025 May 10:heartjnl-2025-325765. doi: 10.1136/heartjnl-2025-325765.
  • Garan AR, Bhimaraj A, Kataria R, Rali A, Grandin EW, Delgado A, Kochar A, Li B, Kanwar MK, Sinha SS, Hernandez-Montfort J, Abraham J, Li S, Arias-Mendoza A, Bezerra H, Blumer V, Chiang IH, Farr MJ, Fried J, Gage A, Hall S, Hickey GW, Ilonze O, Guglin M, Khalife W, Kim J, Lundgren S, Marbach J, Mishkin J, Nathan S, Pahuja M, Schwartzman A, Ton VK, Vishnevsky OA, Vorovich E, Wald J, Zweck E, Kong Q, Sangal P, Walec KD, Zazzali P, Harwani NM, John K, Mahr C, Burkhoff D, Kapur NK. Outcomes with Femoral IABP in Heart failure and Acute Myocardial Infarction Related Cardiogenic Shock. J Card Fail. 2025 May 8:S1071-9164(25)00199-X. doi: 10.1016/j.cardfail.2025.04.007.
  • Sarraju A, Brennan D, Hayden K, Stronczek A, Goldberg AC, Michos ED, McGuire DK, Mason D, Tercek G, Nicholls SJ, Kling D, Neild AL, Kastelein J, Davidson M, Ditmarsch M, Nissen SE. Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2025 May 17;405(10491):1757-1768. doi: 10.1016/S0140-6736(25)00721-4. Epub 2025 May 7.
  • Gagnon E, Gill D, Bourgault J, Gobeil E, Mitchell PL, Girard A, Paulin A, Couture C, Bosse Y, Theriault S, Mathieu P, Vohl MC, Tchernof A, Ray KK, Kastelein JJP, Arsenault BJ. RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: A drug-target Mendelian randomization study. Cardiovasc Res. 2025 May 10:cvaf078. doi: 10.1093/cvr/cvaf078.
  • Bate AP, Psaltis PJ, Nicholls SJ, Nelson AJ. Upfront Combination Therapy for LDL-C Lowering in Acute Coronary Syndrome: The Rule Rather than the Exception? Heart Lung Circ. 2025 May;34(5):409-411. doi: 10.1016/j.hlc.2025.04.076.
  • Wang JY, Vu S, McGuinness M, Barrette R, Trudeau S, Price H, Zimetbaum P, Selim M, Dearborn-Tomazos J. Factors associated with increased atrial fibrillation detection in patients with embolic stroke of undetermined source. J Stroke Cerebrovasc Dis. 2025 Jul;34(7):108343. doi: 10.1016/j.jstrokecerebrovasdis.2025.108343. Epub 2025 May 7.
  • Celia AI, Vescovo GM, Sarto G, Alessandri C, Iaconelli A, D’Amario D, Frati G, Conti F, Sciarretta S, Angiolillo DJ, Fava A, Petri MA, Bikdeli B, Galli M. Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis. Semin Arthritis Rheum. 2025 May 1;73:152741. doi: 10.1016/j.semarthrit.2025.152741.
  • Singh A, Shiyovich A, Freire CV, Peng G, Besser SA, Berman AN, Weber BN, Huck DM, Cardoso R, McCarthy CP, Nasir K, DiCarli MF, Bhatt DL, Blankstein R. Performance of PREVENT equations for cardiovascular risk prediction in young patients with myocardial infarction: From the MGB YOUNG-MI registry. Am J Prev Cardiol. 2025 Apr 12;22:100992. doi: 10.1016/j.ajpc.2025.100992. eCollection 2025 Jun.
  • Sussman TA, Giobbie-Hurder A, Dryg ID, Manos M, Weirather JL, LeBoeuf NR, Hodi FS, Connors JM. Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis. J Immunother Cancer. 2025 May 7;13(5):e010761. doi: 10.1136/jitc-2024-010761.
  • Malas K, Kazmi S, Kang YM, McGuire DK. The contemporary landscape of cardiovascular optimization in type 2 diabetes: overcoming barriers to evidence-based use of newer antihyperglycemic agents. Expert Opin Pharmacother. 2025 May 13:1-12. doi: 10.1080/14656566.2025.2504702.
  • Kronenberg F, Bedlington N, Ademi Z, Geanta M, Silberzahn T, Rijken M, Kaal A, Harada-Shiba M, Chen Z, Thanassoulis G, Eliasen B, Eisele JL, Wiegman A, Ballantyne CM, Broome E, Calabro M, Corral P, Dol A, Donato LJ, Evans E, Funabashi S, Gouni-Berthold I, Ibarluzea IG, Johnson N, Lane J, Mora S, Nordestgaard BG, Pecin I, Kaal-Poppelaars R, Langlois MR, Ray KK, Rodenbach A, Santos RD, Stroes ESG, Tada H, Vrablik M, Winokur M, Yoshida M, Nicholls SJ, Daccord M. The Brussels International Declaration on Lipoprotein(a) Testing and Management. Atherosclerosis. 2025 Jul;406:119218. doi: 10.1016/j.atherosclerosis.2025.119218. Epub 2025 May 5.
  • Blumer V, Januzzi JL Jr, Liu Y, Butler J, Ezekowitz JA, Perfetti R, Rosenstock J, Del Prato S, Tang WHW, Urbinati A, Zannad F, Lewis GD, Solomon SD, Hedge S, Ibrahim NE, Lam CSP. Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study. JACC Heart Fail. 2025 May 8:102433. doi: 10.1016/j.jchf.2025.02.015.
  • Cotoban AG, Mahabadi AA, Rassaf T, Vinereanu D, Al-Rashid F. Comparative Profiles and Invasive Management of Patients With High-Risk Non-ST Elevation Acute Coronary Syndromes in Two University Hospitals From Romania and Germany. Am J Ther. 2025 May-Jun 01;32(3):e234-e241. doi: 10.1097/MJT.0000000000001864.
  • Nicholls SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, Ballantyne CM, Ray KK, Navar AM, Nissen SE, Harada-Shiba M, Curcio DL, Neild A, Kling D, Hsieh A, Butters J, Ference BA, Laufs U, Banach M, Mehran R, Catapano AL, Huo Y, Szarek M, Balinskaite V, Davidson MH, BROADWAY Investigators. Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. N Engl J Med. 2025 May 7. doi: 10.1056/NEJMoa2415820.
  • Ferreira JP, Anker SD, Butler J, Filippatos G, Januzzi JL Jr, Schueler E, Panova-Noeva M, Wetzel K, Prochaska J, Pocock SJ, Sattar N, Sumin M, Zannad F, Packer M. Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR Program. J Am Coll Cardiol. 2025 May 13;85(18):1757-1770. doi: 10.1016/j.jacc.2025.03.503.
  • Ahmed-Jushuf F, Foley MJ, Rajkumar CA, Chotai S, Simader FA, Wang D, Macierzanka K, Sehmi J, Kanaganayagam G, Lloyd G, Keenan N, Bual N, Davies JR, Keeble TR, O’Kane PD, Haworth P, Routledge H, Kotecha T, Williams R, Din J, Nijjer SS, Curzen N, Sinha M, Ruparelia N, Gamma R, Spratt JC, Cole GD, Harrell FE Jr, Howard JP, Francis DP, Shun-Shin MJ, Al-Lamee RK, ORBITA-2 Investigators. Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial. J Am Coll Cardiol. 2025 May 13;85(18):1740-1753. doi: 10.1016/j.jacc.2025.02.034.
  • Molina EJ, Mehra MR. Reply: Small Left Ventricular Cavity Size and Big Risks for Females on Durable LVAD Support. JACC Heart Fail. 2025 May;13(5):885. doi: 10.1016/j.jchf.2025.03.020.
  • Goldenberg I, Ezekowitz JA, Butler J. Revisiting ICD Therapy for Primary Prevention: The CONTEMP-ICD Trial. JACC Heart Fail. 2025 May;13(5):880. doi: 10.1016/j.jchf.2025.01.031.
  • Faridi KF, Huang H, Parise H, Ahmad T, Mori M, Chung M, Yeh RW, Petrie MC, Panza JA, Rouleau JL, Dabrowski R, Velazquez EJ. Days Alive Out of Hospital for Patients with Left Ventricular Dysfunction: From the STICH Trial. JACC Heart Fail. 2025 May;13(5):867-869. doi: 10.1016/j.jchf.2025.02.019.
  • Nicholls SJ, Nicholls EG. Expanding Our Understanding of Plaque Stabilization With PCSK9 Inhibitors. JACC Cardiovasc Imaging. 2025 May;18(5):600-601. doi: 10.1016/j.jcmg.2025.02.005.
  • Romeo S, Vidal-Puig A, Husain M, Ahima R, Arca M, Bhatt DL, Diehl AM, Fontana L, Foo R, Fruhbeck G, Kozlitina J, Lonn E, Pattou F, Plat J, Quaggin SE, Ridker PM, Ryden M, Segata N, Tuttle KR, Verma S, Roeters van Lennep J, Benn M, Binder CJ, Jamialahmadi O, Perkins R, Catapano AL, Tokgozoglu L, Ray KK, European Atherosclerosis Society Consensus. Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement. Eur Heart J. 2025 May 7:ehaf314. doi: 10.1093/eurheartj/ehaf314.
  • Winkelmayer WC, Burke SK, Chertow GM, Eckardt KU, Luo W, Minga T, Sarnak MJ, Roy-Chaudhury P. Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO(2)VATE Trial Program. Kidney Med. 2025 Mar 19;7(5):100997. doi: 10.1016/j.xkme.2025.100997. eCollection 2025 May.
  • Sampath-Kumar R, Mohammad M, von Koch S, Reeves R, Al Khiami B, Ang L, Melendez A, Mahmud E, Ben-Yehuda O, Erlinge D. Practice patterns and percutaneous coronary intervention outcomes: a comparison between Sweden and the US. Eur Heart J Open. 2025 Apr 18;5(3):oeaf045. doi: 10.1093/ehjopen/oeaf045. eCollection 2025 May.
  • Savarese G, Schiattarella GG, Lindberg F, Anker MS, Bayes-Genis A, Back M, Braunschweig F, Bucciarelli-Ducci C, Butler J, Cannata A, Capone F, Chioncel O, D’Elia E, Gonzalez A, Filippatos G, Girerd N, Hulot JS, Lam CSP, Lund LH, Maack C, Moura B, Petrie MC, Piepoli M, Shehab A, Yilmaz MB, Seferovic P, Tocchetti CG, Rosano GMC, Metra M. Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2025 May 6. doi: 10.1002/ejhf.3676.
  • Rashid AM, Khan MS, Cherney DZI, Mehta A, Rangaswami J, Shafi T, Butler J. Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes. J Am Soc Nephrol. 2025 May 6. doi: 10.1681/ASN.0000000752.
  • Costa F, Salinas P, Iannaccone M, Cerrato E, Marquez DT, Misra S, Gotzinger F, Carciotto G, Silipigni S, Becerra-Munoz VM, Mennuni M, Stagno A, Bottari A, Pavani M, Varbella F, Alonso-Briales JH, Jurado-Roman A, Secemsky EA, Mahfoud F, Micari A. Catheter-based techniques for pulmonary embolism treatment. EuroIntervention. 2025 May 5;21(9):e450-e462. doi: 10.4244/EIJ-D-24-00535.
  • Philbin SE, Gleason LP, Persell SD, Walter E, Petito LC, Tibrewala A, Yancy CW, Beidas RS, Wilcox JE, Mutharasan RK, Lloyd-Jones D, O’Brien MJ, Kho AN, McHugh MC, Smith JD, Ahmad FS. Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally Qualified Health Centers: A Thematic Qualitative Analysis. J Gen Intern Med. 2025 May 5. doi: 10.1007/s11606-025-09515-5.
  • Bryan AD, Skrzynski CJ, Giordano G, Yang J, Stanger M, Bidwell LC, Hutchison KE, Perreault L. Cannabis Use is Associated with Less Peripheral Inflammation but Similar Insulin Sensitivity as Nonuse in Healthy Adults. Am J Med. 2025 May 3:S0002-9343(25)00281-5. doi: 10.1016/j.amjmed.2025.05.002.
  • Gold MR, Abraham WT, Butler J, Zile MR, Kahwash R, Gerritse B, Linde C. Win ratio analysis of the REVERSE cardiac resynchronization trial. Heart Rhythm. 2025 May 3:S1547-5271(25)02407-5. doi: 10.1016/j.hrthm.2025.04.059.
  • Khairallah P, Liu S, Montez-Rath ME, Erickson KF, Chang TI, Winkelmayer WC. Association Between Parathyroid Hormone Concentration and Incident Atrial Fibrillation in Older Persons with Kidney Failure Initiating Dialysis. Am J Nephrol. 2025 May 5:1-18. doi: 10.1159/000546266.
  • Metra M, Tomasoni D, Adamo M, Anker SD, Bayes-Genis A, von Bardeleben RS, Bohm M, Donal E, Filippatos GS, Maisano F, Ponikowski P, Savarese G, Praz F, Butler J. Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions. Circulation. 2025 May 6;151(18):1342-1363. doi: 10.1161/CIRCULATIONAHA.124.070411. Epub 2025 May 5.
  • Genereux P, Pellikka PA, Lindman BR, Pibarot P, Garcia S, Koulogiannis KP, Rodriguez E, Thourani VH, Dobbles M, Giustino G, Sharma RP, Cohen DJ, Schwartz A, Leon MB, Gillam LD. Acute Valve Syndrome in Aortic Stenosis. Struct Heart. 2024 Oct 28;9(4):100377. doi: 10.1016/j.shj.2024.100377. eCollection 2025 Apr.
  • Chioncel O, Mebazaa A, Farmakis D, Abdelhamid M, Lund LH, Harjola VP, Anker S, Filippatos G, Ben-Gal T, Damman K, Skouri H, Antohi L, Collins SP, Adamo M, Miro O, Hill L, Parissis J, Moura B, Mueller C, Jankowska E, Lopatin Y, Dunlap M, Volterrani M, Fudim M, Flammer AJ, Mullens W, Pang PS, Tica O, Ponikowski P, Ristic A, Butler J, Savarese G, Cicoira M, Thum T, Bayes Genis A, Polyzogopoulou E, Seferovic P, Yilmaz MB, Rosano G, Coats AJS, Metra M. Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2025 May 4. doi: 10.1002/ejhf.3673.
  • Cotter G, Petrie MC, Butler J, Davison B, Chioncel O, Biegus J, Pagnesi M, Voors AA, Metra M, Ponikowski P, Mann D, Bhatt DL. Obesity and inflammation in chronic and acute heart failure. Heart Fail Rev. 2025 May 3. doi: 10.1007/s10741-025-10518-x.
  • Mohammadnia N, van Broekhoven A, Bax WA, Eikelboom JW, Mosterd A, Fiolet ATL, Tijssen JGP, Thompson PL, de Kleijn DPV, Tsimikas S, Cornel JH, Yeang C, El Messaoudi S. Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort. Atherosclerosis. 2025 Jun;405:119211. doi: 10.1016/j.atherosclerosis.2025.119211. Epub 2025 Apr 26.
  • Siddiqi TJ, Liu Y, Zannad F, Tang WHW, Solomon S, Rosenstock J, Perfetti R, Marwick TH, Lewis GD, Lam CSP, Ibrahim NE, Ezekowitz J, Del Prato S, Butler J, Januzzi JL. Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF. J Diabetes Complications. 2025 Jul;39(7):109059. doi: 10.1016/j.jdiacomp.2025.109059. Epub 2025 Apr 25.
  • Santos RD, Ray KK, De Bacquer D, Jennings C, Kotseva K, Ryden L, Lip GYH, Erlund I, Ganly S, Vihervaara T, Adamska A, Abreu A, Almahmeed W, Ambari AM, Ge J, Hasan-Ali H, Huo Y, Jankowski P, Jimenez RM, Li Y, Mahmood Zuhdi AS, Makubi A, Mbakwem AC, Mbau L, Navarro Estrada JL, Ogah OS, Ogola EN, Quintero-Baiz A, Sani MU, Sosa Liprandi MI, Chieh Tan JW, Urina-Triana MA, Yeo TJ, Wood D, McEvoy JW, Libby P, INTERASPIRE Investigators. Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE. Atherosclerosis. 2025 Jun;405:119215. doi: 10.1016/j.atherosclerosis.2025.119215. Epub 2025 Apr 24.
  • Hwang J, Peterson ED, Gupta A, Decicco E, Sarnes E, Navar AM. Prescriber Uptake and Use of Novel Lipid-Lowering Therapies. J Am Heart Assoc. 2025 May 6;14(9):e040768. doi: 10.1161/JAHA.125.040768. Epub 2025 May 2.
  • d’Entremont MA, Poorthuis MHF, Fiolet ATL, Amarenco P, Boczar KE, Buysschaert I, Chan NC, Cornel JH, Jannink J, Jansen S, Kedev S, Keech AC, Layland J, Mewton N, Montalescot G, Pascual-Figal DA, Rodriguez AE, Shah B, Teraa M, van Zelm A, Wang Y, Mosterd A, Kelly P, Eikelboom J, Jolly SS. Colchicine for secondary prevention of vascular events: a meta-analysis of trials. Eur Heart J. 2025 May 2:ehaf210. doi: 10.1093/eurheartj/ehaf210.
  • Vranckx P, Morrow DA, van Diepen S, Verbrugge FH. Breaking barriers, bridging gaps, and redefining acute cardiovascular care: May issue highlights. Eur Heart J Acute Cardiovasc Care. 2025 May 16;14(5):257-258. doi: 10.1093/ehjacc/zuaf062.
  • Burgess S, Cader FA, Gulati M, Sutton NR, Appelman Y, Banerjee S. Challenges in diagnosing coronary microvascular dysfunction and coronary vasospasm. Cardiovasc Revasc Med. 2025 Apr 17:S1553-8389(25)00176-9. doi: 10.1016/j.carrev.2025.04.025.
  • Ilori EO, Cai CR, Sahor F, Wilson B, Veeramachaneni T, Parikh SM, Hashim IA. Performance of the 2021 Estimated Glomerular Filtration Rate CKD-EPI Refit and the European Kidney Function Consortium (EKFC) Formulas. Diagnostics (Basel). 2025 Apr 21;15(8):1047. doi: 10.3390/diagnostics15081047.
  • Williams MS, Levine GN, Kalra D, Agarwala A, Baptiste D, Cigarroa JE, Diekemper RL, Foster MV, Gulati M, Henry TD, Itchhaporia D, Lawton JS, Newby LK, Rogers KC, Soni K, Tamis-Holland JE. 2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. J Am Coll Cardiol. 2025 Apr 22:S0735-1097(25)00282-7. doi: 10.1016/j.jacc.2025.02.001.
  • Mathias RA, Velkoska E, Didichenko SA, Greene BH, Tan X, Navdaev AV, Collins HL, Adelman SJ, Young K, Gille A, Duffy D, Gibson CM, Pelzing M, Kingwell BA. Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol Transport. JACC Basic Transl Sci. 2025 Apr;10(4):405-418. doi: 10.1016/j.jacbts.2024.11.001. Epub 2024 Nov 15.
  • Pabon MA, Filippatos G, Claggett BL, Miao MZ, Desai AS, Jhund PS, Henderson A, Brinker M, Schloemer P, Hofmeister L, Li L, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Vaduganathan M. Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis. J Am Coll Cardiol. 2025 May 6;85(17):1649-1660. doi: 10.1016/j.jacc.2025.03.429. Epub 2025 Mar 17.
  • Williams MS, Levine GN, Kalra D, Agarwala A, Baptiste D, Cigarroa JE, Diekemper RL, Foster MV, Gulati M, Henry TD, Itchhaporia D, Lawton JS, Newby LK, Rogers KC, Soni K, Tamis-Holland JE. 2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. Circ Cardiovasc Qual Outcomes. 2025 Apr 30:e000140. doi: 10.1161/HCQ.0000000000000140.
  • Chan B, Varghese A, Badve SV, Pecoits-Filho R, Guedes M, Arnott C, Kozor R, O’Lone E, Jun M, Kotwal S, Block GA, Chertow GM, Solomon SD, Vaduganathan M, Perkovic V, Neuen BL. Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD. Kidney Int Rep. 2025 Jan 29;10(4):1037-1049. doi: 10.1016/j.ekir.2025.01.029. eCollection 2025 Apr.
  • Kondo T, Jhund PS, Henderson AD, Claggett BL, Desai AS, Brinker M, Lay-Flurrie J, Schloemer P, Viswanathan P, Amarante F, Chiang CE, Filippatos G, Lam CSP, Petrie MC, Senni M, Schou M, Verma S, Voors AA, von Lewinski D, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF. Eur J Heart Fail. 2025 Apr 29. doi: 10.1002/ejhf.3669.
  • Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M, Nosko A, Stas A, Kluge S, Jarczak D, Deheer G, Rybczynski M, Bayes-Genis A, Edelmann F, Filippatos G, Hasenfuss G, Haverkamp W, Lainscak M, Landmesser U, Macdougall IC, Merkely B, Pieske BM, Pinto FJ, Rassaf T, Volterrani M, von Haehling S, Anker MS, Doehner W, Ince H, Koehler F, Savarese G, Rauch-Krohnert U, Gori T, Trenkwalder T, Akin I, Paitazoglou C, Kobielusz-Gembala I, Zmuda W, Kuthi L, Frey N, Licka M, Kaab S, Laugwitz KL, Ponikowski P, Karakas M. Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials. Eur J Heart Fail. 2025 Apr 29. doi: 10.1002/ejhf.3658.
  • Sarkies MN, Watts GF, Gidding SS, Santos RD, Hegele RA, Raal FJ, Sturm AC, Al-Rasadi K, Blom DJ, Daccord M, de Ferranti SD, Folco E, Libby P, Mata P, Nawawi HM, Ramaswami U, Ray KK, Yamashita S, Pang J, Thompson GR, Jones LK. Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice. Am J Prev Cardiol. 2025 Apr 14;22:100993. doi: 10.1016/j.ajpc.2025.100993. eCollection 2025 Jun.
  • Mihailidou AS, Gulati M. Impact of climate change and the environment on cardiovascular health and role of healthcare. Am Heart J Plus. 2025 Feb 20;52:100510. doi: 10.1016/j.ahjo.2025.100510. eCollection 2025 Apr.
  • Castagna F, Desai AS, Mehra MR. DanGerous Extrapolations Within and Beyond STEMI Cardiogenic Shock. JACC Heart Fail. 2025 Apr 26:102474. doi: 10.1016/j.jchf.2025.04.004.
  • Rikken SAOF, Gibson CM, Bahit MC, Duffy D, Chi G, Korjian S, Mohammadnia N, White H, Anschuetz G, Kingwell BA, Ophuis TO, Nicolau JC, Lopes RD, Lewis BS, El Messaoudi S, Vinereanu D, Ten Berg JM, Goodman SG, Bode C, Steg PG, Libby P, Bainey KR, van ‘t Hof AWJ, Ridker PM, Mahaffey KW, Nicholls SJ, Mehran R, Harrington RA, Cornel JH, AEGIS-II Committees and Investigators. Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels. JACC Adv. 2025 May;4(5):101727. doi: 10.1016/j.jacadv.2025.101727. Epub 2025 Mar 29.
  • Sampath-Kumar R, Mahmud E, Palakodeti V, Ang L, Al Khiami B, Melendez A, Reeves R, Ben-Yehuda O. Impact of Hispanic Ethnicity, Geography, and Insurance Status on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention. JACC Adv. 2025 May;4(5):101723. doi: 10.1016/j.jacadv.2025.101723. Epub 2025 Apr 26.
  • Agusala K, Pundi K, Thakkar A, Cho D, Peterson ED, Bhatt A, Avari Silva JN. Recognizing Innovation in Academic Advancement. JACC Adv. 2025 May;4(5):101704. doi: 10.1016/j.jacadv.2025.101704. Epub 2025 Apr 25.
  • Lopez-Jimenez F, Alger HM, Attia ZI, Barry B, Chatterjee R, Dolor R, Friedman PA, Greene SJ, Greenwood J, Gundurao V, Hackett S, Jain P, Kinaszczuk A, Mehta K, O’Grady J, Pandey A, Pullins C, Puranik AR, Ranganathan MK, Rushlow D, Stampehl M, Subramanian V, Vassor K, Zhu X, Awasthi S. A multicenter pragmatic implementation study of AI-ECG-based clinical decision support software to identify low LVEF: Clinical trial design and methods. Am Heart J Plus. 2025 Mar 21;54:100528. doi: 10.1016/j.ahjo.2025.100528. eCollection 2025 Jun.
  • Hajhosseiny R, Hartley A, Cole G, Munoz C, Sethi A, Al-Lamee R, Khawaja S, Zaman S, Howard J, Gopalan D, Ariff B, Kaprielian R, Neji R, Kunze KP, Kaura A, Prieto C, Khamis R, Botnar RM. Free-breathing, non-contrast, three-dimensional whole-heart coronary magnetic resonance imaging for the identification of culprit and vulnerable atherosclerotic plaque. J Cardiovasc Magn Reson. 2025 Apr 22;27(1):101898. doi: 10.1016/j.jocmr.2025.101898.
  • Frobert O, Stone GW, Larsen AI, Zhou Z, Kotinkaduwa LN, Engstrom T, Kjoller-Hansen L, Maeng M, Matsumura M, Ben-Yehuda O, Botker HE, Persson J, Wiseth R, Jensen LO, Nordrehaug JE, Trovik T, Jensen U, Bleie O, James SK, Ali ZA, Omerovic E, Erlinge D, Maehara A. Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial. JACC Cardiovasc Interv. 2025 May 26;18(10):1217-1228. doi: 10.1016/j.jcin.2025.01.440. Epub 2025 Apr 23.
  • Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber FX, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip DE, Krucoff MW, Stone GW, Garg S, Onuma Y, Serruys PW. Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium. EuroIntervention. 2025 Apr 24:EIJ-E-25-00021. doi: 10.4244/EIJ-E-25-00021.
  • Swaminathan RV, Marquis-Gravel G, Boivin-Proulx LA, Benjamin DK, Rikhi A, Raveendran G, Chambers JW, Seto AH, Bagai J, White R, Gutierrez JA, Povsic TJ, Rao SV, Krucoff MW. Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study. Circ Cardiovasc Interv. 2025 Apr 24:e015240. doi: 10.1161/CIRCINTERVENTIONS.125.015240.
  • Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber FX, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip DE, Krucoff MW, Stone GW, Garg S, Onuma Y, Serruys PW. Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium. Eur Heart J. 2025 Apr 24:ehaf029. doi: 10.1093/eurheartj/ehaf029.
  • Yogendrakumar V, Ayan D, Field TS, Andrade JG, Saposnik G, Hill MD, Sposato LA. Current Practices of Cardiac Monitoring and Early Rhythm-Control Therapy for Atrial Fibrillation and Stroke Prevention. Can J Neurol Sci. 2025 Apr 24:1-3. doi: 10.1017/cjn.2025.81.
  • Ferreira JP, Zannad F, Vasques-Novoa F, Marques P, Filippatos G, Pocock SJ, Butler J, Packer M, Anker SD. NSAIDs Use, Kidney Outcomes and the Effect of Empagliflozin: An Analysis from EMPEROR-Preserved. J Card Fail. 2025 Apr 19:S1071-9164(25)00165-4. doi: 10.1016/j.cardfail.2025.03.019.
  • Bansal B, Lajeunesse-Trempe F, Keshvani N, Lavie CJ, Pandey A. Impact of Metabolic Dysfunction-associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure. Can J Cardiol. 2025 Apr 19:S0828-282X(25)00315-0. doi: 10.1016/j.cjca.2025.04.012.
  • de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Zoungas S, Rossing P. GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary. Kidney Int. 2025 May;107(5):767-771. doi: 10.1016/j.kint.2024.12.019.
  • Mesnier J, Giovachini L, Ducrocq G, Danchin N, Ford I, Tendera M, Feldman LJ, Ferrari R, Tardif JC, Fox KM, Vidal-Petiot E, Steg PG. Smoking Trajectories and Residual Cardiovascular Risk in Patients with Stable Coronary Artery Disease: An international Cohort Study. Eur J Prev Cardiol. 2025 Apr 19:zwaf222. doi: 10.1093/eurjpc/zwaf222.
  • Jering KS, Claggett BL, Braunwald E, Granger CB, Kober L, Landmesser U, Lewis EF, Maggioni AP, Mann DL, McMurray JJ, Mehran R, Petrie MC, Prescott MF, Rouleau JL, Schou M, Solomon SD, Steg PG, VON Lewinski D, Pfeffer MA. NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial. J Card Fail. 2025 Apr 16:S1071-9164(25)00164-2. doi: 10.1016/j.cardfail.2025.03.018.
  • Caldwell JS, Cheng XS, Bendavid E, Chertow GM, Lakdawalla DN, Lin E. Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis. JAMA Health Forum. 2025 Apr 4;6(4):e250452. doi: 10.1001/jamahealthforum.2025.0452.
  • Khan MS, Rashid AM, Van Spall HGC, Greene SJ, Bhatt AS, Pandey A, Keshvani N, Mentz RJ, Ambrosy AP, DiMaio JM, Butler J. Integrating cardiovascular implementation science research within healthcare systems. Prog Cardiovasc Dis. 2025 Apr 15:S0033-0620(25)00059-3. doi: 10.1016/j.pcad.2025.04.005.
  • Wong LL, Koh HWL, Choi H, Zou R, Zhou L, Lim JY, Phua DCY, Liew OW, Chong JPC, Ng JYX, Chan SP, Chen YT, Yeo PSD, Ling LH, Sim D, Leong KTG, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Lund M, Devlin G, Troughton R, Doughty RN, Lam CSP, Too HP, Richards AM. Combined circulating microRNA and peptide biomarkers for prognostication in heart failure. Cardiovasc Res. 2025 Apr 17:cvaf065. doi: 10.1093/cvr/cvaf065.
  • Quinn S, Sarnari R, Zbihley A, Sherlock D, Raikar C, Engel J, Pedamallu H, Lin K, Ghafourian K, Lee DC, Vorovich EE, Yancy CW, Rigolin VH, Lomasney JW, Carr JC, Allen BD, Markl M. Multiparametric quantitative structural and functional cardiac MRI in orthotopic heart transplant recipients with cardiac allograft vasculopathy. Int J Cardiovasc Imaging. 2025 Apr 17. doi: 10.1007/s10554-025-03384-z.
  • Landmesser U, Koenig W, Leiter LA, Raal FJ, Ray KK, Schwartz GG, Han J, Conde LG, Wright RS. Efficacy and safety of inclisiran based on background lipid-lowering treatment. Eur J Prev Cardiol. 2025 Apr 17:zwaf214. doi: 10.1093/eurjpc/zwaf214.
  • Zywicka EM, Moore AJ, Twine C, Behrendt CA, Bosiers M, Brodmann M, Choke E, deBorst GJ, Diamantopoulos A, Enzmann F, Farber A, Ansel G, Gattuso D, Goh GS, Yann G, Jansen S, Landini M, Lejay A, Lichtenberg M, Menard M, Mezes P, Mills J, Nixon J, Nordanstig J, O’Connell K, Ozdemir B, Patrone L, Puppala S, Saratzis A, Secemsky EA, Sigrid N, Stavroulakis K, Steiner S, Teraa M, Van Herzeele I, Venermo M, Zeller T, Mouton R, Hinchliffe RJ. Endovascular treatment of peripheral arterial disease: Endo-STAR framework for the design, conduct, and reporting of trials. Br J Surg. 2025 Mar 28;112(4):znaf020. doi: 10.1093/bjs/znaf020.
  • Venema CS, van Bergeijk KH, Krikken JA, van der Werf HW, van den Heuvel AFM, Douglas YL, Mordi IR, Girerd N, Lang CC, Lam CSP, Leon MB, Lipsic E, Rienstra M, Voors AA, Wykrzykowska JJ. Heart Failure With Preserved Ejection Fraction Phenotype Is Associated With Early Symptom Onset in Aortic Stenosis and Residual Symptoms After Transcatheter Aortic Valve Implantation. J Am Heart Assoc. 2025 May 6;14(9):e038786. doi: 10.1161/JAHA.124.038786. Epub 2025 Apr 16.
  • Sandhu A, Qin L, Minges K, Zimmerman S, Borne RT, Polsinelli VB, Ho PM, Hsu JC, Al-Khatib SM, Freeman JV, Bradley SM, Rao SV, Hernandez AF, Tzou WS, Varosy PD, Hess PL. Same-Day Discharge After Catheter Ablation of Atrial Fibrillation in the United States. J Am Heart Assoc. 2025 May 6;14(9):e039190. doi: 10.1161/JAHA.124.039190. Epub 2025 Apr 16.
  • Kaur G, Berman AN, Biery DW, Besser SA, Wu WY, Weber B, Honigberg MC, Nasir K, Gulati M, Di Carli MF, Shaw LJ, Bhatt DL, Blankstein R. Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry. J Am Heart Assoc. 2025 May 6;14(9):e035353. doi: 10.1161/JAHA.124.035353. Epub 2025 Apr 16.
  • Kashyap VS, Beckman JA, Doros G, Menard MT, Rosenfield K, Creager MA, Tuttle KR, McGinigle KL, Huber T, Kinlay S, Drooz AT, Strong MB, Weinberg I, Farber A, Jaff MR, BEST-CLI Investigators. Optimal Medical Therapy Is Associated With Improved Limb Outcomes in PAD Patients: A BEST-CLI Substudy. J Am Coll Cardiol. 2025 Apr 22;85(15):1568-1572. doi: 10.1016/j.jacc.2025.03.452.
  • Leosdottir M, Schubert J, Brandts J, Gustafsson S, Cars T, Sundstrom J, Jernberg T, Ray KK, Hagstrom E. Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry. J Am Coll Cardiol. 2025 Apr 22;85(15):1550-1564. doi: 10.1016/j.jacc.2025.02.007.
  • Greenberg GS, Lorenzatti D, Filtz A, Jaspan VN, Park CM, Kalich B, Kathe N, Sidelnikov E, Di Palo KE, Browne C, Lipsitz E, Forest S, Scotti A, Latib A, Garcia MJ, Rodriguez CJ, Shapiro MD, Gulati M, Slipczuk L. Disparities in Achieving LDL-C Goals After Revascularization in a Diverse Real-World Cohort. Eur J Prev Cardiol. 2025 Apr 16:zwaf235. doi: 10.1093/eurjpc/zwaf235.
  • Webster ER, Perkovic A, Neuen BL, Tuttle KR, Perkovic V. Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials. Clin Kidney J. 2025 Jan 14;18(3):sfaf001. doi: 10.1093/ckj/sfaf001. eCollection 2025 Mar.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH. Spring into innovation: connecting minds, transforming care, saving lives. Eur Heart J Acute Cardiovasc Care. 2025 Apr 26;14(4):201-202. doi: 10.1093/ehjacc/zuaf040.
  • Ostrominski JW, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Borentian M, Rohwedder K, Lay-Flurrie J, Lavagnino MA, McMurray JJV, Solomon SD. Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial. JACC Heart Fail. 2025 Apr 2:102440. doi: 10.1016/j.jchf.2025.03.007.
  • Karchmer AW, Park SY, Zimetbaum PJ. Diagnosing Staphylococcal Cardiac Electronic Implantable Device Endocarditis: The Potential of Quantitative Plasma Cell-Free Microbial DNA. Clin Infect Dis. 2025 Apr 15:ciaf196. doi: 10.1093/cid/ciaf196.
  • Aggarwal R, Bhatt DL, Bonaca MP, Deck C, Lesogor A, Patel MR, Stroes ESG, Taub PR, Windecker S. Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population. Am J Prev Cardiol. 2025 Mar 8;22:100957. doi: 10.1016/j.ajpc.2025.100957. eCollection 2025 Jun.
  • Bayes-Genis A, Anderson L, Harding E, Metra M, Teerlink JR, Januzzi JL, Butler J, Rosano GMC. Late diagnosis in cancer sparks outrage-so why not heart failure? Eur J Heart Fail. 2025 Apr 15. doi: 10.1002/ejhf.3667.
  • Heijman MWJ, van den Ende CHM, Cornel JH, Smolders JMH, Schers HJ, Kievit W, Koeter S, van den Bemt BJF, Popa CD. Design of a randomised, placebo-controlled, double-blind multicentre study assessing the effect of colchicine on the incidence of knee or hip replacements in symptomatic knee or hip osteoarthritis: the ECHO trial. BMJ Open. 2025 Apr 14;15(4):e098096. doi: 10.1136/bmjopen-2024-098096.
  • Butler J, Usman MS, Gandotra C, Salman A, Farb A, Thompson AM, Stockbridge N, Zeller C, Folkvaljon F. Patient-Reported Outcomes as End Points in Heart Failure Trials. Circulation. 2025 Apr 15;151(15):1111-1125. doi: 10.1161/CIRCULATIONAHA.124.072158. Epub 2025 Apr 14.
  • Cusick MM, Tisdale RL, Adams AS, Chertow GM, Owens DK, Salomon JA, Goldhaber-Fiebert JD. Balancing Efficiency and Equity in Population-Wide CKD Screening. JAMA Netw Open. 2025 Apr 1;8(4):e254740. doi: 10.1001/jamanetworkopen.2025.4740.
  • Serpa F, Tale A, Zimetbaum PJ, Kramer DB. Trends in health care expenditures and incremental health care cost in adults with atrial fibrillation in the United States. Heart Rhythm O2. 2024 Oct 21;6(1):11-20. doi: 10.1016/j.hroo.2024.10.003. eCollection 2025 Jan.
  • Zile MR, Abraham WT, Stevenson LW, Costanzo MR, Angermann CE, Mehra MR, Desai AS, Ducharme A, Johnson N, Henderson J, Lindenfeld J. Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and All-Cause Mortality in Patients With Chronic Heart Failure. Circ Heart Fail. 2025 Apr 14:e012754. doi: 10.1161/CIRCHEARTFAILURE.124.012754.
  • Butt JH, Jhund PS, Henderson AD, Claggett BL, Desai AS, Lam CSP, Mueller K, Scheerer MF, Viswanathan P, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial. Eur J Heart Fail. 2025 Apr 13. doi: 10.1002/ejhf.3661.
  • Sarkies M, Sullivan D, Black A, Aylward P, Kostner K, Nicholls SJ, Horton A, Abhayaratna WP, Kangaharan N, Pang J, Bishop W, Elias L, Srinivasan S, Waddell-Smith KE, Della-Vedova J, Hespe C, Tiller J, Braithwaite J, Birkenhead K, Watts GF. Developing a national implementation strategy for enhancing the detection of familial hypercholesterolemia: An Australian experience. J Clin Lipidol. 2025 Mar 20:S1933-2874(25)00057-1. doi: 10.1016/j.jacl.2025.03.004.
  • Darling JD, Li S, Lee A, Liang P, Wyers MC, Schermerhorn ML, Secemsky EA, Stangenberg L. Outcomes following deep venous arterialization in Medicare patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 Apr 11:S0741-5214(25)00933-4. doi: 10.1016/j.jvs.2025.04.003.
  • Doudesis D, Lee KK, Anwar M, Singer AJ, Hollander JE, Chenevier-Gobeaux C, Claessens YE, Wussler D, Weil D, Kozhuharov N, Strebel I, Sabti Z, deFilippi C, Seliger S, Mesquita ET, Wiemer JC, Mockel M, Coste J, Jourdain P, Kimiaki K, Yoshimura M, Ibrahim I, Ooi SBS, Sen Kuan W, Gegenhuber A, Mueller T, Hanon O, Vidal JS, Cameron P, Lam L, Freedman B, Chung T, Collins SP, Lindsell CJ, Newby DE, Japp AG, Shah ASV, Villacorta H, Richards AM, McMurray JJV, Mueller C, Januzzi JL, Mills NL. Machine learning to optimise use of natriuretic peptides in the diagnosis of acute heart failure. Eur Heart J Acute Cardiovasc Care. 2025 Apr 12:zuaf051. doi: 10.1093/ehjacc/zuaf051.
  • Isath A, Pfeffer M, Mehra MR. Advancing antithrombotic therapies for left ventricular assist devices: challenges, innovations, and future perspectives. Future Cardiol. 2025 Jun;21(7):411-413. doi: 10.1080/14796678.2025.2491196. Epub 2025 Apr 12.
  • Szklarzewicz J, Floege U, Gallego D, Gibson K, Kalantar-Zadeh K, Helm K, Robinson D, Schneider B, Smith P, Tullus K, Poyan-Mehr A, Hendry B, Balkaran BL, Jauregui AK, Wang A, Nason I, Hazra NC, Xu C, Liu J, Zhou ZY, Bensink M. The humanistic burden of focal segmental glomerulosclerosis on patients and care-partners in the United States. Qual Life Res. 2025 Apr 11. doi: 10.1007/s11136-025-03951-w.
  • Bhatt RD, Pitt B, Steg PG, Bhatt DL. Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin. Prog Cardiovasc Dis. 2025 Apr 9:S0033-0620(25)00056-8. doi: 10.1016/j.pcad.2025.04.004.
  • Iba T, Levy JH, Maier CL, Helms J, Umemura Y, Moore H, Othman M, Thachil J, Connors JM, Levi M, Scarlatescu E. Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation. J Thromb Haemost. 2025 Apr 9:S1538-7836(25)00220-X. doi: 10.1016/j.jtha.2025.03.038.
  • Rong R, Gu Z, Lai H, Nelson TL, Keller T, Walker C, Jin KW, Chen C, Navar AM, Velasco F, Peterson ED, Xiao G, Yang DM, Xie Y. A deep learning model for clinical outcome prediction using longitudinal inpatient electronic health records. JAMIA Open. 2025 Apr 10;8(2):ooaf026. doi: 10.1093/jamiaopen/ooaf026. eCollection 2025 Apr.
  • Ben-Yehuda O, Reeves RR. Transcatheter Aortic Valve Replacement Sizing: Getting It Right. Struct Heart. 2024 May 9;9(3):100302. doi: 10.1016/j.shj.2024.100302. eCollection 2025 Mar.
  • Omar W, Genereux P. The Staging of Cardiac Damage for Aortic Stenosis: A Review. Struct Heart. 2024 Oct 24;9(3):100370. doi: 10.1016/j.shj.2024.100370. eCollection 2025 Mar.
  • Butt JH, Jhund PS, Henderson AD, Claggett BL, Desai AS, Lam CSP, Brinker M, Schloemer P, Viswanathan P, Lage A, Rohwedder K, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial. Eur J Heart Fail. 2025 Apr 10. doi: 10.1002/ejhf.3649.
  • Sanchez AC, Lahoud RN, VanBuren P, Dauerman HL, Gupta T. Transcatheter treatment of dual aortic-mitral pathology using transcatheter aortic valve replacement and transcatheter mitral edge-to-edge repair. Cardiovasc Revasc Med. 2025 Apr 3:S1553-8389(25)00154-X. doi: 10.1016/j.carrev.2025.04.003.
  • Dupre ME, Dhingra R, Xu H, Hammill BG, Lynch SM, West JS, Green MD, Curtis LH, Peterson ED. Racial and ethnic disparities in longitudinal trajectories of hospitalizations in patients diagnosed with heart failure. Am Heart J. 2025 Sep;287:32-40. doi: 10.1016/j.ahj.2025.04.006. Epub 2025 Apr 8.
  • Kalra PR, Gogorishvili I, Khabeishvili G, Malek F, Toman O, Critoph C, Flett AS, Cowburn PJ, Mehra MR, Sheridan WS, Britton JR, Buxo T, Kealy RM, Kent A, Greene BR, Guha K, Gardner RS, Loke I, Vazir A, Brugts JJ, Gray A, Testani JM, Damman K. First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HF. JACC Heart Fail. 2025 Jun;13(6):1000-1010. doi: 10.1016/j.jchf.2025.01.019. Epub 2025 Apr 9.
  • Ostrominski JW, Mc Causland FR, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Schloemer P, Brinker M, Scheerer MF, McMurray JJV, Solomon SD, Vaduganathan M. Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial. JACC Heart Fail. 2025 Apr 2:102439. doi: 10.1016/j.jchf.2025.03.006.
  • Pagani FD, Netuka I, Jorde UP, Katz JN, Gustafsson F, Connors JM, Uriel N, Soltesz EG, Ivak P, Bansal A, Bitar A, Vega JD, Goldstein D, Danter M, Pya Y, Ravichandran A, Conway J, Adler ED, Chung ES, Grinstein J, Dirckx N, Iravani B, Mehra MR. Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy. JACC Heart Fail. 2025 Apr 9:102411. doi: 10.1016/j.jchf.2025.01.017.
  • Bozkurt B, Mullens W, Leclercq C, Russo AM, Savarese G, Bohm M, Hill L, Kinugawa K, Sato N, Abraham WT, Bayes-Genis A, Mebazaa A, Rosano GMC, Zieroth S, Linde C, Butler J. Cardiac rhythm devices in heart failure with reduced ejection fraction – role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Apr 9. doi: 10.1002/ejhf.3641.
  • McCarthy CP, McEvoy JW, Januzzi JL Jr. Troponin Testing for Cardiovascular Primary Prevention Decision Making? J Am Coll Cardiol. 2025 Apr 15;85(14):1485-1487. doi: 10.1016/j.jacc.2025.02.026.
  • Tuttle KR, Kornowske LM, Jones CR, Daratha KB, Alicic RZ, Reynolds CL, Neumiller JJ, Bensink ME, Gong W, Norris KC, Nicholas SB, CURE-CKD Consortium. Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry. Kidney Med. 2025 Feb 13;7(4):100981. doi: 10.1016/j.xkme.2025.100981. eCollection 2025 Apr.
  • Chiew K, Chotai S, Al-Lamee R. Mode of revascularization for ischaemic cardiomyopathy: comparing apples with oranges? Eur Heart J. 2025 Jun 9;46(22):2063-2065. doi: 10.1093/eurheartj/ehaf201.
  • Barber T, Neumiller JJ, Fravel MA, Page RL 2nd, Tuttle KR. Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease. Am J Health Syst Pharm. 2025 Apr 8:zxaf045. doi: 10.1093/ajhp/zxaf045.
  • Bahit MC, Gibson M, Kuleta M, Szarpak L, Malinowski KP, Kowalska-Bobko I, Siudak Z. Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful? Pol Arch Intern Med. 2025 Apr 24;135(4):16987. doi: 10.20452/pamw.16987. Epub 2025 Apr 7.
  • Gornik HL, Aronow HD, Goodney PP, Arya S, Packard Brewster L, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Antonio Gutierrez J, Hawkins BM, Hess CN, Ho KJ, Schuyler Jones W, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, West Pollak A, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR. Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Apr 8;151(14):e918. doi: 10.1161/CIR.0000000000001329. Epub 2025 Apr 7.
  • Steg PG, Szarek M, Jukema JW, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators. Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES. Circulation. 2025 Apr 8;151(14):1047-1050. doi: 10.1161/CIRCULATIONAHA.124.071269. Epub 2025 Apr 7.
  • Rao SV, Razzouk L. Defining what is important to prevent radial artery occlusion. EuroIntervention. 2025 Apr 7;21(7):e337-e338. doi: 10.4244/EIJ-E-25-00010.
  • Appah-Sampong A, Marcaccio C, Li S, Song Y, Hussain MA, Yeh R, Schermerhorn ML, Secemsky EA. Racial Disparities in Long-Term Outcomes After Endovascular Aortic Aneurysm Repair in Black and White Medicare Beneficiaries. Circulation. 2025 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.072018.
  • Genereux P, Redfors B, Pibarot P, Lindman BR, Giustino G, Dratch A, Murphy S, Chikermane S, Leon MB, Baron SJ. Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac Damage. Circ Cardiovasc Interv. 2025 May;18(5):e014945. doi: 10.1161/CIRCINTERVENTIONS.124.014945. Epub 2025 Apr 7.
  • Segar MW, Lambeth K, Rosenblatt A, Paisley RD, Rasekh A, Molina-Razavi J, Razavi M, Pandey A, Saeed M. Electrocardiographic P-wave parameters and lifetime atrial fibrillation risk: A multicohort study. Heart Rhythm. 2025 Apr 4:S1547-5271(25)02308-2. doi: 10.1016/j.hrthm.2025.03.2004.
  • Halaseh R, Sun GK, Bhatt AS, Chang AJ, Svetlichnaya J, Adatya S, Fudim M, Greene SJ, Bensimhon DR, Adler ED, Alexy T, Biegus J, Sauer AJ, Pang PS, Collins SP, Pandey A, Butler J, Ambrosy AP. Outpatient worsening heart failure: innovative decongestion strategies and health equity implications. Heart Fail Rev. 2025 Apr 5. doi: 10.1007/s10741-025-10509-y.
  • Cho L, Nicholls SJ, Nordestgaard BG, Landmesser U, Tsimikas S, Blaha MJ, Leitersdorf E, Lincoff AM, Lesogor A, Manning B, Kozlovski P, Cao H, Wang J, Nissen SE. Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a). Am Heart J. 2025 Sep;287:1-9. doi: 10.1016/j.ahj.2025.03.019. Epub 2025 Apr 2.
  • Minhas AMK, Al-Kindi S, Van Spall HGC, Abramov D. Comparing Cardiovascular Mortality Estimates From Global Burden of Disease and From the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research. Circ Cardiovasc Qual Outcomes. 2025 May;18(5):e011459. doi: 10.1161/CIRCOUTCOMES.124.011459. Epub 2025 Apr 4.
  • Ter Maaten JM, Butler J. Tirzepatide, HFpEF, and the Kidney: A Triangular Relationship Requiring Measurement of GFR, Not Guesses. J Am Coll Cardiol. 2025 May 13;85(18):1736-1739. doi: 10.1016/j.jacc.2025.03.508. Epub 2025 Mar 31.
  • Haywood HB, Kaltenbach LA, Ikeaba U, Fonarow GC, Chiswell K, Kittipibul V, Khan MS, Gupta M, Uchehara B, Hammill BG, Butler J, Hernandez AF, Felker GM, Greene SJ. Site-Level Variation and Factors Associated With an Outpatient Intravenous Diuretic Strategy for Worsening Heart Failure. Am J Cardiol. 2025 Jul 15;247:3-5. doi: 10.1016/j.amjcard.2025.03.041. Epub 2025 Apr 1.
  • Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, Sriswasdi S, Chico TJA, Capodanno D, Colleran R, Sutton NR, Song L, Karam N, Sofat R, Fraccaro C, Chamie D, Alasnag M, Warisawa T, Gonzalo N, Jomaa W, Mehta SR, Cook EES, Sundstrom J, Nicholls SJ, Shaw LJ, Patel MR, Al-Lamee RK. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma. Lancet. 2025 Apr 12;405(10486):1264-1312. doi: 10.1016/S0140-6736(25)00055-8. Epub 2025 Mar 31.
  • Ray KK, Oru E, Rosenson RS, Jones J, Ma X, Walgren J, Haupt A, Verma S, Gaudet D, Nicholls SJ, Ruotolo G. Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2025 May 3;405(10489):1594-1607. doi: 10.1016/S0140-6736(25)00507-0. Epub 2025 Mar 31.
  • Black N, Bradley J, Lewis G, Lagan J, Orsborne C, Soltani F, Farrant JP, McDonagh T, Schmitt M, Cavalcante JL, Ugander M, Butler J, Petrie MC, Miller CA, Schelbert EB. Development and Validation of Imaging-Free Myocardial Fibrosis Prediction Models, Association with Outcomes, and Sample Size Estimation for Phase 3 Trials. J Am Heart Assoc. 2025 Apr 15;14(8):e037254. doi: 10.1161/JAHA.124.037254. Epub 2025 Apr 3.
  • Shah KB, Aridi H, Dake MD, Doros G, Farber A, Menard MT, Motaganahalli R, Ochoa Chaar C, Rosenfield K, Scali S, Shah SK, Strong MB, Upchurch GR, Robinson W. Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI. Circ Cardiovasc Interv. 2025 Apr 3:e014833. doi: 10.1161/CIRCINTERVENTIONS.124.014833.
  • Lee JA, Wise J, Raudsepp SD, Paton LN, Powell J, Jina K, Aldous S, Troughton RW, Adamson PD, Richards AM, Peacock WF, Januzzi JL, Erceg N, Koechlin L, Boeddinghaus J, Lopez-Ayala P, Mueller C, Than MP, Pickering JW, Pemberton CJ. Insulin-like growth factor binding protein-3 (IGFBP-3): a biomarker of coronary artery disease induced myocardial ischaemia. Eur Heart J Open. 2025 Mar 20;5(2):oeaf028. doi: 10.1093/ehjopen/oeaf028. eCollection 2025 Mar.
  • Rubboli A, Angiolillo DJ, Becattini C, Lip GYH. Chronic Coronary Syndrome and New-Onset Atrial Fibrillation or Venous Thromboembolism: How Best to Manage Antithrombotic Therapy Strategies. Eur Heart J Cardiovasc Pharmacother. 2025 Apr 2:pvaf021. doi: 10.1093/ehjcvp/pvaf021.
  • Vranckx P, Halvorsen S. Cracking the clot: the RIVAWAR trial challenges warfarin’s reign in left ventricular thrombus post-acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2025 Apr 26;14(4):243-244. doi: 10.1093/ehjacc/zuaf052.
  • Alicic RZ, Duru OK, Jones CR, Kornowske LM, Daratha KB, Reynolds CL, Pavkov ME, Koyama AK, Xu F, Nicholas SB, Neumiller JJ, Norris KC, Hennessey KA, Tuttle KR. Incidence of chronic kidney disease among adults with prediabetes in the CURE-CKD registry, 2013-2020. Diabetes Obes Metab. 2025 Jun;27(6):3536-3541. doi: 10.1111/dom.16365. Epub 2025 Apr 2.
  • Shi SM, Rapley FA, Margulis H, Laham RJ, Guibone K, Percy E, Kaneko T, Wang KY, Kim DH. Home-Based Rehabilitation After Transcatheter Aortic Valve Replacement (REHAB-TAVR): A Pilot Randomized Controlled Trial. J Am Geriatr Soc. 2025 Apr 2. doi: 10.1111/jgs.19456.
  • Chotai S, Salih A, Ahmed-Jushuf F, Foley M, Al-Lamee RK. Angina in stable coronary artery disease: Data from ORBITA and ORBITA-2. Cardiovasc Revasc Med. 2025 Mar 22:S1553-8389(25)00119-8. doi: 10.1016/j.carrev.2025.03.018.
  • Colasurdo M, Chen K, Chen H, McIntyre MK, Matouk C, Selim M, Whitehead WE, Heilman CB, Malek AM, Kan P. Morphometric analysis of the inferior petrosal sinus and cerebellopontine angle cistern to assess feasibility of endovascular shunting in pediatric patients. J Neurointerv Surg. 2025 Mar 31:jnis-2025-023137. doi: 10.1136/jnis-2025-023137.
  • Cordova Sanchez A, Holmes CE, Dauerman HL, Gupta T. Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition. J Thromb Thrombolysis. 2025 Apr;58(4):538-546. doi: 10.1007/s11239-025-03092-4. Epub 2025 Apr 1.
  • Capodanno D, Alexander JH, Bahit MC, Eikelboom JW, Gibson CM, Goodman SG, Kunadian V, Lip GYH, Lopes RD, Mehran R, Mehta SR, Patel MR, Piccini JP, Rao SV, Ruff CT, Steg PG, Weitz JI, Angiolillo DJ. Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism. Nat Rev Cardiol. 2025 Mar 31. doi: 10.1038/s41569-025-01144-z.
  • Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS. Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Apr;151(13):e865. doi: 10.1161/CIR.0000000000001328. Epub 2025 Mar 31.
  • Khan SS, Yancy CW. Rural America-Expanding the Lens of Health Disparities: Endorsing the Need for Health Equity Research. JAMA Cardiol. 2025 Mar 31. doi: 10.1001/jamacardio.2025.0555.
  • Berman AN, Hidrue MK, Ginder C, Shirkey L, Kwatra J, O’Kelly AC, Murphy SP, Searl Como JM, Daly D, Sun YP, Curry WT, Del Carmen MG, Blankstein R, Dodson JA, Morrow DA, Scirica BM, Choudhry NK, Januzzi JL Jr, Wasfy JH. Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial. JAMA Cardiol. 2025 Mar 31. doi: 10.1001/jamacardio.2025.0871.
  • Nissen SE, Ni W, Shen X, Wang Q, Navar AM, Nicholls SJ, Wolski K, Michael L, Haupt A, Krege JH, ALPACA Trial Investigators. Lepodisiran – A Long-Duration Small Interfering RNA Targeting Lipoprotein(a). N Engl J Med. 2025 May 1;392(17):1673-1683. doi: 10.1056/NEJMoa2415818. Epub 2025 Mar 30.
  • McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB, SOUL Study Group. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes. N Engl J Med. 2025 May 29;392(20):2001-2012. doi: 10.1056/NEJMoa2501006. Epub 2025 Mar 29.
  • Ben-Yehuda O. Aortic Stenosis – When Valve Intervention Is Not Enough. N Engl J Med. 2025 Apr 10;392(14):1443-1444. doi: 10.1056/NEJMe2503345. Epub 2025 Mar 29.
  • Huang H, Balaji S, Aslan B, Wen Y, Selim M, Thomas AJ, Filippidis A, Spincemaille P, Wang Y, Soman S. Quantitative Susceptibility Mapping MRI with Computer Vision Metrics to Reduce Scan Time for Brain Hemorrhage Assessment. Int J Imaging Syst Technol. 2025 Mar;35(2):e70070. doi: 10.1002/ima.70070. Epub 2025 Mar 20.
  • Talmor N, Graves C, Kozloff S, Major VJ, Xia Y, Shah B, Babaev A, Razzouk L, Rao SV, Attubato MJ, Feit F, Slater J, Smilowitz NR. Periprocedural Myocardial Injury Using CKMB Following Elective PCI: Incidence and Associations With Long-Term Mortality. Circ Cardiovasc Interv. 2025 May;18(5):e014934. doi: 10.1161/CIRCINTERVENTIONS.124.014934. Epub 2025 Mar 31.
  • Herrmann JJ, Brunner-La Rocca HP, Baltussen LEHJM, Beckers-Wesche F, Bekkers SCAM, Bellersen L, van Eck JWM, Hassing HC, Jaarsma T, Linssen GCM, Pisters R, Sanders-van Wijk S, Verdijk MHI, Handoko ML, van der Meer P, Verbrugge FH, Januzzi JL Jr, Bayes-Genis A, Nieuwlaat R, Rodwell L, Gommans DHF, van Kimmenade RRJ. Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial. Nat Med. 2025 Mar 30. doi: 10.1038/s41591-025-03628-4.
  • Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M, Nosko A, Stas A, Kluge S, Jarczak D, deHeer G, Rybczynski M, Bayes-Genis A, Bohm M, Coats AJS, Edelmann F, Filippatos G, Hasenfuss G, Haverkamp W, Lainscak M, Landmesser U, Macdougall IC, Merkely B, Pieske BM, Pinto FJ, Rassaf T, Visser-Rogers JK, Rosano G, Volterrani M, von Haehling S, Anker MS, Doehner W, Ince H, Koehler F, Savarese G, Khan MS, Rauch-Krohnert U, Gori T, Trenkwalder T, Akin I, Paitazoglou C, Kobielusz-Gembala I, Kuthi L, Frey N, Licka M, Kaab S, Laugwitz KL, Ponikowski P, Karakas M. Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial. JAMA. 2025 Jun 10;333(22):1965-1976. doi: 10.1001/jama.2025.3833.
  • Warisawa T, Cook CM, Ahmad Y, Howard JP, Seligman H, Rajkumar C, Doi S, Yuasa S, Nakajima A, Toya T, Nakayama M, Kikuta Y, Kawase Y, Nishina H, Al-Lamee R, Lerman A, Matsuo H, Akashi YJ, Escaned J, Davies JE. Difference in Strategy and Clinical Outcomes of Left Main Disease in Japan and Non-Japanese Countries. Int Heart J. 2025;66(2):202-212. doi: 10.1536/ihj.24-375.
  • Anker SD, Karakas M, Mentz RJ, Ponikowski P, Butler J, Khan MS, Talha KM, Kalra PR, Hernandez AF, Mulder H, Rockhold FW, Placzek M, Rover C, Cleland JGF, Friede T. Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency. Nat Med. 2025 Mar 30. doi: 10.1038/s41591-025-03671-1.
  • Desai AS, Jhund PS, Vaduganathan M, Claggett BL, Cunningham JW, Pabon MA, Lam CSP, Senni M, Shah S, Voors AA, Zannad F, Pitt B, Amarante F, Lay-Flurrie J, Scheerer MF, Lage A, McMurray JJV, Solomon SD. Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025 Mar 30:e250860. doi: 10.1001/jamacardio.2025.0860.
  • Rao SV, Brooks MM, D’Agostino HEA, Steg PG, Simon T, Aronow HD, Goldsweig AM, Malik S, Alsweiler C, Ho KKL, Dehghani P, Caixeta A, Quraishi AR, Robinson S, Traverse JH, Siddiqi O, Fergusson DA, Potter BJ, Schulman-Marcus J, Keating FK, Carson JL, MINT Trial Investigators. Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial. Circ Cardiovasc Interv. 2025 May;18(5):e015249. doi: 10.1161/CIRCINTERVENTIONS.125.015249. Epub 2025 Mar 30.
  • Kar S, Makkar RR, Whisenant BK, Hamid N, Naik H, Tadros P, Price MJ, Singh G, Schwartz JG, Kapadia S, Alli O, Horr S, Seshiah P, Batchelor W, Jones BM, Ahmed MI, Benza R, Jorde U, Thourani VH, Ghobrial AA, Tang GHL, Trusty PM, Huang D, Hahn RT, Adams DH, Sorajja P, TRILUMINATE Pivotal Investigators. Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial. Circulation. 2025 Jun 10;151(23):1630-1638. doi: 10.1161/CIRCULATIONAHA.125.074536. Epub 2025 Mar 30.
  • Leyva H, Fanikos J, Lan Z, Scimeca G, Bikdeli B, Piazza G, Goldhaber SZ. Aspirin for Venous Thromboembolism Prophylaxis in Hip Fracture, Total Knee, and Hip Arthroplasty. Am J Med. 2025 Mar 28:S0002-9343(25)00197-4. doi: 10.1016/j.amjmed.2025.03.020.
  • Ray KK, Linnebjerg H, Michael LF, Shen X, Ma X, Lim S, Zhen EY, Dudek H, Abrams M, Saxena U, Turanov A, Nicholls SJ, Ruotolo G. Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies. J Am Coll Cardiol. 2025 May 20;85(19):1803-1818. doi: 10.1016/j.jacc.2025.03.005. Epub 2025 Mar 30.
  • Lee MMY, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter NR, Badve SV, Pratley RE, Perkovic V, Buse JB, McGuire DK, SOUL Trial Investigators. Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials. Diabetes Care. 2025 May 1;48(5):846-859. doi: 10.2337/dc25-0241.
  • Marx N, Deanfield JE, Mann JFE, Arechavaleta R, Bain SC, Bajaj HS, Bayer Tanggaard K, Birkenfeld AL, Buse JB, Davicevic-Elez Z, Desouza C, Emerson SS, Engelmann MDM, Hovingh GK, Inzucchi SE, Jhund PS, Mulvagh SL, Pop-Busui R, Poulter NR, Rasmussen S, Tu ST, McGuire DK, SOUL Study Group. Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial. Circulation. 2025 Jun 10;151(23):1639-1650. doi: 10.1161/CIRCULATIONAHA.125.074545. Epub 2025 Mar 29.
  • Matsumoto S, Henderson AD, Jhund PS, Bauersachs J, Chioncel O, Claggett BL, Comin-Colet J, Desai AS, Filippatos G, Lam CSP, Pitt B, Scheerer MF, Lay-Flurrie J, Amarante F, Brinker M, Schou M, Senni M, Shah SJ, Voors AA, Zannad F, Zieroth S, Vaduganathan M, Solomon SD, McMurray JJV. Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025 Mar 29:e250848. doi: 10.1001/jamacardio.2025.0848.
  • Lalani C, Medina F, Oseran AS, Liang L, Song Y, Butala NM, Kazi DS, Cohen DJ, Strom JB, Wadhera RK, Yeh RW. Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes. 2025 May;18(5):e011991. doi: 10.1161/CIRCOUTCOMES.125.011991. Epub 2025 Mar 29.
  • Regensteiner JG, McNeil M, Faubion SS, Bairey-Merz CN, Gulati M, Joffe H, Redberg RF, Rosen SE, Reusch JE, Klein W. Barriers and solutions in women’s health research and clinical care: a call to action. Lancet Reg Health Am. 2025 Mar 14;44:101037. doi: 10.1016/j.lana.2025.101037. eCollection 2025 Apr.
  • Ali ZA, Al-Lamee R, Bittl JA. Evidence of Benefit for Chronic Total Occlusion Revascularization From ISCHEMIA: New Road or Dead End? J Am Coll Cardiol. 2025 Apr 1;85(12):1350-1352. doi: 10.1016/j.jacc.2025.02.011.
  • Balmaceda P, Hitzeman TC, Shaw KE, Kolhepp LM, Killeen M, Fang JC, Butler J, Hernandez AF, Hong T, Shaw RM. Design of the First in Human Gene Therapy Trial of TLT-101 for Chronic Heart Failure (FIGHT-HF). JACC Basic Transl Sci. 2025 Mar;10(3):276-278. doi: 10.1016/j.jacbts.2025.01.019. Epub 2025 Feb 11.
  • Occhipinti G, Brugaletta S, Angiolillo DJ. Platelet-Fibrin Clot Strength for Risk Stratification After PCI in Patients With Diabetes Mellitus: Finding the Sweet Spot. JACC Cardiovasc Interv. 2025 Mar 24;18(6):734-737. doi: 10.1016/j.jcin.2025.01.002.
  • Wattchow NE, Pullen BJ, Indraratna AD, Nankivell V, Everest-Dass A, Psaltis PJ, Kolarich D, Nicholls SJ, Packer NH, Bursill CA. The emerging role of glycans and the importance of sialylation in cardiovascular disease. Atherosclerosis. 2025 Apr;403:119172. doi: 10.1016/j.atherosclerosis.2025.119172. Epub 2025 Mar 20.
  • Alexander JH, Lydon EJ, Piccini JP, Viethen T, Oldgren J, Goodman SG, Steffel J, Russo AM, van Gelder IC, Ferdinand KC, Lopes RD, Mundl H, Benczur B, Gomez-Doblas JJ, Glikson M, Goudev A, Grove EL, Halvorsen S, Kiviniemi T, Martin AC, Sandhu RK, Vinereanu D, Rockhold FW, Caso V, Coppolecchia R, Patel MR. Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial. JAMA Cardiol. 2025 Mar 26:e250277. doi: 10.1001/jamacardio.2025.0277.
  • Schneider DJ, McMahon SR, Angiolillo DJ, Fanaroff AC, Ibrahim H, Hohl PK, Wanamaker BL, Effron MB, DiBattiste PM, Investigators. Predictive Value of Platelet FcgammaRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction. Circ Cardiovasc Interv. 2025 Apr;18(4):e014939. doi: 10.1161/CIRCINTERVENTIONS.124.014939. Epub 2025 Mar 26.
  • Goldsweig AM, Kostis WJ, Herbert BM, Bouleti C, Potter BJ, Strom JB, Benatar J, Huynh T, Vallurupalli S, Figueiredo EL, Abbott JD, Cooper HA, DeFilippis AP, Fergusson DA, Goodman SG, Hebert PC, Lopes RD, Rao SV, Simon T, Carson JL, Brooks MM, Alexander JH, MINT Investigators. Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINT. Circ Heart Fail. 2025 Apr;18(4):e012495. doi: 10.1161/CIRCHEARTFAILURE.124.012495. Epub 2025 Mar 26.
  • Tsukagoshi J, Secemsky EA, Kuno T. On versus Off Label Device Techniques for Percutaneous Deep Venous Arterialisation. Eur J Vasc Endovasc Surg. 2025 Mar 23:S1078-5884(25)00258-8. doi: 10.1016/j.ejvs.2025.03.024.
  • Angrist JD, Gao C, Hull P, Yeh RW. Instrumental Variables in Randomized Trials. NEJM Evid. 2025 Apr;4(4):EVIDctw2400204. doi: 10.1056/EVIDctw2400204. Epub 2025 Mar 25.
  • Kumar M, Nso N, Khlidj Y, Ali S, Kumar N, Ponna PK, Attanasio S, Aronow WS, Butler J, Valencia JG, Alaxendar KM, Zelniker TA, Pursnani A, Erwin JP, Ricciardi MJ, Pareek M, Bangalore S, Qamar A. Management and outcomes of patients with ST-elevation myocardial infarction and liver disease-Insights from the Nationwide Readmissions Database. Am Heart J Plus. 2025 Feb 22;52:100516. doi: 10.1016/j.ahjo.2025.100516. eCollection 2025 Apr.
  • Caldwell JS, Cheng XS, Chertow GM, Goldhaber-Fiebert JD. Kidney Transplant Wait Times Under Waiting List Expansion Scenarios. JAMA Netw Open. 2025 Mar 3;8(3):e251665. doi: 10.1001/jamanetworkopen.2025.1665.
  • Dubosq-Lebaz M, Secemsky EA. Rethinking common femoral artery disease treatment: When and how to choose endovascular over open surgery? Vasc Med. 2025 Apr;30(2):183-185. doi: 10.1177/1358863X251328645. Epub 2025 Mar 24.
  • Filtz A, Gulati M. Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio. Prog Cardiovasc Dis. 2025 Mar-Apr;89:13-15. doi: 10.1016/j.pcad.2025.03.009. Epub 2025 Mar 22.
  • Namba HF, Boerhout CKM, Damman P, Kunadian V, Escaned J, Ong P, Perera D, Berry C, van de Hoef TP, Piek JJ. Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes. Int J Cardiol. 2025 Jul 1;430:133176. doi: 10.1016/j.ijcard.2025.133176. Epub 2025 Mar 22.
  • Hathorn B, Haykowsky MJ, Almandoz J, Pandey A, Sarma S, Hearon CM Jr, Babb TG, Balmain BN, Fu Q, Zaha VG, Levine BD, Nelson MD. Insights Into the Role of Obesity in Heart Failure With Preserved Ejection Fraction Pathophysiology and Management. Can J Cardiol. 2025 Mar 21:S0828-282X(25)00199-0. doi: 10.1016/j.cjca.2025.03.015.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Hernandez-Montfort J, Araiza-Garaygordobil D, Manzur-Sandoval D, Gopar-Nieto R, Sierra-Lara-Martinez D, Kanwar M, Sinha SS, Garan AR, Burkhoff D, Abraham J, Kapur NK, Arias-Mendoza A. International cooperation in cardiogenic shock is key to improving outcomes: Cardiogenic Shock Working Group impacts a single center in a developing country. J Heart Lung Transplant. 2025 Jul;44(7):1165-1171. doi: 10.1016/j.healun.2025.03.003. Epub 2025 Mar 20.
  • Galindo RJ, Moazzami B, Gerges A, Flores I, Arevalo G, Peng L, Tuttle KR, Umpierrez GE. Continuous glucose monitoring improves detection of glycemic excursions in hemodialysis patients with type 2 diabetes. J Clin Endocrinol Metab. 2025 Mar 22:dgaf187. doi: 10.1210/clinem/dgaf187.
  • Fakhraei R, Song Y, Kazi DS, Wadhera RK, de Lemos JA, Das SR, Morrow DA, Dahabreh IJ, Rutan CM, Thomas K, Yeh RW. Social Vulnerability and Long-Term Cardiovascular Outcomes After COVID-19 Hospitalization: An Analysis of the American Heart Association COVID-19 Registry Linked With Medicare Claims Data. J Am Heart Assoc. 2025 Apr;14(7):e038073. doi: 10.1161/JAHA.124.038073. Epub 2025 Mar 21.
  • Levy JH, Shaw JR, Connors JM, Douketis J, Weitz JI. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH: reply. J Thromb Haemost. 2025 May;23(5):1727-1729. doi: 10.1016/j.jtha.2025.03.010. Epub 2025 Mar 19.
  • Chertow GM. Embracing the Generational Opportunity to Improve the Care of Kidney Disease. Am J Kidney Dis. 2025 Mar 19:S0272-6386(25)00773-5. doi: 10.1053/j.ajkd.2025.01.023.
  • Presch A, Coughlan JJ, Bar S, Brugaletta S, Maeng M, Kufner S, Ortega-Paz L, Raber L, Laugwitz KL, Jensen LO, Windecker S, Warnakula Olesen KK, Sabate M, Heg D, Kastrati A, Cassese S. Smoking Status at Baseline and 10-Year Outcomes After Drug-Eluting Stent Implantation: Insights From the DECADE Cooperation. JACC Cardiovasc Interv. 2025 Apr 28;18(8):1001-1010. doi: 10.1016/j.jcin.2024.12.028. Epub 2025 Mar 19.
  • Nicholls SJ, Nelson AJ. Can Vulnerable Plaque Imaging PREVENT Cardiovascular Events? JACC Cardiovasc Imaging. 2025 Jun;18(6):707-708. doi: 10.1016/j.jcmg.2024.12.009. Epub 2025 Mar 19.
  • Juni P, Antoniou S, Arbelo E, Buccheri S, Cikes M, da Costa BR, Fauchier L, Gale CP, Halvorsen S, James S, Koskinas KC, Kotecha D, Landmesser U, Lewis BS, Lochen ML, Nielsen JC, Rossello X, Vaartjes I, Prescott EB, Baigent C. 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention. Eur Heart J. 2025 May 21;46(20):1885-1894. doi: 10.1093/eurheartj/ehaf009.
  • Sauer AJ, Beon C, Cherkur S, Mallas-Serdynski L, Thomas K, Spertus J, Chahoud G, Mody KP, Saltzberg MT, Goldberg LR, Lindenfeld J, Sweitzer N, Butler J, Kittleson MM, Pina I, Paul S, Lewis EF, Wald J, Allen LA, Jessup M, Congdon M, Kiser R, Yancy C, Fonarow GC. Multiregional Implementation Initiative’s Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HF. Circ Heart Fail. 2025 May;18(5):e012547. doi: 10.1161/CIRCHEARTFAILURE.124.012547. Epub 2025 Mar 21.
  • Paquin A, Nelson MD, Wei J, Zamani SK, Maughan J, Cook-Wiens G, Gulati M, Shufelt C, Petersen JW, Handberg EM, Pepine CJ, Bairey Merz CN. Coronary microvascular dysfunction and right ventricular structure and function. Cardiovasc Diagn Ther. 2025 Feb 28;15(1):259-264. doi: 10.21037/cdt-24-303. Epub 2025 Feb 25.
  • Morton JI, Liew D, Watts GF, Zoungas S, Nicholls SJ, Dixon P, Ademi Z. Rethinking Cardiovascular Prevention: Cost-Effective Cholesterol Lowering for Statin-Intolerant Patients in Australia and the UK. Eur J Prev Cardiol. 2025 Feb 26:zwaf114. doi: 10.1093/eurjpc/zwaf114.
  • van der Waerden RGA, Volleberg RHJA, Luttikholt TJ, Cancian P, van der Zande JL, Stone GW, Holm NR, Kedhi E, Escaned J, Pellegrini D, Guagliumi G, Mehta SR, Pinilla-Echeverri N, Moreno R, Raber L, Roleder T, van Ginneken B, Sanchez CI, Isgum I, van Royen N, Thannhauser J. Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review. Eur Heart J Digit Health. 2025 Jan 28;6(2):270-284. doi: 10.1093/ehjdh/ztaf005. eCollection 2025 Mar.
  • Wang Y, Courcelles E, Peyronnet E, Porte S, Diatchenko A, Jacob E, Angoulvant D, Amarenco P, Boccara F, Cariou B, Mahe G, Steg PG, Bastien A, Portal L, Boissel JP, Granjeon-Noriot S, Bechet E. Credibility assessment of a mechanistic model of atherosclerosis to predict cardiovascular outcomes under lipid-lowering therapy. NPJ Digit Med. 2025 Mar 19;8(1):171. doi: 10.1038/s41746-025-01557-7.
  • Wallentin L, Lindback J, Hijazi Z, Oldgren J, Carnicelli AP, Alexander JH, Berg DD, Eikelboom JW, Goto S, Lopes RD, Ruff CT, Siegbahn A, Giugliano RP, Granger CB, Morrow DA. Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2025 Mar 25;85(11):1173-1185. doi: 10.1016/j.jacc.2024.11.052.
  • Osude N, Spall HV, Bosworth H, Krychtiuk K, Spertus J, Fatoba S, Fleisher L, Fry E, Green J, Greene S, Ho M, Jackman J, Leopold J, Magwire M, McGuire D, Mensah G, Tuttle KR, Willey V, Pagidipati N, Granger C. Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective. Am Heart J. 2025 Aug;286:18-34. doi: 10.1016/j.ahj.2025.03.005. Epub 2025 Mar 17.
  • Guidi JL, Allen BR, Headden G, Winden N, Alahapperuma D, Christenson RH, Peacock WF, Januzzi JL. A novel NT-proBNP assay for heart failure diagnosis: A prospective, multicenter clinical trial. Clin Chim Acta. 2025 May 15;572:120249. doi: 10.1016/j.cca.2025.120249. Epub 2025 Mar 17.
  • Conte MS, Farber A, Barleben A, Chisci E, Doros G, Kashyap VS, Kayssi A, Kolh P, Moreira CC, Nypaver T, Rosenfield K, Rowe VL, Schanzer A, Singh N, Siracuse JJ, Strong MB, Menard MT. Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia. Circ Cardiovasc Interv. 2025 Mar;18(3):e014716. doi: 10.1161/CIRCINTERVENTIONS.124.014716. Epub 2025 Mar 18.
  • Kovach CP, Lipinski J, Mesenbring EC, Boulos P, Pribish A, Sola M, Glorioso TJ, Fearon WF, Yeh RW, Waldo SW. Characteristics and Outcomes of PCI Among Patients Ineligible for Surgical Revascularization in the Veterans Affairs Healthcare System. Circ Cardiovasc Interv. 2025 Mar;18(3):e014899. doi: 10.1161/CIRCINTERVENTIONS.124.014899. Epub 2025 Mar 18.
  • Dubosq-Lebaz M, Secemsky EA, Goueffic Y. The Data We Overlook, the Insights We Miss: Rethinking Vascular Research. Eur J Vasc Endovasc Surg. 2025 Mar 15:S1078-5884(25)00243-6. doi: 10.1016/j.ejvs.2025.03.015.
  • Joundi RA, Fang J, Austin PC, Smith EE, Yu AYX, Hachinski V, Sposato LA, Ganesh A, Sharma M, Kapral MK. Magnitude and Time-Course of Dementia Risk in Stroke Survivors: A Population-Wide Matched Cohort Study. Neurology. 2025 Apr 22;104(8):e213478. doi: 10.1212/WNL.0000000000213478. Epub 2025 Mar 17.
  • Hoeper MM, Oerke B, Wissmuller M, Leuchte H, Opitz C, Halank M, Seyfarth HJ, Baldus S, Bauersachs J, Bohm M, Ghofrani HA, Konstantinides S, Olsson KM, Wachter R, Lam CSP, Aminossadati B, Rosenkranz S. Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study. Circulation. 2025 Mar 18;151(11):e763. doi: 10.1161/CIR.0000000000001321. Epub 2025 Mar 17.
  • Stolfo D, Iacoviello M, Chioncel O, Anker MS, Bayes-Genis A, Braunschweig F, Cannata A, El Hadidi S, Filippatos G, Jhund P, Mebazaa A, Moura B, Piepoli M, Ray R, Ristic AD, Seferovic P, Simpson M, Skouri H, Tocchetti CG, Van Linthout S, Vitale C, Volterrani M, Keramida K, Wassmann S, Lewis BS, Metra M, Rosano GMC, Savarese G. How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2025 May;27(5):747-759. doi: 10.1002/ejhf.3642. Epub 2025 Mar 17.
  • Tedford RJ, Houston BA, Lindenfeld J, Kahwash R, Urey MA, Amoroso NS, Hibbert B, Zahr F, Gray WA, Butler J. Left atrial to coronary sinus shunting in more advanced heart failure with preserved ejection fraction. ESC Heart Fail. 2025 Mar 16. doi: 10.1002/ehf2.15270.
  • Kondo T, Jhund PS, Anand IS, Claggett BL, Desai AS, Docherty KF, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez FA, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Solomon SD, McMurray JJV. Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF. JACC Heart Fail. 2025 Jun;13(6):927-939. doi: 10.1016/j.jchf.2024.12.010. Epub 2025 Mar 12.
  • Brodeur PG, Ferro EG, Maher TG, Waks JW, d’Avila A, Zheng Z, Zimetbaum PJ, Michaud GF, Yang S, Buxton AE, Tung P, Yeh RW, Locke AH, Kramer DB. Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases. Heart Rhythm. 2025 Mar 12:S1547-5271(25)02173-3. doi: 10.1016/j.hrthm.2025.03.1939.
  • Rinaldi R, Kunadian V, Crea F, Montone RA. Management of angina pectoris. Trends Cardiovasc Med. 2025 Mar 12:S1050-1738(25)00033-7. doi: 10.1016/j.tcm.2025.03.001.
  • Curzen N, Routledge H, McGrath S, Abouelasaad M, Mamas M, Kinnaird T, Al-Lamee R, O’Kane P, Clesham G, McKenzie D, Nolan J, Banerjee S, Appleby C, Banning A, Muir DF, Spratt J, Gudde E, Carson S, Aggarwal S, Irving J, Sharma V, Purcell I, Zaman A, Hildick-Smith D. Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention Society. Interv Cardiol. 2025 Jan 23;20:e01. doi: 10.15420/icr.2024.43. eCollection 2025.
  • Leyva H, Hamade N, Krishnathasan D, Goldhaber SZ, Welker J, Carroll B, Bonaca M, Lan Z, Bikdeli B, Piazza G. Non-O Blood Groups and Cardiovascular Outcomes in COVID-19: Findings From a Large Multicenter Study. JACC Adv. 2025 Apr;4(4):101641. doi: 10.1016/j.jacadv.2025.101641. Epub 2025 Mar 12.
  • Moloney BM, Chertow GM, Mc Causland FR. Association of Diabetes with Heart Rate Variability during Hemodialysis: Insights from the Frequent Hemodialysis Network Daily Trial. Kidney360. 2025 Mar 13. doi: 10.34067/KID.0000000765.
  • Laudani C, Abbate A, Angiolillo DJ, Galli M. CLEAR results, cloudy impact: colchicine’s neutral role in ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2025 May 2;11(3):215-217. doi: 10.1093/ehjcvp/pvaf011.
  • Wang M, He X, Crawford K, Ko YA, Dickert NW, Patel SA, Pandey A, DeFilippis EM, Breathett K, Cogswell R, Yancy CW, Fonarow GC, Morris AA. Racial and Ethnic Disparities in Referral to Outpatient Heart Failure Management at Hospital Discharge: A Get With The Guidelines Analysis. J Am Heart Assoc. 2025 Mar 18;14(6):e036900. doi: 10.1161/JAHA.124.036900. Epub 2025 Mar 13.
  • Rashid M, Abramov D, Naseer MU, Van Spall HGC, Ahmed FZ, Lawson C, Dafaalla M, Kontopantelis E, Mohamed MO, Petrie MC, Mamas MA. 15-Year trends, predictors, and outcomes of heart failure hospitalization complicating first acute myocardial infarction in the modern percutaneous coronary intervention era. Eur Heart J Open. 2025 Feb 19;5(2):oeaf013. doi: 10.1093/ehjopen/oeaf013. eCollection 2025 Mar.
  • Ngo KD, Nguyen T, Pham HD, Tran H, Ha DQ, Dinh TS, Mihas I, Kodenchery M, Gibson CM, Nguyen HQ, Nguyen T, Loc VT, Nguyen CD, Tien HA, Talarico E Jr, Zuin M, Rigatelli G, Nanjundappa A, Nguyen QTN, Nguyen TH. Water Hammer Phenomenon in Coronary Arteries: Scientific Basis for Diagnostic and Predictive Modeling with Acoustic Action Mapping. Diagnostics (Basel). 2025 Feb 25;15(5):553. doi: 10.3390/diagnostics15050553.
  • El Khalili L, El Khalili L, Rawshani A, Boren J, Bhatt DL, Gerstein HC, McGuire DK, Helleryd E, Omerovic E, Eliasson B, Ramunddal T, Sattar N, Rawshani A. Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study. Cardiovasc Diabetol. 2025 Mar 12;24(1):117. doi: 10.1186/s12933-024-02561-z.
  • Korosoglou G, Schmidt A, Lichtenberg M, Malyar N, Stavroulakis K, Reinecke H, Grozinger G, Patrone L, Varcoe RL, Soukas PA, Bockler D, Behrendt CA, Secemsky EA, Zeller T, Blessing E, Langhoff R, Rammos C. Global Algorithm for the Endovascular Treatment of Chronic Femoropopliteal Lesions: An Interdisciplinary Expert Opinion Statement. JACC Cardiovasc Interv. 2025 Mar 10;18(5):545-557. doi: 10.1016/j.jcin.2024.11.038.
  • Pitt B, Budden J, Anker SD, Butler J. Reply: The Impact of Patiromer on Heart Failure Treatment With Angiotensin Inhibitors and MRAs. J Am Coll Cardiol. 2025 Mar 18;85(10):e115. doi: 10.1016/j.jacc.2024.12.029.
  • Doehner W, Boriani G, Potpara T, Blomstrom-Lundqvist C, Passman R, Sposato LA, Dobrev D, Freedman B, Van Gelder IC, Glotzer TV, Healey JS, Karapanayiotides T, Lip GYH, Merino JL, Ntaios G, Schnabel RB, Svendsen JH, Svennberg E, Wachter R, Haeusler KG, Camm AJ. Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association. Europace. 2025 Mar 5;27(3):euaf019. doi: 10.1093/europace/euaf019.
  • Neumiller JJ, Tuttle KR. Extending Kidney Protective Therapy to Type 1 Diabetes: The Time is Now. Clin J Am Soc Nephrol. 2025 Apr 1;20(4):474-476. doi: 10.2215/CJN.0000000685. Epub 2025 Mar 12.
  • Pandey A, Lewis GD, Borlaug BA, Shah SJ, Sauer AJ, Litwin S, Sharma K, Jorkasky DK, Tarka EA, Khan SM, Kitzman DW. Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial. JAMA Cardiol. 2025 Mar 12:e250103. doi: 10.1001/jamacardio.2025.0103.
  • Goodyear E, Kunamalla A, Ferro EG, Modi RM, D’Avila A, Locke AH, Liu D, Laham RJ. Successful Percutaneous Extraction of a WATCHMAN FLX Device From the Left Ventricular Outflow Tract. JACC Case Rep. 2025 Jan 23;30(8):103186. doi: 10.1016/j.jaccas.2024.103186.
  • Christenson RH, Alahapperuma D, Allen BR, Guidi JL, Headden G, Peacock WF, Winden N, Januzzi JL Jr. Analytical Characterization and Validation of a Novel Automated Amino-Terminal proB-Type Natriuretic Peptide Assay. J Appl Lab Med. 2025 May 2;10(3):659-670. doi: 10.1093/jalm/jfaf012.
  • Volterrani M, Halasz G, Adamopoulos S, Agostoni PG, Butler J, Coats AJS, Cohen-Solal A, Doehner W, Filippatos G, Jankowska E, Lam CSP, Lambrinou E, Lund LH, Rosano G, Metra M, Paolillo S, Perrone Filardi P, Rakisheva A, Savarese G, Seferovic P, Tocchetti CG, Piepoli M. Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2025 Mar 12:zwad400. doi: 10.1093/eurjpc/zwad400.
  • Volterrani M, Halasz G, Adamopoulos S, Agostoni PG, Butler J, Coats AJS, Cohen-Solal A, Doehner W, Filippatos G, Jankowska E, Lam CSP, Lambrinou E, Lund LH, Rosano G, Metra M, Paolillo S, Perrone Filardi P, Rakisheva A, Savarese G, Seferovic P, Tocchetti CG, Piepoli M. Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Heart Fail. 2025 Mar 12. doi: 10.1002/ejhf.3440.
  • Anand SS, Bosch J, Mehran R, Mehta SR, Patel MR. Designing inclusive clinical trials: how researchers can drive change to improve diversity. BMJ. 2025 Mar 11;388:e082485. doi: 10.1136/bmj-2024-082485.
  • Karchmer AW, Kaufman NJ, Park SY, Modi RM, Abdul-Azim A, van den Berg P, Matos JD, Kramer DB, Zimetbaum PJ. Quantitative Microbial Cell-Free DNA Sequencing from Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices. Clin Infect Dis. 2025 Mar 11:ciaf113. doi: 10.1093/cid/ciaf113.
  • Scimeca G, Krishnathasan D, Rashedi S, Lan Z, Sato A, Hamade N, Bejjani A, Khairani CD, Davies J, Porio N, Assi AA, Armero A, Tristani A, Ortiz-Rios MD, Nauffal V, Almarzooq Z, Wei E, Zuluaga-Sanchez V, Zarghami M, Achanta A, Jesudasen SJ, Tiu B, Merli GJ, Leiva O, Fanikos J, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll B, Goldhaber SZ, Campia U, Bikdeli B, Piazza G. Predictors of venous thromboembolic events in hospitalized patients with COVID-19. J Thromb Thrombolysis. 2025 Apr;58(4):485-496. doi: 10.1007/s11239-025-03078-2. Epub 2025 Mar 10.
  • Schwartz GG, Szarek M, Steg PG. Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: Reply. Eur J Prev Cardiol. 2025 Mar 10:zwaf136. doi: 10.1093/eurjpc/zwaf136.
  • Kim JM, Secemsky EA. Addition by Subtraction: A Novel Device for Pulmonary Embolus Thrombectomy. J Soc Cardiovasc Angiogr Interv. 2024 Dec 28;4(1):102508. doi: 10.1016/j.jscai.2024.102508. eCollection 2025 Jan.
  • Sampath-Kumar R, Mahmud E, Korkmaz K, Ang L, Al Khiami B, Melendez A, Reeves R, Ben-Yehuda O. Patient Characteristics and Outcomes of Radial to Femoral Access-Site Crossover. J Soc Cardiovasc Angiogr Interv. 2025 Jan 21;4(1):102450. doi: 10.1016/j.jscai.2024.102450. eCollection 2025 Jan.
  • Helms J, Frere C, Thiele T, Tanaka KA, Neal MD, Steiner ME, Connors JM, Levy JH. Corrigendum to ‘Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis.’: [Journal of Thrombosis and Haemostasis (2023) Volume 21, Issue 2, February 2023, Pages 373-396]. J Thromb Haemost. 2025 May;23(5):1739. doi: 10.1016/j.jtha.2025.02.021. Epub 2025 Mar 8.
  • Byrne RA, Valgimigli M, Bhatt DL, Coughlan JJ, Gibson CM, Rossello X, Gorog DA, Ibanez B, James S, Landi A, Steg PG, Stone GW, Andreotti F. Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months. Eur Heart J. 2025 Jun 2;46(21):1965-1978. doi: 10.1093/eurheartj/ehaf070.
  • Gill K, Mills GB, Wang W, Pompei G, Kunadian V. Latest evidence on assessment and invasive management of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in the older population. Expert Rev Cardiovasc Ther. 2025 Jan-Mar;23(3):73-86. doi: 10.1080/14779072.2025.2476125. Epub 2025 Mar 12.
  • Abdel-Razek O, Rastegar H, Liu D, Senthilnathan V, Poulin MF, Cutlip D, Kavinsky C, Laham R. Spontaneous Partial Dehiscence of Trifecta Bioprosthetic Valve Leaflet. JACC Case Rep. 2025 Mar 5;30(5):103075. doi: 10.1016/j.jaccas.2024.103075.
  • Parhofer KG, Aguiar C, Banach M, Drexel H, Gouni-Berthold I, de Isla LP, Rietzschel E, Zambon A, Ray KK. Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia. Eur Heart J Cardiovasc Pharmacother. 2025 Mar 6:pvaf007. doi: 10.1093/ehjcvp/pvaf007.
  • Stehlik J, Farr MA, Mehra MR, Schroder JN, D’Alessandro DA, Pal JD, Villavicencio MA, Gruber PJ, Couper GS, Shudo Y, Patel PC, Daneshmand MA, Klein L, Shah AS, Skipper ER, Esmailian F, Goldstein D, Ohira S, Lozonschi L, Kaczorowski DJ, Takeda K, Malyala RSR, Haft JW, Meyer DM, Sun BC, Pretorius V, Kilic A, Anyanwu AC, Williams CT, Pham DT, Kai M, Sulemanjee NZ, Itoh A, Funamoto M, Salerno CT, Ikonomidis JS, Durham LA, Shaffer A, Zhou X, Zafar F, Pinney SP, Milano CA. Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry. Circulation. 2025 Apr;151(13):896-909. doi: 10.1161/CIRCULATIONAHA.124.071743. Epub 2025 Mar 7.
  • Sankaranarayanan R, Hartshorne-Evans N, Mclean L, Jones J, Salla M, Chakrabarti B, Hadcroft J, Pritchard C, Smith A, Lam CSP. Early Detection of Cardiorespiratory Diseases at Everton BEAT-Breathlessness Community Hub: How Football Can Help Save Lives. JACC Heart Fail. 2025 Apr;13(4):663-665. doi: 10.1016/j.jchf.2025.01.008. Epub 2025 Mar 5.
  • Inciardi RM, Lu H, Claggett BL, Desai AS, Jhund PS, Lam CSP, Kosiborod MN, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Kober L, Ponikowski P, Sabatine MS, Petersson M, Langkilde AM, McMurray JJV, Vaduganathan M, Solomon SD. Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum: DAPA-HF and DELIVER. JACC Heart Fail. 2025 Apr;13(4):618-627. doi: 10.1016/j.jchf.2024.11.023. Epub 2025 Mar 5.
  • Kar S, Price MJ, Morse MA, Rinaldi MJ, Mahoney P, Denti P, Asch FM, Zamorano JL, Aiyer J, Huang R, Maisano F, von Bardeleben RS, Rodriguez E. Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease: 1-Year Results From EXPANDed. JACC Cardiovasc Interv. 2025 Apr 14;18(7):898-908. doi: 10.1016/j.jcin.2024.12.023. Epub 2025 Mar 5.
  • Bobi J, Jimenez-Trinidad FR, Ortega-Paz L, Cortes-Serra N, Lazaro I, Rodriguez JJ, Fernandez-Becerra C, Garcia-Alvarez A, Sabate M, Brugaletta S, Dantas AP. Antiangiogenic effect of circulating extracellular vesicles in acute coronary syndrome: Role of miR-199a-3p and miR-125a-5p. Eur J Clin Invest. 2025 Mar 6:e70022. doi: 10.1111/eci.70022.
  • McDowell K, Docherty KF, Campbell RT, Henderson AD, Jhund PS, Claggett BL, Desai AS, Lay-Flurrie J, Hofmeister L, Scalise A, Lam CSP, Petrie MC, Schou M, Senni M, Shah SJ, Udell JA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model: A Secondary Analysis of FINEARTS-HF. JAMA Cardiol. 2025 Mar 5:e250025. doi: 10.1001/jamacardio.2025.0025.
  • Nerlekar N, Vasanthakumar SA, Whitmore K, Soh CH, Chan J, Goel V, Ryan J, Jones C, Stanton T, Mitchell G, Tonkin A, Watts GF, Nicholls SJ, Marwick TH, Coronary Artery Calcium Score: Use to Guide Management of Hereditary Coronary, Artery Disease (CAUGHT-CAD) Investigators. Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial. JAMA. 2025 Apr 22;333(16):1403-1412. doi: 10.1001/jama.2025.0584.
  • Greene SJ, Butler J, Fonarow GC. Simultaneous or Rapid Initiation of Combination Therapy for Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2025 May 1;10(5):407-408. doi: 10.1001/jamacardio.2025.0038.
  • Bohm M, Butler J, Coats A, Lauder L, Mahfoud F, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Hauske SJ, Schueler E, Wanner C, Verma S, Zannad F, Packer M, Anker SD. Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur Heart J. 2025 Apr 7;46(14):1304-1317. doi: 10.1093/eurheartj/ehae938.
  • Cheng K, Hii R, Lim E, Yuvaraj J, Nicholls SJ, Dey D, Lin A, Wong DTL. Effect of statin therapy on coronary inflammation assessed by pericoronary adipose tissue computed tomography attenuation. Eur Heart J Cardiovasc Imaging. 2025 Apr 30;26(5):784-793. doi: 10.1093/ehjci/jeaf062.
  • Gale CP, Hurst JR, Hawkins NM, Bourbeau J, Han MK, Lam CSP, Marciniuk DD, Price D, Stolz D, Gluckman T, Zieroth S, Nadarajah R, Young RP, Singh D, Martinez FJ, Berg DD, Bhutani M, Global Working Group on Cardiopulmonary Risk. Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study. Eur J Prev Cardiol. 2025 Mar 3:zwaf119. doi: 10.1093/eurjpc/zwaf119.
  • Lalani C, Secemsky EA, Yeh RW. Drug-coated balloons in small vessel de novo coronary artery disease: better than DES? Eur Heart J. 2025 May 2;46(17):1600-1602. doi: 10.1093/eurheartj/ehaf083.
  • Gibson CM, Desai UR, Wesling ME. Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas. Expert Opin Pharmacother. 2025 Apr;26(5):605-616. doi: 10.1080/14656566.2025.2475192. Epub 2025 Mar 5.
  • Mills GB, Kotanidis CP, Mehta S, Tiong D, Badings EA, Engstrom T, van ‘t Hof AWJ, Hofsten D, Holmvang L, Jobs A, Kober L, Milasinovic D, Milosevic A, Stankovic G, Thiele H, Mehran R, Kunadian V. Early Versus Delayed Invasive Management of Female Patients With Non-ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis. Circ Cardiovasc Interv. 2025 Mar;18(3):e014763. doi: 10.1161/CIRCINTERVENTIONS.124.014763. Epub 2025 Mar 4.
  • Gu Z, He L, Naeem A, Chan PM, Mohamed A, Khalil H, Guo Y, Shi W, Dupre ME, Xiao G, Peterson ED, Xie Y, Navar AM, Yang DM. SBDH-Reader: an LLM-powered method for extracting social and behavioral determinants of health from medical notes. medRxiv [Preprint]. 2025 Feb 21:2025.02.19.25322576. doi: 10.1101/2025.02.19.25322576.
  • Yancy CW. Heart Failure: A Century View, From Failure to Function. Circulation. 2025 Mar 4;151(9):585-588. doi: 10.1161/CIRCULATIONAHA.124.072249. Epub 2025 Mar 3.
  • Suzuki T, Loyde E, Chen S, Etzrodt V, Idowu TO, Clark AJ, Saade MC, Flores BM, Lu S, Birrane G, Vemireddy V, Seeliger B, David S, Parikh SM. Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis. J Clin Invest. 2025 Mar 3;135(8):e174135. doi: 10.1172/JCI174135. eCollection 2025 Apr 15.
  • Yang M, Kondo T, Dewan P, Desai AS, Lam CSP, Lefkowitz MP, Packer M, Rouleau JL, Vaduganathan M, Zile MR, Jhund PS, Kober L, Solomon SD, McMurray JJV. Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction. Circ Heart Fail. 2025 Mar;18(3):e011598. doi: 10.1161/CIRCHEARTFAILURE.124.011598. Epub 2025 Mar 3.
  • Margineanu C, Antohi L, Ambrosy A, Bartos D, Collins S, Sinescu C, Tatu Chitoiu G, Lighezan D, Vinereanu D, Pop D, Pang PS, Butler J, Chioncel O. Impact of iron deficiency on congestion and postdischarge survival in patients recently hospitalised for decompensated heart failure: a multicentre, prospective, observational analysis of the FERIC-RO study. Open Heart. 2025 Feb 27;12(1):e002851. doi: 10.1136/openhrt-2024-002851.
  • Nagao A, Goto S, Goto S. Antithrombotic Therapy in People with Hemophilia-A Narrative Review. Thromb Haemost. 2025 Mar 28. doi: 10.1055/a-2548-4192.
  • Fujino M, Di Giovanni G, Butters Bhsc J, Kataoka Y, Hucko T, Nelson AJ, Nissen SE, Psaltis PJ, Nicholls SJ. Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS. Atherosclerosis. 2025 Apr;403:119145. doi: 10.1016/j.atherosclerosis.2025.119145. Epub 2025 Feb 20.
  • Diaz-Herrera BA, Roman-Rangel E, Castro-Garcia CA, Sierra-Lara Martinez D, Gopar-Nieto R, Velez-Talavera KG, Espinosa-Martinez MP, March-Mifsut S, Latapi-Ruiz-Esparza X, Preciado-Gutierrez OU, Alba-Valencia S, Sanchez-Alfaro HA, Gonzalez-Pacheco H, Arias-Mendoza A, Araiza-Garaygordobil D. Derivation of an artificial intelligence-based electrocardiographic model for the detection of acute coronary occlusive myocardial infarction. Arch Cardiol Mex. 2025 Feb 28;95(2):178-87. doi: 10.24875/ACM.24000195.
  • Ostrominski JW, Claggett BL, Miao ZM, Filippatos G, Desai AS, Jhund PS, Henderson A, Brinker M, Schloemer P, Viswanathan P, Lage A, Rohwedder K, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Vaduganathan M. Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease. Diabetes Care. 2025 May 1;48(5):745-755. doi: 10.2337/dc24-1873.
  • Fioretti F, Hibbert B, Eckman PM, Simard T, Labinaz M, Nazer B, Wiley M, Gupta B, Sauer AJ, Shah H, Sorajja P, Pineda AM, Missov E, Aldaia L, Koulogiannis K, Gray WA, Zahr F, Butler J. Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year Results. JACC Heart Fail. 2025 Jun;13(6):987-999. doi: 10.1016/j.jchf.2025.02.003. Epub 2025 Feb 11.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara-Martinez D, Manzur-Sandoval D, Briseno-De-La-Cruz JL, Mendoza-Garcia S, Montanez-Orozco A, Arzate-Ramirez A, Arenas-Diaz JO, Gomez-Rodriguez CA, Santos-Alfaro HA, Hernandez-Montfort J, Arias-Mendoza A. Higher vasoactive usage despite hemodynamic goals is associated with higher mortality in acute myocardial infarction-related cardiogenic shock. Front Cardiovasc Med. 2025 Feb 13;12:1461714. doi: 10.3389/fcvm.2025.1461714. eCollection 2025.
  • Khaliel FH, Haq MI, Alsulbud AK, Altwaijri YA, Alenazy AB, Almustafa AR, Aly AA, Mehra MR. “First-in-human” totally robotic orthotopic heart transplant. J Heart Lung Transplant. 2025 Jun;44(6):1000-1003. doi: 10.1016/j.healun.2025.02.1685. Epub 2025 Feb 25.
  • Powell RJ, Farber A, Doros G, Chew D, Conte MS, Dake MD, Kiang S, Menard MT, Rosenfield K, Schneider PA, Siracuse JJ, Shaw P, Strong MB, Todoran T, White CJ, Kaufman JA. The Incidence and Consequences of Endovascular Technical Failure in Patients with Chronic Limb-Threatening Ischemia: Results from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb-Threatening Ischemia (BEST-CLI) Trial. J Vasc Interv Radiol. 2025 Jun;36(6):950-959. doi: 10.1016/j.jvir.2025.02.020. Epub 2025 Feb 25.
  • Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Apr;151(13):e771-e862. doi: 10.1161/CIR.0000000000001309. Epub 2025 Feb 27.
  • Isath A, Mehra MR. Cardio-systemic Stress and Trained Innate Immune Memory in Heart Failure. Transplantation. 2025 Apr 1;109(4):565-568. doi: 10.1097/TP.0000000000005278. Epub 2024 Nov 15.
  • Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS, Peer Review Committee Members. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025 Jun 10;85(22):2135-2237. doi: 10.1016/j.jacc.2024.11.009. Epub 2025 Feb 27.
  • Skouri H, Girerd N, Monzo L, Petrie MC, Bohm M, Adamo M, Mullens W, Savarese G, Yilmaz MB, Amir O, Bayes-Genis A, Bozkurt B, Butler J, Chioncel O, Mebazaa A, Merino JL, Moura B, Ponikowski P, Seferovic P, Rosano GMC, Metra M. Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025 Apr;27(4):707-722. doi: 10.1002/ejhf.3618. Epub 2025 Feb 26.
  • Takahashi T, Wei J, Iribarren AC, Gulati M, Cook-Wiens G, Nelson MD, Sharif B, Handberg EM, Anderson RD, Petersen J, Berman DS, Pepine CJ, Merz CNB. Rationale and design of the women’s ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF). Am Heart J. 2025 Jun;284:47-56. doi: 10.1016/j.ahj.2025.02.017. Epub 2025 Feb 24.
  • Fonarow GC, Hernandez AF, Udelson JE, Yancy CW. What Counts for Worsening Heart Failure Events. JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2025.0042.
  • Cunningham JW, Chatur S, Claggett BL, Vaduganathan M, Desai AS, Jhund PS, Llamas Esperon G, Lam CSP, Sato N, Senni M, Shah S, Voors A, Zannad F, Pitt B, Zieroth S, Brinker M, Rohwedder K, Kim SY, Lay-Flurrie J, Viswanathan P, McMurray JJV, Solomon SD. Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025 Feb 26;10(4):370-8. doi: 10.1001/jamacardio.2025.0016.
  • Nichol G, Dickert NW, Moeller JE, Hochman JS, Facemire C, Adams KN, Stone GW, Morrow DA, Thiele H, Henry TD, Simonton C, Rao SV, O’Neill W, Gilchrist I, Egelund R, Proudfoot A, Waksman R, West NEJ, Sapirstein JS, Krucoff MW. A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST-Segment-Elevation Myocardial Infarction and Cardiogenic Shock. J Am Heart Assoc. 2025 Mar 4;14(5):e037946. doi: 10.1161/JAHA.124.037946. Epub 2025 Feb 26.
  • Bullock-Palmer RP, Gulati M, Lundberg G, Sanghavi M, Quesada O, Reza N, Grapsa J, Lee J, Volgman AS, Mehta L, Lewis SJ, Tamirisa KP. Cultivating a thriving environment for women in cardiology through leadership and inclusion. Am Heart J Plus. 2025 Jan 15;50:100500. doi: 10.1016/j.ahjo.2025.100500. eCollection 2025 Feb.
  • Romoli M, Urbinati G, Tudisco V, Toscano A, Eusebi P, Giammello F, D’Anna L, Palaiodimou L, Katsanos AH, Diana F, Sacco S, Yaghi S, Zini A, Rubiera Del Fueyo MA, Cameron AC, Sposato LA, Paciaroni M, Tsivgoulis G. Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke. Neurology. 2025 Mar 25;104(6):e213426. doi: 10.1212/WNL.0000000000213426. Epub 2025 Feb 25.
  • Arslani K, Engstrom T, Maeng M, Kjoller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Botker HE, Matsumura M, Mintz GS, Frobert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie O, Omerovic E, Held C, James SK, Ali ZA, Erlinge D, Stone GW. Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy. JACC Cardiovasc Imaging. 2025 Jun;18(6):696-706. doi: 10.1016/j.jcmg.2024.11.002. Epub 2025 Feb 24.
  • van der Bijl MF, van der Veen J, Fiolet ATL, Boersma E, Cornel JH, Eikelboom JW, Nidorf SM, Thompson PL, Jannink J, Westendorp ICD, Mosterd A, den den Ruijter HM, Roeters van Lennep JE. Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial. J Am Heart Assoc. 2025 Mar 4;14(5):e040412. doi: 10.1161/JAHA.124.040412. Epub 2025 Feb 25.
  • Vidal-Petiot E, Kab S, Steg PG. New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence. Circulation. 2025 Feb 25;151(8):518-520. doi: 10.1161/CIRCULATIONAHA.124.072696. Epub 2025 Feb 24.
  • Al Said S, Kaier K, Nury E, Alsaid D, Gibson CM, Bax J, Westermann D, Meerpohl JJ. Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis. Cochrane Database Syst Rev. 2025 Feb 24;2(2):CD013745. doi: 10.1002/14651858.CD013745.pub2.
  • Kritchevsky S, Zamora E, Bhasin S, Cohen A, Chandler A, Covinsky K, Crane H, Cummings S, Erlandson K, Espeland M, Espinoza S, Ferrucci L, Fleming A, Forman D, LaCroix-Fralish M, Gonzales M, Justice J, Kiel D, Kuchel G, Mannick J, Menetski J, Miller M, Musi N, Newman A, Newman J, Owens SS, Pandey A, Reilly K, Sedrak M, Wagner J, Whitson H, Williamson J. Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus. Res Sq [Preprint]. 2025 Feb 12:rs.3.rs-5920485. doi: 10.21203/rs.3.rs-5920485/v1.
  • Costa IBSDS, Furtado RHM, Drager LF, de Barros E Silva PGM, Melo MDT, Araruna P, Bacchiega BC, Cauduro S, Walter E, Fialho GL, Silvestre O, Damiani LP, Barbosa LM, Luz MN, Silva ACA, de Mattos RR, Saretta R, Rehder MHHS, Hajjar LA, Lopes-Fernandez T, Dent S, Gibson CM, Lopes RD, Kalil Filho R, on behalf the CARDIOTOX Investigators. Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: Design and rationale of the CARDIOTOX trial. Am Heart J. 2025 Jul;285:1-11. doi: 10.1016/j.ahj.2025.02.014. Epub 2025 Feb 22.
  • Mauch J, Puthenpura M, Martens P, Engelman T, Grodin JL, Segar MW, Pandey A, Tang WHW. Adequacy of Loop Diuretic Dosing in Treatment of Acute Heart Failure: Insights from the BAN-ADHF Diuretic Resistance Risk Score. Am J Cardiol. 2025 Jun 1;244:18-27. doi: 10.1016/j.amjcard.2025.02.018. Epub 2025 Feb 20.
  • Herzig MS, Kochar A, Hermiller JB, Davies RE, Nicholson WJ, Orui H, Secemsky EA. Real-World Reductions in Lead-Free Radiation Exposure with the Rampart System during Endovascular Procedures. Am J Cardiol. 2025 May 15;243:59-64. doi: 10.1016/j.amjcard.2025.02.019. Epub 2025 Feb 20.
  • Gibson CM, Bahit MC, Mehran R, Mehta SR, Lamee RA, Goto S, Weitz JI, Horrow J, Barnathan ES, Harrington RA, Mahaffey KW, Lam CSP, Pieper KS, Johnston SC, Hankey GJ, Plotnikov AN, Li D, Deng H, Steg PG, Librexia ACS Committees and Investigators.. Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS). Am Heart J. 2025 Jul;285:21-28. doi: 10.1016/j.ahj.2025.02.011. Epub 2025 Feb 20.
  • Gouin-Thibault I, Castellucci LA, Connors JM, Hardy M, Mansour A, Siguret V, Frere C, Levy JH, Cuker A, Lecompte T, Mullier F. Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTH. J Thromb Haemost. 2025 May;23(5):1717-1726. doi: 10.1016/j.jtha.2025.02.012. Epub 2025 Feb 19.
  • Barleben AR, Patel RJ, Farber A, Menard MT, Venermo M, Creager MA, Reitz KM, Strong M, Rosenfield K, Doros G, Dake M, Chaer RA. An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia. J Vasc Surg. 2025 Jun;81(6):1411-1419.e1. doi: 10.1016/j.jvs.2025.02.015. Epub 2025 Feb 19.
  • Goel H, Kapadia MV, Goenka KV, Schaefer CM, Revere FL, Januzzi JL Jr, Datar SS, McCarthy CP, Mehta AG. Utilization of Cardiovascular Procedures, Consultation Services, and Cardioprotective Medications Among Type 2 Myocardial Infarction Patients. JACC Adv. 2025 Mar;4(3):101629. doi: 10.1016/j.jacadv.2025.101629. Epub 2025 Feb 20.
  • Myhre PL, Grupper A, Mebazaa A, Davison B, Edwards C, Takagi K, Adamo M, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Deniau B, Diaz R, Filippatos G, Gayat E, Kimmoun A, Ter Maaten JM, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Tomasoni D, Voors A, Cotter G, Lam CSP. Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial. JACC Adv. 2025 Mar;4(3):101607. doi: 10.1016/j.jacadv.2025.101607. Epub 2025 Feb 21.
  • Sridhar VS, Kugathasan L, Lovblom LE, Huajing N, Lanctot SO, Maahs DM, Bjornstad P, Caramori ML, Rosas SE, Rossing P, Tuttle KR, Pop-Busui R, Polsky S, Karger AB, Wu C, Galecki AT, Perkins BA, Mauer M, Doria A, Cherney DZI. Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney Disease. J Am Soc Nephrol. 2025 Feb 21. doi: 10.1681/ASN.0000000668.
  • Lee MMY, Ghouri N, Misra A, Kang YM, Rutter MK, Gerstein HC, McGuire DK, Sattar N. Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity. Diabetes Care. 2025 Mar 1;48(3):489-493. doi: 10.2337/dc24-1533.
  • Rong R, Gu Z, Lai H, Nelson TL, Keller T, Walker C, Jin KW, Chen C, Navar AM, Velasco F, Peterson ED, Xiao G, Yang DM, Xie Y. A deep learning model for clinical outcome prediction using longitudinal inpatient electronic health records. medRxiv [Preprint]. 2025 Jan 23:2025.01.21.25320916. doi: 10.1101/2025.01.21.25320916.
  • Khan MS, Butler J, Anker M. Weight Gain Among Cancer Patients Receiving Chemotherapy-Facts and Numbers. J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13694. doi: 10.1002/jcsm.13694.
  • Radakrishnan A, Agrawal S, Singh N, Barbieri A, Shaw LJ, Gulati M, Lala A. Underpinnings of Heart Failure With Preserved Ejection Fraction in Women – From Prevention to Improving Function. A Co-publication With the American Journal of Preventive Cardiology and the Journal of Cardiac Failure. J Card Fail. 2025 Feb 10:S1071-9164(25)00037-5. doi: 10.1016/j.cardfail.2025.01.008.
  • McCarthy CP, Bruno RM, Rahimi K, Touyz RM, McEvoy JW. What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension? Hypertension. 2025 Mar;82(3):432-444. doi: 10.1161/HYPERTENSIONAHA.124.24173. Epub 2024 Dec 31.
  • Hanlon EL, Carroll BJ, Krawisz AK, Mewaldt C, Secemsky EA, Cluett JL. Under Pressure: Renal Artery Stenosis Treatment for Resistant Hypertension. Hypertension. 2025 Mar;82(3):403-406. doi: 10.1161/HYPERTENSIONAHA.125.23978. Epub 2025 Feb 19.
  • Kunadian V, Gitto M, Vogel B, Sartori S, Angiolillo DJ, Bhatt DL, Chehab BM, Feng Y, de la Torre Hernandez JM, Krucoff MW, Maksoud A, Mankerious N, Oliva A, Picon H, Richardt G, Sardella G, Thiele H, Toelg R, Varenne O, Vranckx P, Windecker S, Valgimigli M, Mehran R. 1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI. JACC Cardiovasc Interv. 2025 Apr 14;18(7):866-878. doi: 10.1016/j.jcin.2025.01.424. Epub 2025 Feb 19.
  • Nathan AS, Kennedy KF, Reddy KP, Fanaroff AC, Kolansky DM, Kobayashi TJ, Khatana SAM, Dayoub EJ, Eberly L, Rao SV, Mehran R, Bhatt D, Yeh RW, Spertus JA, Giri J. Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among US Hospitals. J Am Heart Assoc. 2025 Mar 4;14(5):e038317. doi: 10.1161/JAHA.124.038317. Epub 2025 Feb 19.
  • Aggarwal R, Bhatt DL, Steg PG, Miller M, Brinton EA, Dunbar RL, Ketchum SB, Tardif JC, Martens FMAC, Ballantyne CM, Szarek M, Mason RP, REDUCE-IT Investigators. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025 Mar 4;14(5):e038656. doi: 10.1161/JAHA.124.038656. Epub 2025 Feb 19.
  • Bonaca MP, Lang NN, Chen A, Amiri-Kordestani L, Lipka L, Zwiewka M, Strnadova C, Klaar S, Dent S, Janicijevic TK, Herrmann J, Barac A, de Boer RA, Deswal A, Schou M, Neilan TG, van der Meer P, Moslehi J, Kondapalli L, Ky B, Fernandez TL, Cornell RF, Flaig TW, Hsia J, Sharon E, de Azambuja E, Seltzer J, Januzzi JL, Petrie MC. Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer. JACC CardioOncol. 2025 Feb;7(2):83-95. doi: 10.1016/j.jaccao.2024.09.014. Epub 2024 Dec 10.
  • Juhasz V, Quinaglia T, Drobni ZD, Heemelaar JC, Neuberg DS, Han Y, Ky B, Kwong RY, Januzzi JL, Asnani A, Redd RA, Mousavi N, Jerosch-Herold M, Scherrer-Crosbie M, Neilan TG. Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy. JACC CardioOncol. 2025 Feb;7(2):125-137. doi: 10.1016/j.jaccao.2024.11.008. Epub 2025 Jan 28.
  • Balagny P, D’Ortho MP, Berard L, Rousseau A, Gourmelen J, Ravaud P, Durand-Zaleski I, Simon T, Steg PG, AMI SLEEP investigators. AMI-Sleep: protocol for a prospective study of sleep-disordered breathing/sleep apnoea syndrome and incident cardiovascular events after acute myocardial infarction. BMJ Open. 2025 Feb 18;15(2):e090093. doi: 10.1136/bmjopen-2024-090093.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH. This month: from groundbreaking insights to global conversations-we are just one step away from Florence! Join the leading edge of Acute Cardiovascular Care! Eur Heart J Acute Cardiovasc Care. 2025 Mar 22;14(3):129-130. doi: 10.1093/ehjacc/zuaf021.
  • Gupta T, Barrett T, Dauerman HL, Lahoud RN. Novel Wire-Based Technique for Percutaneous Balloon Mitral Valvuloplasty. JACC Case Rep. 2025 Feb 5;30(3):103130. doi: 10.1016/j.jaccas.2024.103130. eCollection 2025 Feb 5.
  • Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG. Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial. Lancet Diabetes Endocrinol. 2025 Apr;13(4):321-332. doi: 10.1016/S2213-8587(24)00362-0. Epub 2025 Feb 14.
  • Gragnano F, Calabro P, Angiolillo DJ. Deciphering the Role of In-hospital Bleeding in Acute Coronary Syndromes. J Cardiovasc Pharmacol. 2025 May 1;85(5):319-321. doi: 10.1097/FJC.0000000000001685.
  • Packer M, Butler J. The win ratio for trials for heart failure: Academic desperation or investigator decadence? Eur J Heart Fail. 2025 Apr;27(4):620-622. doi: 10.1002/ejhf.3608. Epub 2025 Feb 16.
  • Saldarriaga CI, Zannad F, McMullan CJ, Xing A, Gates D, Anstrom KJ, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O’Connor C, Patel M, Ponikowski P, Reddy YNV, Rosano GMC, Senni M, Udelson J, Voors AA, Butler J. Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial. Eur J Heart Fail. 2025 Feb 16. doi: 10.1002/ejhf.3598.
  • Shishikura D, Kataoka Y, Nicholls SJ, Ray KK, Puri R, Kusumoto H, Yamauchi Y, Sakane K, Fujisaka T, Morita H, Murai K, Iwai T, Sawada K, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Nakao K, Otsuka F, Nishihira K, Takamisawa I, Asaumi Y, Noguchi T, Harada-Shiba M, Hoshiga M. Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL. J Clin Lipidol. 2025 Jan 3:S1933-2874(24)00305-2. doi: 10.1016/j.jacl.2024.12.019.
  • Nicholls SJ, Nelson AJ. Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering Therapy. Curr Atheroscler Rep. 2025 Feb 15;27(1):32. doi: 10.1007/s11883-025-01280-4.
  • Cutlip DE, Mehran R, Doros G, Kaplinskiy V, Lee J, Zheng L, Kausik M, Osborn E, Waksman R. Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: Rationale and design. Am Heart J. 2025 Jun;284:11-19. doi: 10.1016/j.ahj.2025.02.001. Epub 2025 Feb 12.
  • Bainey KR, Welsh RC, Zheng Y, Arias-Mendoza A, Ristic AD, Averkov OV, Lambert Y, Temple T, Ly E, Bogaerts K, Sinnaeve P, Westerhout CM, Van de Werf F, Armstrong PW, STREAM-2 Investigators. Pharmaco-invasive strategy and dosing of tenecteplase in STEMI patients 60 to <75 years: An inter-trial comparison of the STREAM-1 and STREAM-2 trials. Am Heart J. 2025 Jun;284:20-31. doi: 10.1016/j.ahj.2025.02.002. Epub 2025 Feb 12.
  • Cotter G, Davison B, Biegus J, Pagnesi M, Metra M, Butler J, Chioncel O, Ponikowski P, Mebazaa A. Increasing Evidence Supports the Benefits of Rapid Uptitration of the Neurohormonal Blockade in HFmrEF/HFpEF Patients With AHF. J Card Fail. 2025 Apr;31(4):721-724. doi: 10.1016/j.cardfail.2024.12.015. Epub 2025 Feb 11.
  • Silkowski MK, Tedford RJ, Butler J, Houston BA. PCWL: A Compelling Hemodynamic Metric in Advancing HFpEF Diagnosis. J Card Fail. 2025 May;31(5):845-847. doi: 10.1016/j.cardfail.2025.02.005. Epub 2025 Feb 11.
  • Ivey-Miranda JB, Rao VS, Shaburishvili T, Verulava I, Khabeishvili N, Petrie MC, Butler J, Nunez J, Biegus J, Ponikowski P, Damman K, Collins SP, Testani JM, Cox ZL. Reprieve System for the Treatment of Patients With Acute Decompensated Heart Failure. J Card Fail. 2025 Feb 11:S1071-9164(25)00053-3. doi: 10.1016/j.cardfail.2025.02.002.
  • Mirzai S, Chen H, Pastva AM, Reeves GR, Mentz RJ, Kitzman DW, Whellan DJ, Nelson MB, Peters AE, Pandey A, Kritchevsky SB, Bertoni AG. Functional Sarcopenia and Physical Rehabilitation Response in Older Adults Hospitalized for Acute Heart Failure: A Secondary Analysis of the REHAB-HF Trial. Circ Heart Fail. 2025 Mar;18(3):e012550. doi: 10.1161/CIRCHEARTFAILURE.124.012550. Epub 2025 Feb 13.
  • Fioretti F, Nair AP, Anker SD, Borlaug BA, Kereiakes DJ, Lindenfeld J, Stone GW, Butler J. Therapeutic left-to-right shunting in heart failure. Eur Heart J. 2025 May 14;46(19):1787-1802. doi: 10.1093/eurheartj/ehaf120.
  • Giordano S, Camera M, Brambilla M, Sarto G, Spadafora L, Bernardi M, Iaconelli A, D’Amario D, Biondi-Zoccai G, Celia AI, Tremoli E, Frati G, Angiolillo DJ, Sciarretta S, Galli M. Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition? Int J Mol Sci. 2025 Jan 28;26(3):1136. doi: 10.3390/ijms26031136.
  • Fioretti F, Stone GW, Butler J. Failure to improve cardiac remodelling and outcomes post-myocardial infarction: Insights from EMPRESS-MI. Eur J Heart Fail. 2025 May;27(5):800-803. doi: 10.1002/ejhf.3602. Epub 2025 Feb 12.
  • Laufs U, Lincoff AM, Nicholls SJ, Li N, Bloedon L, Sasiela WJ, Powell HA, Herout PM, Thompson PD, Nissen SE. Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial. J Clin Lipidol. 2025 Mar-Apr;19(2):337-347. doi: 10.1016/j.jacl.2024.12.014. Epub 2024 Dec 25.
  • Gill K, Kunadian V. Updated evidence on selection and implementation of an invasive treatment strategy for older patients with non-ST-segment elevation myocardial infarction. Heart. 2025 May 23;111(12):546-556. doi: 10.1136/heartjnl-2024-325157.
  • Damasceno A, Saidu H, Cotter G, Davison B, Edwards C, Celutkiene J, Adamo M, Arrigo M, Barros M, Biegus J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Deniau B, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Ter Maaten JM, Tomasoni D, Voors AA, Takagi K, Mebazaa A, Sliwa K. Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study. ESC Heart Fail. 2025 Jun;12(3):1594-1605. doi: 10.1002/ehf2.15156. Epub 2025 Feb 12.
  • Incontri D, Marchina S, Wilson M, Wang JY, Losso M, Andreev A, Lin D, Heistand EC, Carvalho F, Marchal J, Nallaparaju A, Lioutas V, Selim MH. Sex Differences in Markers of Cerebral Small Vessel Disease in Patients with Lobar Intracerebral Hemorrhage. Eur Neurol. 2025;88(1):11-17. doi: 10.1159/000542983. Epub 2025 Feb 12.
  • Khan MS, Jamil A, Shakoor M, Greene SJ, Fonarow GC, Bhatt DL, DiMaio JM, Mack MJ, Butler J. Patient Enrollment for Cardiovascular Clinical Trials in the United States. JAMA Cardiol. 2025 Mar 1;10(3):298-300. doi: 10.1001/jamacardio.2024.5537.
  • Embi PJ, Rhew DC, Peterson ED, Pencina MJ. Launching the Trustworthy and Responsible AI Network (TRAIN): A Consortium to Facilitate Safe and Effective AI Adoption. JAMA. 2025 May 6;333(17):1481-1482. doi: 10.1001/jama.2025.1331.
  • Chevli PA, Razavi AC, Evans JK, Kazibwe R, Connelly MA, Khan SS, Pandey A, Tattersall MC, Stein JH, Shapiro MD. Association between circulating ketone bodies and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Comput Tomogr. 2025 Feb 8:S1934-5925(25)00041-3. doi: 10.1016/j.jcct.2025.02.001.
  • El Beze N, Hamzi K, Henry P, Trimaille A, El Ouahidi A, Zakine C, Nallet O, Delmas C, Aboyans V, Goralski M, Albert F, Bonnefoy-Cudraz E, Bochaton T, Schurtz G, Lim P, Lequipar A, Goncalves T, Gall E, Pommier T, Lemarchand L, Meune C, Azzakani S, Bouleti C, Amar J, Dillinger JG, Steg PG, Vicaut E, Toupin S, Pezel T, ADDICT-ICCU investigators. Machine learning to detect recent recreational drug use in intensive cardiac care units. Arch Cardiovasc Dis. 2025 May;118(5):277-286. doi: 10.1016/j.acvd.2024.12.010. Epub 2025 Jan 30.
  • Sanchis J, Bueno H, Marti Sanchez D, Martinez-Selles M, Diez Villanueva P, Barrabes JA, Marin F, Villa A, Sanmartin Fernandez M, Llibre C, Sionis A, Elizaga J, Alfonso F, Nunez E, Nunez J, Kunadian V, Ariza-Sole A. Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial. Heart. 2025 Feb 8:heartjnl-2024-325254. doi: 10.1136/heartjnl-2024-325254.
  • Bays HE, Bloedon L, Brennan D, Lei L, Lincoff AM, Nicholls SJ, Plutzky J, Powell HA, Nissen SE. Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis. J Am Heart Assoc. 2025 Feb 18;14(4):e037898. doi: 10.1161/JAHA.124.037898. Epub 2025 Feb 8.
  • Schwartz GG, Szarek M, Reijnders E, Jukema JW, Bhatt DL, Bittner VA, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Ruhaak LR, Stevanovic I, Cobbaert CM, Steg PG. Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome. Eur J Prev Cardiol. 2025 Feb 8:zwaf067. doi: 10.1093/eurjpc/zwaf067.
  • Mesnier J, Steg PG. Navigating PCI Risks in Cancer Patients. Eur J Prev Cardiol. 2025 Feb 8:zwaf065. doi: 10.1093/eurjpc/zwaf065.
  • Bart NK, Zuckermann A, Mehra MR. The Emerging Myth of Primary Graft Dysfunction in the Era of Advanced Organ Preservation in Heart Transplantation. J Card Fail. 2025 Feb 6:S1071-9164(25)00043-0. doi: 10.1016/j.cardfail.2025.01.013.
  • Fukui S, Winkelmayer WC, Tedeschi SK, Marrugo J, Guan H, Harrold L, Litman HJ, Shinozaki T, Solomon DH. Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb;84(2):201-209. doi: 10.1136/ard-2024-226156. Epub 2025 Jan 2.
  • Liu Y, Zhang J, Thabane L, Bai X, Kang L, Lip GYH, Van Spall HGC, Xia M, Li G. Data-Sharing Statements Requested from Clinical Trials by Public, Environmental, and Occupational Health Journals: Cross-Sectional Study. J Med Internet Res. 2025 Feb 7;27:e64069. doi: 10.2196/64069.
  • Dupre ME, Dhingra R, Xu H, Lynch SM, Yang Q, Ford C, Green MD, Xian Y, Navar AM, Peterson ED. Racial and ethnic disparities in longitudinal trajectories of cardiovascular risk factors in U.S. middle-aged and older adults. PLoS One. 2025 Feb 7;20(2):e0318419. doi: 10.1371/journal.pone.0318419. eCollection 2025.
  • Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, Zhang S, Moore H, Rangaswami J, Bakris G, Butler J, Sheriff HM, Allman RM, Zeng-Treitler Q, Wu WC, Ahmed A. Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF. JACC Heart Fail. 2025 Mar;13(3):467-479. doi: 10.1016/j.jchf.2024.11.007. Epub 2025 Feb 5.
  • Chyou JY, Tay WT, Tromp J, Ouwerkerk W, Yiu KH, Cleland JGF, Collins SP, Angermann CE, Ertl G, Dahlstrom U, Dickstein K, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Lam CSP. Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure. JACC Heart Fail. 2025 Mar;13(3):453-464. doi: 10.1016/j.jchf.2024.11.009. Epub 2025 Feb 5.
  • Subramanian V, Betts T, Segar MW, Patel L, Keshvani N, Chandra A, Pandey A. m-Health Based Cardiac Rehabilitation Program for Management of Older Patients With HFpEF: A Pilot RCT. JACC Heart Fail. 2025 Apr;13(4):653-656. doi: 10.1016/j.jchf.2024.10.024. Epub 2025 Feb 5.
  • Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Pina IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. Heart Rhythm. 2025 Apr;22(4):1040-1051. doi: 10.1016/j.hrthm.2024.10.078. Epub 2025 Feb 5.
  • Bikdeli B, Angiolillo DJ, Valgimigli M. Incorporating the Totality of Ischemic and Hemorrhagic Events: The Case of the AUGUSTUS Trial. J Am Coll Cardiol. 2025 Mar 25;85(11):1169-1172. doi: 10.1016/j.jacc.2024.11.047. Epub 2025 Feb 5.
  • Rashedi S, Keykhaei M, Sato A, Steg PG, Piazza G, Eikelboom JW, Lopes RD, Bonaca MP, Yasuda S, Ogawa H, Shizuta S, Kimura T, Okumura Y, Andreotti F, Bertoletti L, Stone GW, Mehran R, Cohen DJ, Lip GYH, Bikdeli B. Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials. J Am Coll Cardiol. 2025 Mar 25;85(11):1189-1203. doi: 10.1016/j.jacc.2024.12.030. Epub 2025 Jan 17.
  • Ren QW, Teng TK, Ouwerkerk W, Tse YK, Tsang CTW, Wu MZ, Tse HF, Voors AA, Tromp J, Lam CSP, Yiu KH. Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure. Nat Commun. 2025 Feb 6;16(1):1408. doi: 10.1038/s41467-025-56790-1.
  • Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Pina IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. J Card Fail. 2025 Jan 22:S1071-9164(24)00971-0. doi: 10.1016/j.cardfail.2024.12.001.
  • Cheng CY, Lian TY, Zhu XJ, Virdone S, Sun K, Camm J, Li XM, Goto S, Pieper K, Kayani G, Fang XH, Jing ZC, Kakkar AK, GARFIELD-AF Investigators. Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF. Open Heart. 2025 Feb 6;12(1):e003109. doi: 10.1136/openhrt-2024-003109.
  • Senarathne UD, Lu ZX, Desra AP, Brown J, Nicholls SJ, Doery JCG. Incidental diagnosis of familial hypercholesterolaemia in a mother-daughter pair: the underdiagnosis of the disease highlighting the need for universal screening. BMJ Case Rep. 2025 Feb 5;18(2):e263538. doi: 10.1136/bcr-2024-263538.
  • Ulloa JG, Alabi O, McGinigle K, Lane J, Doros G, Menard M, Moreira CC, Judelson DR, Farber A, Conte MS, Rosenfeld K, Hamouda M, Kirksey L, Strong MB, Malas M, Kernodle A, Rowe VL. Outcomes for Hispanic patients undergoing open bypass in BEST-CLI. J Vasc Surg. 2025 Jun;81(6):1420-1429. doi: 10.1016/j.jvs.2025.01.212. Epub 2025 Feb 4.
  • Schwartz GG, Szarek M, Jukema JW, Cobbaert CM, Reijnders E, Bittner VA, Schwertfeger M, Bhatt DL, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Steg PG. Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial. Diabetes Care. 2025 Apr 1;48(4):596-604. doi: 10.2337/dc24-2110.
  • Zoller B, Connors JM. Response to Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism. Haematologica. 2025 Feb 6. doi: 10.3324/haematol.2025.287469.
  • Ingraham BS, Valgimigli M, Angiolillo DJ, Capodanno D, Rao SV, Urban P, Singh M. Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention. Mayo Clin Proc. 2025 Feb;100(2):304-331. doi: 10.1016/j.mayocp.2024.09.010.
  • Yang M, Kondo T, Talebi A, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Kober L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV. EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction: A Patient-Level Analysis of DAPA-HF and DELIVER. JACC Heart Fail. 2025 Feb;13(2):277-292. doi: 10.1016/j.jchf.2024.10.020.
  • Kobo O, Kaur G, Tamis-Holland JE, Zaman S, Bullock-Palmer RP, Tamirisa K, Gulati M, Mamas MA. Association of American Heart Association’s Life’s Essential 8 and mortality among US adults with and without cardiovascular disease. J Cardiol. 2025 Feb 3:S0914-5087(25)00015-2. doi: 10.1016/j.jjcc.2025.01.015.
  • Neuen BL, Catanese B, Chang A, Heise M, Tricoci P, Eckardt KU, Felker GM, Mahaffey KW, Wolf M, Chertow GM, on behalf of the POSIBIL ESKD Investigators. Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure. J Am Soc Nephrol. 2025 May 1;36(5):923-925. doi: 10.1681/ASN.0000000654. Epub 2025 Feb 5.
  • Dunlay SM, Pinney SP, Lala A, Stewart GC, McIlvennan C, Wong RP, Morris AA, Pagani FD, Allen LA, Breathett K, Cogswell R, Colvin MM, Cowger JA, Drakos SG, Gelfman LP, Kanwar MK, Kiernan MS, Kittleson MM, Lewis EF, Moazami N, Ogunniyi MO, Pandey A, Rogers JG, Schumacher KR, Slaughter MS, Tedford RJ, Teuteberg J, Valantine HA, DeFilippis EM, Dixon DD, Golbus JR, Gulati G, Hanff TC, Hsiao S, Lewsey SC, McCormick AD, Nayak A, Fenton KN, Longacre LS, Shanbhag SM, Taddei-Peters WC, Stevenson LW. Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action. JAMA Cardiol. 2025 Apr 1;10(4):391-398. doi: 10.1001/jamacardio.2024.5328.
  • Berg FH, Lassen MCH, Vaduganathan M, Fonarow GC, Yeh RW, Zheng Z, Gislason GH, Biering-Sorensen T, Wadhera RK. Cardiovascular Hospitalizations Among Older Adults in the US and Denmark. JAMA Cardiol. 2025 Apr 1;10(4):351-358. doi: 10.1001/jamacardio.2024.5303.
  • Lee HK, McCarthy CP, Jaffe AS, Body R, Alotaibi A, Sandoval Y, Januzzi JL Jr. High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness. J Appl Lab Med. 2025 May 2;10(3):710-730. doi: 10.1093/jalm/jfae161.
  • Alicic RZ, Neumiller JJ, Tuttle KR. Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease. Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i3-i17. doi: 10.1093/ndt/gfae212.
  • Mandel H, Yoo YJ, Allen AJ, Abedian S, Verzani Z, Karlson EW, Kleinman LC, Mudumbi PC, Oliveira CR, Muszynski JA, Gross RS, Carton TW, Kim C, Taylor E, Park H, Divers J, Kelly JD, Arnold J, Geary CR, Zang C, Tantisira KG, Rhee KE, Koropsak M, Mohandas S, Vasey A, Mohammad Mosa AS, Haendel M, Chute CG, Murphy SN, O’Brien L, Szmuszkovicz J, Guthe N, Santana JL, De A, Bogie AL, Halabi KC, Mohanraj L, Kinser PA, Packard SE, Tuttle KR, Hirabayashi K, Kaushal R, Pfaff E, Weiner MG, Thorpe LE, Moffitt RA. Long-COVID incidence proportion in adults and children between 2020 and 2024. Clin Infect Dis. 2025 Feb 5:ciaf046. doi: 10.1093/cid/ciaf046.
  • Kellner CP, Ali M, Kalagara R, Rao A, Smith C, Finesilver J, Hardigan T, Shigematsu T, Liang J, Poyraz FC, Waters MF, Selim M, Mocco J. SCUBA evacuation within 24 hours of basal ganglia hemorrhage results in promising functional outcomes. J Neurointerv Surg. 2025 Feb 4:jnis-2024-022591. doi: 10.1136/jnis-2024-022591.
  • Naik H, Price MJ, Kapadia S, Whisenant BK, Tadros P, Makkar R, Asgar AW, Fam N, Tang GHL, Mehta SR, Byrne T, Singh G, Panaich SS, Peterman K, Trusty PM, Hamid N, Hahn RT, Adams DH, Sorajja P. Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal Trial. JACC Clin Electrophysiol. 2025 May;11(5):1012-1020. doi: 10.1016/j.jacep.2025.01.001. Epub 2025 Jan 20.
  • Ferro EG, Kim JM, Lalani C, Abbott DJ, Yeh RW. Mechanical circulatory support for complex, high-risk percutaneous coronary intervention. EuroIntervention. 2025 Feb 3;21(3):e149-e160. doi: 10.4244/EIJ-D-24-00386.
  • Rao SV, Gutierrez JAT. A Win for Clinical Evidence: The First Head-to-Head Trial of Interventional Strategies for the Treatment of Pulmonary Embolism. Circulation. 2025 Feb 4;151(5):274-276. doi: 10.1161/CIRCULATIONAHA.124.072972. Epub 2025 Feb 3.
  • Pollock C, Carrero JJ, Kanda E, Ofori-Asenso R, Chen H, Garcia Sanchez JJ, Pentakota S, Pecoits-Filho R, Fishbane S, Lam CSP, Kashihara N, Wheeler DC. Correction: Baseline Characteristics of the DISCOVER CKD Prospective Cohort. Adv Ther. 2025 Mar;42(3):1419-1420. doi: 10.1007/s12325-025-03107-9.
  • Spruill TM, Park C, Kalinowski J, Arabadjian ME, Xia Y, Shallcross AJ, Visvanathan P, Smilowitz NR, Hausvater A, Bangalore S, Zhong H, Park K, Mehta PK, Thomas DK, Trost J, Bainey KR, Heydari B, Wei J, Dickson VV, Ogedegbe G, Berger JS, Hochman JS, Reynolds HR. Brief Mindfulness-Based Cognitive Therapy in Women With Myocardial Infarction: Results of a Multicenter Randomized Controlled Trial. JACC Adv. 2025 Jan 16;4(2):101530. doi: 10.1016/j.jacadv.2024.101530. eCollection 2025 Feb.
  • Gupta R, Estrella MM, Scherzer R, Brewster PS, Dworkin LD, Nguyen HT, Xie Y, Ix JH, Shlipak MG, Murphy TP, Cutlip DE, Lewis EF, Cooper CJ. Incident Heart Failure in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of the CORAL Trial. Kidney Med. 2024 Dec 17;7(2):100948. doi: 10.1016/j.xkme.2024.100948. eCollection 2025 Feb.
  • Small AM, Watson NW, Wadhera RK, Secemsky EA, Yeh RW. Advancing Health Equity in the Cardiovascular Device Life Cycle. Circ Cardiovasc Qual Outcomes. 2025 Mar;18(3):e011310. doi: 10.1161/CIRCOUTCOMES.124.011310. Epub 2025 Feb 3.
  • Carson P, Teerlink JR, Komajda M, Anand I, Packer M, Butler J, Doehner W, Ferreira JP, Filippatos G, Haass M, Miller A, Pehrson S, Pocock SJ, Iwata T, Brueckmann M, Gasior T, Zannad F, Anker SD. Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial. JACC Heart Fail. 2025 May;13(5):710-721. doi: 10.1016/j.jchf.2024.10.021. Epub 2025 Jan 29.
  • Elam M, Moyal-Smith R, Canfora M, Cohen W, Eum KD, Fischer C, Margo J, McCune M, Moin O, Selim M, Wendell L, Kumar S. A Checklist to Improve Acute Stroke Evaluation and Treatment in the Emergency Department. Am J Med Qual. 2025 Mar-Apr 01;40(2):53-63. doi: 10.1097/JMQ.0000000000000217. Epub 2025 Feb 3.
  • Jin X, Tay WT, Soon D, Sim D, Loh SY, Lee S, Jaufeerally F, Ling LH, Richards AM, Voors AA, Lam CSP, van Melle JP. Patients with chronic heart failure and predominant left atrial versus left ventricular myopathy. Cardiovasc Ultrasound. 2025 Feb 3;23(1):1. doi: 10.1186/s12947-024-00336-w.
  • Mosarla RC, Chowdhury M, Smolderen KG, Mena-Hurtado C, Spertus J, Yeh RW, Secemsky EA. Health Status Improvement After Peripheral Vascular Intervention: Insights From the LIBERTY 360 Study. Am J Cardiol. 2025 May 15;243:22-31. doi: 10.1016/j.amjcard.2025.01.017. Epub 2025 Jan 31.
  • Yuzefpolskaya M, Schwartz S, Ladanyi A, Abraham J, Gale CP, Grinstein J, Klein L, Majure DT, Phancao A, Sheikh FH, Colombo PC, Januzzi JL, Molina EJ. The Role of Lactate Metabolism in Heart Failure and Cardiogenic Shock: Clinical Insights and Therapeutic Implications. J Card Fail. 2025 Jan 29:S1071-9164(25)00041-7. doi: 10.1016/j.cardfail.2025.01.011.
  • Ezekowitz JA, Mulder H, Mentz RJ, Butler J, DE Pasquale CG, Lewis GD, O’Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Numan S, Blackman N, Rockhold FW, Hernandez AF. Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial. J Card Fail. 2025 Jan 29:S1071-9164(25)00039-9. doi: 10.1016/j.cardfail.2025.01.009.
  • Steg PG, Nicolas J, Baber U, Sartori S, Zhang Z, Feng Y, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dangas G, Dudek D, Escaned J, Gibson CM, Han YL, Huber K, Kastrati A, Kaul U, Marx SO, Kornowski R, Kunadian V, Vogel B, Oliva A, Mehta SR, Moliterno D, Sardella G, Krucoff M, Shlofmitz RA, Sharma S, Pocock S, Mehran R. Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trial. Am Heart J. 2025 Aug;286:97-107. doi: 10.1016/j.ahj.2025.01.016. Epub 2025 Jan 30.
  • Crespo-Leiro MG, Mehra MR. Decoding cardiac allograft vasculopathy: Harnessing multimodal imaging to improve prognosis. J Heart Lung Transplant. 2025 Jun;44(6):913-915. doi: 10.1016/j.healun.2025.01.015. Epub 2025 Jan 29.
  • Robles-Mezcua A, Januzzi JL, Pavon-Moron FJ, Rodriguez-Capitan J, Lopez-Garrido MA, Cruzado-Alvarez C, Robles-Mezcua M, Gutierrez-Bedmar M, Couto-Mallon D, Rueda-Calle EC, Barreiro-Perez M, Sanchez PL, Gomez-Doblas JJ, Jimenez-Navarro MF, Garcia-Pinilla JM. Effects of sacubitril/valsartan on cardiac remodeling in heart failure with reduced ejection fraction: An integrated study of molecular biomarkers and imaging techniques. Biomed Pharmacother. 2025 Feb;183:117874. doi: 10.1016/j.biopha.2025.117874. Epub 2025 Jan 30.
  • Roman M, Cheng A, Lai FY, Aujla H, Sanders J, Dearling J, Murray S, Loubani M, Kunadian V, Gale C, Murphy GJ. Intersectionality of inequalities in revascularisation and outcomes for acute coronary syndrome in England: nationwide linked cohort study. Eur Heart J Qual Care Clin Outcomes. 2025 Jan 30:qcae112. doi: 10.1093/ehjqcco/qcae112.
  • Wu KY, Mao R, Butler C, Gouda P, Alhulaimi N, Parab R, Dicken BJ, Khandekar S, Graham M, Bainey KR. Stellate Ganglion Block and Bilateral Sympathectomy for Recurrent Coronary Vasospasm Secondary to Severe Eosinophilic Asthma. JACC Case Rep. 2025 Jan 15;30(2):102813. doi: 10.1016/j.jaccas.2024.102813. eCollection 2025 Jan 15.
  • Thyagaturu H, Abdelhadi O, Younas HMW, Abugrin M, Padala V, Atti L, Altarawneh T, Sekar V, Gonuguntla K, Balla S, Gulati M. Psychological Distress in Adults With Myocardial Infarction: Implications for Health Care Utilization and Expenditure. JACC Adv. 2025 Jan 9;4(2):101540. doi: 10.1016/j.jacadv.2024.101540. eCollection 2025 Feb.
  • Tang WHW, Liu Y, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Marwick TH, Perfetti R, Rosenstock J, Solomon SD, Zannad F, Januzzi JL, Lewis GD. Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis. Circ Heart Fail. 2025 Mar;18(3):e012200. doi: 10.1161/CIRCHEARTFAILURE.124.012200. Epub 2025 Jan 30.
  • Alkhiri A, Alshaikh H, Alqahtani MS, Alqurashi S, Alsharif MM, Bukhari AM, AlWadee RM, Alreshaid AA, Selim M, Alrajhi E, Al-Ajlan FS, Alhazzani A. Antithrombotic resumption after middle meningeal artery embolization or surgery for chronic subdural hematoma: a systematic review and meta-analysis. J Neurointerv Surg. 2025 Jan 29:jnis-2024-022988. doi: 10.1136/jnis-2024-022988.
  • Dhoble A, Ahmed T, Mckay RG, Kliger C, Beohar N, Baron SJ, Hermiller JB. Timing and Outcomes of PCI in Conjunction With TAVR With Balloon-Expandable Valves. JACC Cardiovasc Interv. 2025 Jan 27;18(2):244-254. doi: 10.1016/j.jcin.2024.10.055.
  • Zahger D, Schwartz GG, Szarek M, Fazio S, Steg PG. Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution. J Am Coll Cardiol. 2025 Feb 4;85(4):e55. doi: 10.1016/j.jacc.2024.11.039.
  • Kunadian V. Invasive Strategy for Older Patients with MI. Reply. N Engl J Med. 2025 Jan 30;392(5):517-518. doi: 10.1056/NEJMc2415597.
  • Lewis BS. Cardiovascular disease and cardiovascular pharmacotherapy: the challenges and the research continue. Eur Heart J Cardiovasc Pharmacother. 2025 Feb 8;11(1):1-2. doi: 10.1093/ehjcvp/pvae099.
  • Wong WK, Takeuchi F, Thao LTP, Nicholls SJ, Chew DP, Peter K. Integration of apolipoprotein B into the SCORE2 framework: implications for cardiovascular risk prediction. Eur J Prev Cardiol. 2025 May 12;32(7):575-584. doi: 10.1093/eurjpc/zwaf039.
  • Bugiardini R, Gale CP, Gulati M. Introducing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health. Eur Heart J. 2025 Mar 24;46(12):1088-1090. doi: 10.1093/eurheartj/ehae793.
  • Rivera FB, Cha SW, Linnaeus Louisse C, Carado GP, Magalong JV, Tang VA, Enriquez MG, Gulati M, Enkhmaa B, Pagidipati N, Shah NP. Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials. JACC Adv. 2025 Jan 10;4(2):101549. doi: 10.1016/j.jacadv.2024.101549. eCollection 2025 Feb.
  • Tay WT, Teng TK, Ouwerkerk W, Angermann CE, Dickstein K, Cleland JGF, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Collins SP, Filippatos G, Lam CSP, Tromp J. Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry. EClinicalMedicine. 2025 Jan 10;80:103031. doi: 10.1016/j.eclinm.2024.103031. eCollection 2025 Feb.
  • Shoji S, Shah NP, Shrader P, Thomas LE, Arnold JD, Dhalwani NN, Thomas NA, Kalich B, Priest EL, Syed M, Wojcik C, Peterson ED, Navar AM. Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cvMOBIUS2 registry. Am J Prev Cardiol. 2024 Dec 21;21:100921. doi: 10.1016/j.ajpc.2024.100921. eCollection 2025 Mar.
  • Anker SD, Friede T, Butler J, Talha KM, Diek M, Nosko A, Placzek M, Hasenfuss G, Ponikowski P, Karakas M. Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure. Eur J Heart Fail. 2025 Apr;27(4):681-689. doi: 10.1002/ejhf.3574. Epub 2025 Jan 28.
  • Woelders ECI, Onuma Y, Ninomiya K, O’Leary N, Damman P, Peeters DAM, Hof AWJV’, Valgimigli M, Vranckx P, Windecker S, Serruys PWJC, van Geuns RM. Parsimonious versus extensive bleeding score: can we simplify risk stratification after percutaneous coronary intervention and reduce bleeding events by de-escalation of the antiplatelet strategy? Open Heart. 2025 Jan 28;12(1):e003083. doi: 10.1136/openhrt-2024-003083.
  • Butler J, Hammonds K, Talha KM, Alhamdow A, Bennett MM, Bomar JVA, Ettlinger JA, Traba MM, Priest EL, Schmedt N, Zeballos C, Shaver CN, Afzal A, Widmer RJ, Gottlieb RL, Mack MJ, Packer M. Incident heart failure and recurrent coronary events following acute myocardial infarction. Eur Heart J. 2025 Apr 22;46(16):1540-1550. doi: 10.1093/eurheartj/ehae885.
  • Polymeris AA, Branca M, Sylaja PN, Sandset EC, de Sousa DA, Thomalla G, Paciaroni M, Gattringer T, Strbian D, Trelle S, Michel P, Nedeltchev K, Bonati LH, Ntaios G, Koga M, Gdovinova Z, Lemmens R, Bornstein NM, Kelly P, Goeldlin MB, Abend S, Selim M, Katan M, Horvath T, Dawson J, Fischer U, ELAN Investigators. Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. JAMA Netw Open. 2025 Jan 2;8(1):e2456307. doi: 10.1001/jamanetworkopen.2024.56307.
  • Peikert A, Vaduganathan M, Claggett BL, Kulac IJ, Litwin S, Zile M, Desai AS, Jhund PS, Butt JH, Lam CSP, Martinez F, Van Veldhuisen DJ, Zannad F, Rouleau J, Lefkowitz M, McMurray JJV, Solomon SD, Packer M. Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. Eur Heart J. 2025 Jan 28:ehaf057. doi: 10.1093/eurheartj/ehaf057.
  • Butler J, Kahwash R, Khan MS, Gerritse B, Laechelt A, Wehking J, Sarkar S, van Dorn B, Laager V, Patel N, Zile MR,  on behalf of the ALLEVIATE-HF Investigators. Continuous risk monitoring and management of heart failure: Rationale and design of the ALLEVIATE-HF trial. Eur J Heart Fail. 2025 Apr;27(4):697-706. doi: 10.1002/ejhf.3595. Epub 2025 Jan 27.
  • Zoccali C, Mallamaci F, Kanbay M, Tuttle KR, Kotanko P, De Caterina R, Grassi G, Mancia G. The Autonomic Nervous System and Inflammation in Chronic Kidney Disease. Nephrol Dial Transplant. 2025 Jan 27:gfaf020. doi: 10.1093/ndt/gfaf020.
  • McCarthy CP, Watson NW, Wasfy JH, Baugh CW, Januzzi JL Jr, Secemsky EA. Cardiac Biomarker Testing in US Emergency Departments. JAMA Intern Med. 2025 Mar 1;185(3):343-346. doi: 10.1001/jamainternmed.2024.7554.
  • Zoni CR, Mukherjee D, Gulati M. Classification of Acute Coronary Syndrome From a Therapeutic Perspective. JACC Adv. 2025 Jan 8;4(2):101552. doi: 10.1016/j.jacadv.2024.101552. eCollection 2025 Feb.
  • Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Gibbs BB, Heard DG, Hiremath S, Johansen MC, Kazi DS, Ko D, Leppert MH, Magnani JW, Michos ED, Mussolino ME, Parikh NI, Perman SM, Rezk-Hanna M, Roth GA, Shah NS, Springer MV, St-Onge MP, Thacker EL, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong ND, Wong SS, Yaffe K, Palaniappan LP, American Heart Association Council on Epidemiology and Prevention Statistics, Committee and Stroke Statistics Committee. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
  • Sposato LA, Wachter R. Anticoagulation for patients with device-detected atrial fibrillation and a history of stroke. Lancet Neurol. 2025 Feb;24(2):92-94. doi: 10.1016/S1474-4422(24)00524-6.
  • Rashedi S, Bejjani A, Hunsaker AR, Aghayev A, Khairani CD, McGonagle B, Lo YC, Mahajan S, Caraballo C, Jimenez JV, Krishnathasan D, Zarghami M, Monreal M, Barco S, Secemsky EA, Klok FA, Muriel A, Hussain MA, Appah-Sampong A, Rahaghi FN, Sadeghipour P, Lin Z, Mojibian H, Aneja S, Konstantinides S, Goldhaber SZ, Wang L, Zhou L, Jimenez D, Krumholz HM, Piazza G, Bikdeli B, PE-EHR+ Investigators. Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports. Thromb Res. 2025 Mar;247:109271. doi: 10.1016/j.thromres.2025.109271. Epub 2025 Jan 20.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Gopar-Nieto R, Sierra-Lara-Martinez D, Araiza-Garaygordobil D, Mendoza-Garcia S, Castillo AA, Lopez Villasenor LG, Neri-Bale RR, Adib-Gracia AE, Arias-Mendoza A. ST-elevation myocardial infarction incidence in a high-risk seismic zone. Am J Emerg Med. 2025 Apr;90:115-119. doi: 10.1016/j.ajem.2025.01.044. Epub 2025 Jan 20.
  • Sayer G, Ahmed MM, Mehra MR, Gosev I, Vidula H, Devore AD, Horstmanshof DA, Cleveland JC Jr, Stewart GC, Slaughter MS, Mudy K, Wang A, Uriel N. Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist DevicesA MOMENTUM 3 Trial Analysis. J Card Fail. 2025 Jan 22:S1071-9164(25)00012-0. doi: 10.1016/j.cardfail.2024.12.011.
  • Kittipibul V, Lam CSP. Heart failure with preserved ejection fraction and atrial fibrillation: epidemiology, pathophysiology, and diagnosis interplay. Heart Fail Rev. 2025 Jan 24. doi: 10.1007/s10741-025-10488-0.
  • Davies MJ, van der Meer P, Verma S, Patel S, Chinnakondepalli KM, Borlaug BA, Butler J, Kitzman DW, Shah SJ, Harring S, Salsali A, Rasmussen S, von Lewinski D, Abhayaratna W, Petrie MC, Kosiborod MN, STEP-HFpEF Trials Committees and Investigators. Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA(1c) levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2025 Mar;13(3):196-209. doi: 10.1016/S2213-8587(24)00304-8. Epub 2025 Jan 20.
  • Malas MB, Hamouda M, Farber A, Menard MT, Conte MS, Rosenfield K, Strong MB, Doros G, Powell RJ, Mena-Hurtado C, Gasper W, Schermerhorn ML, Allievi S, Smolderen KG, Dake MD, Rymer JA, Tuttle KR. Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial. J Vasc Surg. 2025 Apr;81(4):945-956.e3. doi: 10.1016/j.jvs.2024.12.128. Epub 2025 Jan 23.
  • Dushay J, Rickers ES, Wang E, Gilman J, Zhang Y, Blankstein R, Gervino EV, Jerosch-Herold M, Veves A. Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals With Type 2 Diabetes. J Am Heart Assoc. 2025 Feb 4;14(3):e037863. doi: 10.1161/JAHA.124.037863. Epub 2025 Jan 23.
  • Winkelmayer WC, Hu A, Khairallah P, Airy M, Erickson KF, Chang TI, Niu J. Oral Anticoagulant Initiation in Patients With Kidney Failure on Hemodialysis Newly Diagnosed With Atrial Fibrillation (2007-2020): An Observational Study of Trends and Disparities. Kidney Med. 2024 Nov 9;7(2):100926. doi: 10.1016/j.xkme.2024.100926. eCollection 2025 Feb.
  • Angiolillo DJ, Capodanno D. Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI. N Engl J Med. 2025 Jan 23;392(4):400-403. doi: 10.1056/NEJMe2414209.
  • Yancy CW, Guseh JS 2nd, Ghoshhajra BG, Falk RH, Yee AJ, Hutchison BM. Case 3-2025: A 54-Year-Old Man with Exertional Dyspnea and Chest Pain. N Engl J Med. 2025 Jan 23;392(4):383-394. doi: 10.1056/NEJMcpc2300900.
  • Stedman MR, Ahearn PC, Liu CK, Chertow GM, Tan JC. Estimating the Benefit of Transplant Over Dialysis in Candidates Over 55 Years. Kidney360. 2025 Jan 22. doi: 10.34067/KID.0000000710.
  • Medicherla S, Reddy G, Gupta P, Chertow GM, Gupta S. Combination Oxylanthanum Carbonate and Tenapanor Lowers Urinary Phosphate Excretion in Rats. Kidney360. 2025 Mar 1;6(3):361-368. doi: 10.34067/KID.0000000709. Epub 2025 Jan 22.
  • Shah DP, Thaweethai T, Karlson EW, Bonilla H, Horne BD, Mullington JM, Wisnivesky JP, Hornig M, Shinnick DJ, Klein JD, Erdmann NB, Brosnahan SB, Lee-Iannotti JK, Metz TD, Maughan C, Ofotokun I, Reeder HT, Stiles LE, Shaukat A, Hess R, Ashktorab H, Bartram L, Bassett IV, Becker JH, Brim H, Charney AW, Chopra T, Clifton RG, Deeks SG, Erlandson KM, Fierer DS, Flaherman VJ, Fonseca V, Gander JC, Hodder SL, Jacoby VL, Kotini-Shah P, Krishnan JA, Kumar A, Levy BD, Lieberman D, Lin JJ, Martin JN, McComsey GA, Moukabary T, Okumura MJ, Peluso MJ, Rosen CJ, Saade G, Shah PK, Sherif ZA, Taylor BS, Tuttle KR, Urdaneta AE, Wallick JA, Wiley Z, Zhang D, Horwitz LI, Foulkes AS, Singer NG, RECOVER Consortium. Sex Differences in Long COVID. JAMA Netw Open. 2025 Jan 2;8(1):e2455430. doi: 10.1001/jamanetworkopen.2024.55430.
  • Butala NM, Lalani C, Tale A, Song Y, Kolte D, Baron S, Strom J, Cohen DJ, Yeh RW. Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial. Circ Cardiovasc Interv. 2025 Jan;18(1):e014592. doi: 10.1161/CIRCINTERVENTIONS.124.014592. Epub 2025 Jan 21.
  • Averbuch T, Zafari A, Islam S, Lee SF, Sankaranarayanan R, Greene SJ, Mamas MA, Pandey A, Van Spall HG. Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization. ESC Heart Fail. 2025 Apr;12(2):1227-1236. doi: 10.1002/ehf2.15129. Epub 2025 Jan 21.
  • Ebrahimi N, Gholizadeh Ghozloujeh Z, Poyan Mehr A, Seethapathy H, Robson K, Waguespack DR, Pitogo RM, Norouzi S. GlomCon Hawaii: The First International Hybrid Glomerular Diseases Conference. Nephron. 2025;149(6):364-370. doi: 10.1159/000543592. Epub 2025 Jan 18.
  • Portela GT, Ducrocq G, Bertolet M, Alexander JH, Goodman SG, Glynn S, Strom JB, Swanson SA, Lemesle G, Rao SV, Tessalee M, Polonsky TS, Goldfarb M, Traverse JH, Uhl L, Herbert BM, Silvain J, Carson JL, Brooks MM, MINT Trial Investigators. Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. Am Heart J. 2025 Apr;282:146-155. doi: 10.1016/j.ahj.2025.01.009. Epub 2025 Jan 17.
  • McCarthy CP, Bruno RM, Rahimi K, Touyz RM, McEvoy JW. Global and European landscape of major hypertension guidelines. Lancet. 2025 Mar 15;405(10482):874-876. doi: 10.1016/S0140-6736(24)02795-8. Epub 2025 Jan 15.
  • Theriault-Lauzier P, Dawson LP, Wong CCY, Sharma RP, Fearon WF, Kang G, MacArthur JW, Pogatchnik BP, Krishnam MS, Yeung AC. Transcatheter Aortic Valve Replacement in Patients With Interventricular Membranous Septal Aneurysms. JACC Case Rep. 2024 Dec 4;30(1):102715. doi: 10.1016/j.jaccas.2024.102715. eCollection 2025 Jan 1.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH. Looking back, moving forward: a bold start to 2025. Eur Heart J Acute Cardiovasc Care. 2025 Jan 31;14(1):1-2. doi: 10.1093/ehjacc/zuaf009.
  • Niu J, Rosales O, Oluyomi A, Lew SQ, Chertow GM, Winkelmayer WC, Erickson KF. Utilization of Telemedicine for Patients Receiving In-Center Hemodialysis in the United States. J Am Soc Nephrol. 2025 Jan 16. doi: 10.1681/ASN.0000000619.
  • Piayda K, Bertog S, Sievert K, Sievert H, Shaburishvili T, Gogorishvili I, Rothman M, Januzzi JL Jr, Lindenfeld J, Stone GW. 24-Month Outcomes of Endovascular Baroreflex Amplification With the MobiusHD Device in Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2025 Feb;13(2):386-388. doi: 10.1016/j.jchf.2024.11.005. Epub 2025 Jan 15.
  • Samsky MD, Kadosh BS, Nanna MG, Rao SV. The DanGer of Using Age to Decide About Using Microaxial Flow Pumps in Cardiogenic Shock. J Am Coll Cardiol. 2025 Feb 18;85(6):604-605. doi: 10.1016/j.jacc.2024.11.035. Epub 2025 Jan 15.
  • Butt JH, Jhund PS, Henderson AD, Claggett BL, Desai AS, Viswanathan P, Kolkhof P, Schloemer P, Amarante F, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV, FINEARTS-HF Committees and Investigators. Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial. Lancet Diabetes Endocrinol. 2025 Feb;13(2):107-118. doi: 10.1016/S2213-8587(24)00309-7. Epub 2025 Jan 13.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee. Mind the gap in kidney care: translating what we know into what we do. Kidney Res Clin Pract. 2025 Jan;44(1):6-19. doi: 10.23876/j.krcp.24.100. Epub 2025 Jan 15.
  • Shahid I, Khan MS, Butler J, Fonarow GC, Greene SJ. Initiation and sequencing of guideline-directed medical therapy for heart failure across the ejection fraction spectrum. Heart Fail Rev. 2025 May;30(3):515-523. doi: 10.1007/s10741-025-10481-7. Epub 2025 Jan 15.
  • Butler J, Usman MS, Harrell FE Jr, Packer M. Did Finerenone Improve Health Status in the FINEARTS Trial?: A Critical Reevaluation of the Analysis of Patient-Reported Outcomes in Heart Failure. J Am Coll Cardiol. 2025 Jan 21;85(2):190-195. doi: 10.1016/j.jacc.2024.12.005.
  • Matsumoto S, Jhund PS, Henderson AD, Bauersachs J, Claggett BL, Desai AS, Brinker M, Schloemer P, Viswanathan P, Mares JW, Scalise A, Lam CSP, Linssen GCM, Kerr Saraiva JF, Senni M, Troughton R, Udell JA, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF. J Am Coll Cardiol. 2025 Jan 21;85(2):173-185. doi: 10.1016/j.jacc.2024.11.020.
  • Russo AM, Desai MY, Do MM, Butler J, Chung MK, Epstein AE, Guglin ME, Levy WC, Piccini JP, Bhave NM, Russo AM, Desai MY, Do MM, Ambardekar AV, Berg NC, Bilchick KC, Dec GW Jr, Gopinathannair R, Han JK, Klein L, Lampert RJ, Panjrath GS, Reeves RR, Yoerger Sanborn DM, Stevenson LW, Truong QA, Varosy PD, Villines TC, Volgman AS, Zareba KM. ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing. J Am Coll Cardiol. 2025 Mar 25;85(11):1213-1285. doi: 10.1016/j.jacc.2024.11.023. Epub 2025 Jan 13.
  • Marwick TH, Lam C, Liu Y, Del Prato S, Rosenstock J, Butler J, Ezekowitz J, Ibrahim NE, Tang WHW, Zannad F, Perfetti R, Januzzi JL. Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial. Cardiovasc Diabetol. 2025 Jan 13;24(1):16. doi: 10.1186/s12933-024-02554-y.
  • Aragon MA, El Shamy O, Zheng S, Chertow GM, Glickman J, Weinhandl E, Komenda P, Dunning S, Liu F, Lok C. Vascular Access for Home Hemodialysis: A Perspective on Tunneled Central Venous Catheters at Home. Kidney Med. 2024 Oct 15;7(1):100916. doi: 10.1016/j.xkme.2024.100916. eCollection 2025 Jan.
  • Chandra AA, Espiche C, Maliha M, Virani SS, Blumenthal RS, Rodriguez F, Wong ND, Gulati M, Slipczuk L, Shapiro MD. American society for preventive cardiology 2024 cardiovascular disease prevention: Highlights and key sessions. Am J Prev Cardiol. 2024 Dec 15;21:100919. doi: 10.1016/j.ajpc.2024.100919. eCollection 2025 Mar.
  • Elshorbagy A, Vallejo-Vaz AJ, Barkas F, Lyons ARM, Stevens CAT, Dharmayat KI, Catapano AL, Freiberger T, Hovingh GK, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Alhabib KF, Alkhnifsawi M, Almahmeed W, Alnouri F, Alonso R, Al-Rasadi K, Al-Sarraf A, Arca M, Ashavaid TF, Averna M, Banach M, Becker M, Binder CJ, Bourbon M, Brunham LR, Chlebus K, Corral P, Cruz D, Davletov K, Descamps OS, Dwiputra B, Ezhov M, Groselj U, Harada-Shiba M, Holven KB, Humphries SE, Kayikcioglu M, Khovidhunkit W, Lalic K, Latkovskis G, Laufs U, Liberopoulos E, Lima-Martinez MM, Maher V, Marais AD, Marz W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi H, Nordestgaard BG, Panayiotou AG, Paragh G, Petrulioniene Z, Pojskic B, Postadzhiyan A, Reda A, Reiner Z, Reyes X, Sadiq F, Sadoh WE, Schunkert H, Shek AB, Stroes E, Su TC, Subramaniam T, Susekov AV, Tilney M, Tomlinson B, Truong TH, Tselepis AD, Tybjaerg-Hansen A, Vazquez-Cardenas A, Viigimaa M, Vohnout B, Yamashita S, Ray KK. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry. Eur Heart J. 2025 Mar 24;46(12):1127-1140. doi: 10.1093/eurheartj/ehae791.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH. EHJ ACVC where translational science meets care. Eur Heart J Acute Cardiovasc Care. 2025 Feb 20;14(2):57-58. doi: 10.1093/ehjacc/zuaf006.
  • Estep JD, Ben-Yehuda O, Wechsler AS, Puri R, Kao AC, Heimes JK, Pfeiffer MP, Boehmer JP, Ninios V, Zaman A, Stone GW. Transcatheter Left Ventricular Reconstruction in Heart Failure Patients With Prior Anterior Myocardial Infarction: The Prospective ALIVE Trial. JACC Heart Fail. 2025 Feb;13(2):296-308. doi: 10.1016/j.jchf.2024.09.023. Epub 2025 Jan 8.
  • Raja A, Song Y, Li S, Parikh SA, Saab F, Yeh RW, Secemsky EA. Variations in Revascularization Strategies for Chronic Limb-Threatening Ischemia: A Nationwide Analysis of Medicare Beneficiaries. JACC Cardiovasc Interv. 2025 Feb 10;18(3):352-363. doi: 10.1016/j.jcin.2024.09.024. Epub 2025 Jan 8.
  • Pandey A, Kolkailah AA, McGuire DK, Frederich RC, Cater NB, Cosentino F, Pratley RE, Dagogo-Jack S, Cherney DZI, Wynant W, Gantz I, Mancuso JP, Masiukiewicz U, Cannon CP. Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial. Eur J Heart Fail. 2025 Mar;27(3):521-526. doi: 10.1002/ejhf.3511. Epub 2025 Jan 10.
  • Ferro EG, Reynolds MR, Xu J, Song Y, Cohen DJ, Wadhera RK, d’Avila A, Zimetbaum PJ, Yeh RW, Kramer DB. Contemporary Administrative Codes to Identify Pulmonary Vein Isolation Procedures for Atrial Fibrillation. J Am Heart Assoc. 2025 Jan 21;14(2):e037003. doi: 10.1161/JAHA.124.037003. Epub 2025 Jan 10.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee. Mind the gap in kidney care: Translating what we know into what we do. Nephrology (Carlton). 2025 Jan;30(1):e14314. doi: 10.1111/nep.14314.
  • Mosarla RC, Secemsky EA. Intravascular Ultrasound for Lower Extremity Arterial Interventions: What was Once Peripheral is Now Mainstream. Am J Cardiol. 2025 Apr 15;241:86-87. doi: 10.1016/j.amjcard.2025.01.005. Epub 2025 Jan 7.
  • Strom JB, Herbert BM, Bertolet M, Brooks MM, Malik SA, Lemesle G, Madan M, Steg PG, Hebert PC, Traverse JH, White HD, Alsweiler C, Gupta R, Ritt LEF, Menegus MA, Alexander JH, Lopes RD, Chaitman BR, Carson JL, MINT Trial Investigators. Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD. J Am Soc Nephrol. 2025 Jun 1;36(6):1116-1125. doi: 10.1681/ASN.0000000595. Epub 2025 Jan 9.
  • Siddiqi TJ, Packer M, Ezekowitz JA, Fonarow GC, Greene SJ, Kittleson M, Khan MS, Mentz RJ, Testani J, Voors AA, Butler J. Diuretic Potentiation Strategies in Acute Heart Failure. JACC Heart Fail. 2025 Jan;13(1):14-27. doi: 10.1016/j.jchf.2024.09.017.
  • Ben-Yehuda O, Mahmud E. Complete Revascularization Wins in ST-Segment Elevation Myocardial Infarction, But Timing Remains Flexible. J Am Coll Cardiol. 2025 Jan 7;85(1):39-41. doi: 10.1016/j.jacc.2024.10.078.
  • Adusumalli S, McCarthy CP, Magaret CA, Rhyne RF, Jaffer FA, Januzzi JL. Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions. Am J Cardiol. 2025 May 1;242:25-31. doi: 10.1016/j.amjcard.2024.12.037. Epub 2025 Jan 6.
  • Savarese G, Basile C, Adamo M, Anker SD, Bayes-Genis A, Bohm M, Donal E, Filippatos GS, Maisano F, Ponikowski P, Rosano GMC, von Bardeleben RS, Metra M, Butler J. Registries on transcatheter edge-to-edge repair in heart failure: Current evidence and future perspectives. Eur J Heart Fail. 2025 Jan 8. doi: 10.1002/ejhf.3573.
  • Yancy CW, Fonarow GC. Genius and the CVD Polypill-A Step Toward Achieving Health Equity? JAMA Cardiol. 2025 Mar 1;10(3):234. doi: 10.1001/jamacardio.2024.4820.
  • Lan NSR, Chen RT, Dwivedi G, Watts GF, Nicholls SJ, Nelson AJ. Learnings from Implementation Strategies to Improve Lipid Management. Curr Cardiol Rep. 2025 Jan 8;27(1):9. doi: 10.1007/s11886-024-02174-8.
  • Gustafsson F, Uriel N, Netuka I, Katz JN, Pagani FD, Connors JM, Jorde UP, Zimpfer D, Pya Y, Conway J, Anyanwu A, Scandroglio AM, Sulemanjee N, Atluri P, Keebler M, Selzman CH, Alexis JD, Hayward C, Henderson J, Dirckx N, Gazzola C, Mehra MR, ARIES Investigators. Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial. JAMA Cardiol. 2025 Mar 1;10(3):235-242. doi: 10.1001/jamacardio.2024.4849.
  • Hammond-Haley M, Chiew K, Ahmed-Jushuf F, Rajkumar CA, Foley MJ, Simader FA, Chotai S, Shun-Shin MJ, Al-Lamee R. A systematic review of enrolment criteria and treatment efficacy for microvascular angina. EuroIntervention. 2025 Jan 6;21(1):46-57. doi: 10.4244/EIJ-D-24-00404.
  • Schafer A, Alasnag M, Giacoppo D, Collet C, Rudolph TK, Roguin A, Buszman PP, Colleran R, Stefanini G, Lefevre T, Mieghem NV, Cayla G, Naber C, Baumbach A, Witkowski A, Burzotta F, Capodanno D, Dudek D, Al-Lamee R, Banning A, MacCarthy P, Gottardi R, Schoenhoff FS, Czerny M, Thielmann M, Werner N, Tarantini G. High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery. EuroIntervention. 2025 Jan 6;21(1):22-34. doi: 10.4244/EIJ-D-23-01100.
  • Chitsazan M, Van Spall HGC, ACP Journal Club Editorial Team at McMaster University. In HF with mildly reduced or preserved ejection fraction, finerenone reduced worsening HF or CV death at 32 mo. Ann Intern Med. 2025 Jan;178(1):JC2. doi: 10.7326/ANNALS-24-03365-JC. Epub 2025 Jan 7.
  • Alhumaidi R, Huang H, Saade MC, Clark AJ, Parikh SM. NAD(+) metabolism in acute kidney injury and chronic kidney disease transition. Trends Mol Med. 2025 Jan 4:S1471-4914(24)00337-X. doi: 10.1016/j.molmed.2024.12.004.
  • Fujino M, Di Giovanni G, Nicholls SJ. New Approaches to Lipoproteins for the Prevention of Cardiovascular Events. J Atheroscler Thromb. 2025 Mar 1;32(3):265-280. doi: 10.5551/jat.RV22031. Epub 2024 Dec 28.
  • Ramadan OI, Yang L, Shultz K, Genovese E, Damrauer SM, Wang GJ, Secemsky EA, Treat-Jacobson DJ, Womeodu RJ, Fakorede FA, Nathan AS, Eberly LA, Julien HM, Kobayashi TJ, Groeneveld PW, Giri J, Fanaroff AC. Racial, Socioeconomic, and Geographic Disparities in Preamputation Vascular Care for Patients With Chronic Limb-Threatening Ischemia. Circ Cardiovasc Qual Outcomes. 2025 Jan;18(1):e010931. doi: 10.1161/CIRCOUTCOMES.124.010931. Epub 2025 Jan 3.
  • Doll JA, Hebbe AL, Simons CE, Stein EJ, Eisenbarth S, Waldo SW, Rao SV, Au DH. Evaluation of Peer Review of Percutaneous Coronary Intervention Operator Performance. Circ Cardiovasc Qual Outcomes. 2025 Jan;18(1):e011159. doi: 10.1161/CIRCOUTCOMES.124.011159. Epub 2025 Jan 3.
  • Apperloo EM, Tuttle KR, Pavo I, Haupt A, Taylor R, Wiese RJ, Hemmingway A, Cherney DZI, Sattar N, Heerspink HJL. Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials. Diabetes Care. 2025 Mar 1;48(3):430-436. doi: 10.2337/dc24-1773.
  • Paruchuri K, Bernardo R, Haidermota S, Lannery K, Finneran P, Wong M, Sanborn T, Joice M, Boyle-Kelly J, Silacci S, Hornsby W, Linganathan K, Olufade T, Januzzi JL Jr, Natarajan P. Implementation of a Digital Disease Management Platform for Heart Failure: AMAZE. J Card Fail. 2025 May;31(5):863-867. doi: 10.1016/j.cardfail.2024.11.019. Epub 2024 Dec 30.
  • Zannad F, McGuire DK, Ortiz A. Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes. J Intern Med. 2025 May;297(5):460-478. doi: 10.1111/joim.20050. Epub 2024 Dec 31.
  • Mosarla RC, Heindel PV, Hussain MA, Schermerhorn M, Kuno T, D’Oria M, Li S, Secemsky EA. Utilization and Outcomes Associated With Intravascular Ultrasound During Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016-2023). Circ Cardiovasc Interv. 2025 Jan;18(1):e014332. doi: 10.1161/CIRCINTERVENTIONS.124.014332. Epub 2024 Dec 27.
  • Pabon MA, Weisbrod RM, Castro C, Li H, Xia P, Kang J, Ardissino M, Economy KE, Yang Z, Shi Y, Kim E, Perillo A, Barrett L, Brown JM, Divakaran S, Cetinbas M, Sadreyev RI, de Marvao A, Wood MJ, Scott NS, Lau ES, Ho JE, Di Carli MF, Roh JD, Hamburg NM, Honigberg MC. Venous Endothelial Cell Transcriptomic Profiling Implicates METAP1 in Preeclampsia. Circ Res. 2025 Jan 17;136(2):180-190. doi: 10.1161/CIRCRESAHA.124.324606. Epub 2024 Dec 27.
  • Petrie MC, Udell JA, Anker SD, Harrington J, Jones WS, Mattheus M, Gasior T, van der Meer P, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chopra VK, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J. Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial. Eur J Heart Fail. 2025 Mar;27(3):577-588. doi: 10.1002/ejhf.3548. Epub 2024 Dec 26.
  • Chew NWS, Mehta A, Goh RSJ, Zhang A, Chen Y, Chong B, Chew HSJ, Shabbir A, Brown A, Dimitriadis GK, Huang DQ, Foo R, le Roux CW, Figtree GA, Fudim M, Pandey A, Mamas MA, Hausenloy DJ, Richards AM, Nicholls SJ, Chan MY, Muthiah MD, Sanyal A, Sperling LS. Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach. Circulation. 2025 Jan 7;151(1):98-119. doi: 10.1161/CIRCULATIONAHA.124.070535. Epub 2024 Dec 26.
  • Sposato LA, Cameron AC, Johansen MC, Katan M, Murthy SB, Schachter M, B Sur N, Yaghi S, Aspberg S, Caso V, Hsieh CY, J Hilz M, Nucera A, Seiffge DJ, Sheppard MN, Martins SC, Bahit MC, Scheitz JF, Shoamanesh A. Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: A World Stroke Organization (WSO) scientific statement. Int J Stroke. 2025 Apr;20(4):385-400. doi: 10.1177/17474930241312649. Epub 2025 Jan 30.
  • Chung M, Almarzooq ZI, Tale A, Song Y, Dahabreh IJ, Kazi DS, Baron SJ, Yeh RW. Days at Home After Transcatheter Mitral Valve Repair Versus Medical Therapy Alone in Heart Failure. J Am Heart Assoc. 2025 Jan 7;14(1):e038401. doi: 10.1161/JAHA.124.038401. Epub 2024 Dec 24.
  • Agiro A, Mu F, Cook E, Greatsinger A, Chen J, Zhao A, Louden E, Colman E, Desai P, Chertow GM. Hyperkalemia and the Risks of Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease. J Am Heart Assoc. 2025 Jan 7;14(1):e035256. doi: 10.1161/JAHA.124.035256. Epub 2024 Dec 24.
  • Lu H, Inciardi RM, Abanda M, Shah AM, Cikes M, Claggett BL, Prasad N, Lam CSP, Redfield M, McMurray JJV, Pfeffer MA, Solomon SD, Hegde SM, Skali H. Multiparametric Assessment of Right Ventricular Dysfunction in Heart Failure: An Analysis From PARAGON-HF. J Am Heart Assoc. 2025 Jan 7;14(1):e037380. doi: 10.1161/JAHA.124.037380. Epub 2024 Dec 24.
  • Solano S, Yang M, Tolomeo P, Kondo T, Shen L, Jhund PS, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Rouleau JL, Vaduganathan M, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Solomon SD, McMurray JJV. Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM-HF and PARAGON-HF. J Am Heart Assoc. 2025 Jan 7;14(1):e037782. doi: 10.1161/JAHA.124.037782. Epub 2024 Dec 24.
  • Ambrosy AP, Sauer AJ, Patel S, Windsor SL, Borlaug BA, Husain M, Inzucchi SE, Kitzman DW, McGuire DK, Shah SJ, Sharma K, Umpierrez G, Kosiborod MN. Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF. ESC Heart Fail. 2025 Jun;12(3):1676-1681. doi: 10.1002/ehf2.15184. Epub 2024 Dec 24.
  • Nelson AJ, Kaltenbach LA, McGuire DK, Levya M, Al-Khalidi HR, Webb L, Lopes RD, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Pandey A, Gaynor T, Pak J, Washington A, Senyucel C, Green JB, Granger CB, Pagidipati NJ. Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics. Am Heart J. 2025 Apr;282:51-57. doi: 10.1016/j.ahj.2024.12.006. Epub 2024 Dec 21.
  • Carson JL, Fergusson DA, Noveck H, Mallick R, Simon T, Rao SV, Cooper H, Stanworth SJ, Portela GT, Ducrocq G, Bertolet M, DeFilippis AP, Goldsweig AM, Kim S, Triulzi DJ, Menegus MA, Abbott JD, Lopes RD, Brooks MM, Alexander JH, Hebert PC, Goodman SG, Steg PG. Restrictive versus Liberal Transfusion in Myocardial Infarction – A Patient-Level Meta-Analysis. NEJM Evid. 2025 Feb;4(2):EVIDoa2400223. doi: 10.1056/EVIDoa2400223. Epub 2024 Dec 23.
  • Cohoon KP, Henkin S, Tomihama RT, Thomas SE, Porres-Aguilar M, Brunton NE, Hornacek D, Secemsky EA. Implementing the 2024 ACC/AHA Multisocietal PAD guidelines into clinical practice: Key changes from the 2016 guidelines. Vasc Med. 2025 Feb;30(1):110-113. doi: 10.1177/1358863X241306354. Epub 2024 Dec 23.
  • Jason MJ, Marzec LN, Piccini JP, Shrader P, Pieper KS, Blanco RG, Fonarow GC, Gersh BJ, Ho PM, Hylek E, Kowey PR, Mahaffey KW, Steinberg BA, Peterson ED, Allen LA. Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Int J Cardiol. 2025 Feb 15;421:132912. doi: 10.1016/j.ijcard.2024.132912. Epub 2024 Dec 19.
  • Qin H, Tromp J, Ter Maaten JM, Voordes GHD, van Essen BJ, Andre de la Rambelje M, van der Hoef CCS, Santema BT, Lam CSP, Voors AA. Clinical and Proteomic Risk Profiles of New-Onset Heart Failure in Men and Women. JACC Heart Fail. 2025 Mar;13(3):435-449. doi: 10.1016/j.jchf.2024.09.022. Epub 2024 Dec 18.
  • Molina EJ, Ahmed MM, Sheikh FH, Cleveland JC Jr, Goldstein DJ, Uriel NY, Wang A, Revis JJ, Mehra MR. Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2025 May;13(5):798-811. doi: 10.1016/j.jchf.2024.09.019. Epub 2024 Dec 18.
  • Junarta J, Siddiqui MU, Abaza E, Zhang P, Patel A, Park DS, Aizer A, Razzouk L, Rao SV. The Utility of Coronary Revascularization to Reduce Ventricular Arrhythmias in Coronary Artery Disease Patients: A Systematic Review. Catheter Cardiovasc Interv. 2025 Feb;105(3):605-612. doi: 10.1002/ccd.31361. Epub 2024 Dec 18.
  • Abdel-Razek O, Vo N, Weinstein J, Kholdani CA, Liu D, Laham RJ. Percutaneous Transcatheter Approach to Partial Anomalous Pulmonary Venous Return: A Case Series. Am J Cardiol. 2025 Mar 15;239:64-67. doi: 10.1016/j.amjcard.2024.12.014. Epub 2024 Dec 16.
  • Klein KR, Lingvay I, Tuttle KR, Flythe JE. Glycemic Management and Individualized Diabetes Care in Dialysis-Dependent Kidney Failure. Diabetes Care. 2025 Feb 1;48(2):164-176. doi: 10.2337/dci24-0081.
  • Kanbay M, Siriopol D, Mahmoud Abdel-Rahman S, Yilmaz ZY, Ozbek L, Guldan M, Copur S, Tuttle KR. Impact of weight change on kidney transplantation outcomes: A systematic review and meta-analysis. Diabetes Obes Metab. 2025 Mar;27(3):1369-1378. doi: 10.1111/dom.16135. Epub 2024 Dec 18.
  • Vranckx P, Valgimigli M, Aleksic M. Shaping the future of acute coronary syndrome management: a look back at 2024. Eur Heart J Acute Cardiovasc Care. 2025 Jan 31;14(1):40-43. doi: 10.1093/ehjacc/zuae143.
  • Khan MS, Rashid AM, Shafi T, Rangaswami J, Cherney DZI, Butler J. Residual Risk of Adverse Kidney and Cardiovascular Outcomes in Patients with CKD. Clin J Am Soc Nephrol. 2025 Mar 1;20(3):451-454. doi: 10.2215/CJN.0000000588. Epub 2024 Dec 17.
  • Bailey E, Lopes RD, Gibson CM, Eikelboom JW, Rao SV. Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis. J Thromb Thrombolysis. 2025 Feb;58(2):353. doi: 10.1007/s11239-024-03064-0.
  • Mai LM, Joundi RA, Katsanos AH, Selim M, Shoamanesh A. Pathophysiology of Intracerebral Hemorrhage: Recovery Trajectories. Stroke. 2025 Mar;56(3):783-793. doi: 10.1161/STROKEAHA.124.046130. Epub 2024 Dec 16.
  • Wang X, Vardeny O, Claggett B, Vaduganathan M, Hegde SM, Skali H, Pabon MA, Foa A, Chatur S, Kosztin A, O’Meara E, Rouleau J, Redfield M, Lam CSP, Zile M, Packer M, Shah AM, Cikes M, Gori M, Merkely B, Pfeffer MA, McMurray JJV, Solomon SD. Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF. Eur J Heart Fail. 2025 Jan;27(1):96-106. doi: 10.1002/ejhf.3535. Epub 2024 Dec 15.
  • Gibson CM, Howard ML, Haight RC. Validation of an instrument to assess student pharmacist self-authorship. Curr Pharm Teach Learn. 2025 Feb;17(2):102264. doi: 10.1016/j.cptl.2024.102264. Epub 2024 Dec 14.
  • Li S, Bahl A, Li BK, Kanwar MK, Li B, Sinha SS, Hernandez-Montfort J, Kong Q, Sangal P, Yeh RW, Burkhoff D, Mahr C, Kapur NK. Practice Variation in Temporary Mechanical Circulatory Support for Cardiogenic Shock. J Card Fail. 2025 May;31(5):858-862. doi: 10.1016/j.cardfail.2024.10.447. Epub 2024 Dec 12.
  • Isath A, Mehra MR. “Surveillance without scars”: The quest for noninvasive detection of cardiac allograft rejection. J Heart Lung Transplant. 2025 Apr;44(4):570-572. doi: 10.1016/j.healun.2024.12.005. Epub 2024 Dec 11.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Garcia-Ruiz M, Manzur-Sandoval D, Gopar-Nieto R, Sierra-Lara-Martinez D, Araiza-Garaygordobil D, Mendoza-Garcia S, Arzate-Ramirez A, Montanez-Orozco A, Baeza-Herrera LA, Altamirano-Castillo A, Valdespino Trejo AA, Hernandez-Montfort J, Arias-Mendoza A. Effect of pulmonary artery catheter, type & combination of vasoactives for optimizing lactate clearance in acute myocardial infarction complicated by cardiogenic shock. J Crit Care. 2025 Apr;86:154990. doi: 10.1016/j.jcrc.2024.154990. Epub 2024 Dec 11.
  • Gragnano F, Angiolillo DJ. Editorial: Navigating the complexity of bleeding and hypercoagulable disorders in patients with acute myocardial infarction. Cardiovasc Revasc Med. 2025 Mar;72:16-18. doi: 10.1016/j.carrev.2024.11.015. Epub 2024 Dec 5.
  • Ruberti A, Ortega-Paz L, Brugaletta S, CV COVID-19 Registry Investigators. Which patients need thromboprophylaxis for venous thromboembolism prevention after hospitalization due to COVID-19? A sub-analysis from the CV COVID-19 registry. Med Clin (Barc). 2025 Apr 11;164(7):380-381. doi: 10.1016/j.medcli.2024.10.016. Epub 2024 Dec 10.
  • Butt JH, Henderson AD, Jhund PS, Claggett BL, Desai AS, Lay-Flurrie J, Viswanathan P, Lage A, Scheerer MF, Lam CSP, Senni M, Shah SJ, Voors AA, Bauersachs J, Fonseca C, Kosiborod MN, Linssen GCM, Petrie MC, Schou M, Verma S, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF. J Am Coll Cardiol. 2025 Jan 21;85(2):140-155. doi: 10.1016/j.jacc.2024.10.111. Epub 2024 Dec 10.
  • Bimal T, Fishbein J, Gandotra P, Meraj PM, Lee A, Kim MC, Omar W, Ong L, Gruberg L. The Impact of Age in Patients Undergoing Impella-Assisted Percutaneous Coronary Interventions. Catheter Cardiovasc Interv. 2025 Feb;105(2):517-524. doi: 10.1002/ccd.31350. Epub 2024 Dec 12.
  • Lusebrink E, Lanz H, Kellnar A, Karam N, Kapadia S, Makkar R, Abraham WT, Latib A, Leon M, Sannino A, Shuvy M, Guerrero M, Fam N, Butler J, Adamo M, Rudolph V, Tang GHL, Stocker TJ, Rommel KP, Lurz P, Thiele H, Massberg S, Praz F, Prendergast B, Hausleiter J. Management of acute decompensated valvular heart disease. Eur J Heart Fail. 2025 Apr;27(4):630-649. doi: 10.1002/ejhf.3549. Epub 2024 Dec 11.
  • Srivastava PK, Klomhaus AM, Greene SJ, Heidenreich P, Lewsey SC, Yancy CW, Fonarow GC. Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure. JAMA Cardiol. 2025 Mar 1;10(3):276-283. doi: 10.1001/jamacardio.2024.3815.
  • Ferreira JP, Zannad F, Vasques-Novoa F, Neves JS, Filippatos G, Pocock SJ, Butler J, Packer M, Anker SD. Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur Heart J. 2025 Mar 13;46(11):1074-1077. doi: 10.1093/eurheartj/ehae864.
  • Pompei G, Kunadian V. Role of microcirculatory resistance reserve in patients with chronic coronary syndrome undergoing revascularization. Eur Heart J. 2025 Feb 3;46(5):436-438. doi: 10.1093/eurheartj/ehae708.
  • Khan MS, Zile MR, Kahwash R, Sarkar S, Van Dorn B, Koehler J, Franco N, Gerritse B, Butler J. Incidence of atrial fibrillation in patients with an insertable cardiac monitor and symptomatic heart failure. ESC Heart Fail. 2025 Jun;12(3):1693-1702. doi: 10.1002/ehf2.15180. Epub 2024 Dec 9.
  • Noll G, Borelli WV, Mantovani GP, Martins SCO, Sposato LA. Low-dose colchicine for stroke prevention: A systematic overview of systematic reviews and meta-analyses. J Stroke Cerebrovasc Dis. 2025 Feb;34(2):108167. doi: 10.1016/j.jstrokecerebrovasdis.2024.108167. Epub 2024 Dec 7.
  • Kuaban A, Croker AK, Keefer J, Valentino LA, Bierer BE, Boateng S, DiMichele D, Fogarty P, Gibson CM, Hood AM, Hubbard L, Isgro A, Knobe K, Lake L, Martin I, Reid M, Roberts JC, Tomlinson W, Tunji-Ajayi L, Van Spall HGC, Voltz-Girolt C, Wheeler AP, Mast AE, Seremetis S. The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative. Blood Adv. 2025 Feb 25;9(4):687-695. doi: 10.1182/bloodadvances.2024013945.
  • Grave C, Bonaldi C, Carcaillon-Bentata L, Gabet A, Halimi JM, Tzourio C, Bejot Y, Torres MJ, Steg PG, Durand Zaleski I, Blacher J, Olie V. Burden of Cardio-Cerebrovascular and Renal Diseases Attributable to Systolic Hypertension in France in 2021. Hypertension. 2025 Feb;82(2):357-369. doi: 10.1161/HYPERTENSIONAHA.124.23760. Epub 2024 Dec 9.
  • Swearingen CA, Sloan JH, Rhodes GM, Siegel RW, Bivi N, Qian Y, Konrad RJ, Boffa M, Koschinsky M, Krege J, Ruotolo G, Nicholls SJ, Michael LF, Wen Y. Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin. J Lipid Res. 2025 Jan;66(1):100723. doi: 10.1016/j.jlr.2024.100723. Epub 2024 Dec 6.
  • Gibson CM. In the Wake of OCEANIC-AF, Is Equipoise Regarding Factor XI Inhibition Still Afloat? J Am Coll Cardiol. 2025 Mar 25;85(11):1210-1212. doi: 10.1016/j.jacc.2024.10.105. Epub 2024 Dec 4.
  • Kim JM, Li S, Song Y, Yeh RW, Secemsky EA. Dynamic Trends and Practice Patterns in Femoropopliteal Revascularization From 2016 Through 2023. J Am Coll Cardiol. 2025 Feb 18;85(6):645-648. doi: 10.1016/j.jacc.2024.10.102. Epub 2024 Dec 4.
  • McGrath BP, Pinilla-Echeverri N, Wood DA, Bainey KR, Sheth T, Schampaert E, Tanguay JF, Dzavik V, Storey RF, Mehran R, Bossard M, Moreno R, Campo G, Rao SV, Cantor WJ, Lavi S, Johnston PV, Guiducci V, Kim HH, Mani T, Nguyen H, Cairns JA, Mehta SR. Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction. JACC Cardiovasc Interv. 2025 Feb 10;18(3):297-307. doi: 10.1016/j.jcin.2024.09.004. Epub 2024 Dec 4.
  • Sista AK, Troxel AB, Tarpey T, Parpia S, Goldhaber SZ, Stringer WW, Magnuson EA, Cohen DJ, Kahn SR, Rao SV, Morris TA, Goldfeld KS, Vedantham S. Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism. Am Heart J. 2025 Mar;281:112-122. doi: 10.1016/j.ahj.2024.11.016. Epub 2024 Dec 3.
  • Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Doros G, Motaganahalli R, Laskowski IJ, Barshes NR, Genovese EA, Strong MB, Mills JL. Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial. J Vasc Surg. 2025 Mar;81(3):720-729.e1. doi: 10.1016/j.jvs.2024.11.027. Epub 2024 Dec 3.
  • Camm CF, Virdone S, Jerjes-Sanchez C, Oh S, Eikelboom JW, Oto A, Fox KAA, Camm AJ, Pieper KS, Goto S, Ragy H, Kakkar AK, GARFIELD-AF registry. Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry. Int J Cardiol. 2025 Feb 15;421:132866. doi: 10.1016/j.ijcard.2024.132866. Epub 2024 Dec 2.
  • Joundi RA, Fang J, Austin PC, Smith EE, Yu AYX, Hachinski V, Sposato LA, Ganesh A, Sharma M, Kapral MK. Magnitude and Time-Course of Dementia Risk in Stroke Survivors: A Population-Wide Matched Cohort Study. Neurology. 2025 Jan 14;104(1):e210131. doi: 10.1212/WNL.0000000000210131. Epub 2024 Dec 4.
  • Chen HW, Liu J, Yang DM, Xie Y, Peterson ED, Navar AM, Chong BF. Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus. JAMA Dermatol. 2025 Feb 1;161(2):175-182. doi: 10.1001/jamadermatol.2024.4991.
  • Hu JR, Power JR, Zannad F, Lam CSP. Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials. Eur Heart J. 2025 Mar 3;46(9):814-826. doi: 10.1093/eurheartj/ehae794.
  • Zoccali C, Mallamaci F, Kanbay M, Dounousi E, Kotanko P, Jankowski J, Chertow GM. Autonomic Dysfunction and Inflammation in CKD: A High-Risk Pathway. J Am Soc Nephrol. 2025 Mar 1;36(3):529-532. doi: 10.1681/ASN.0000000591. Epub 2024 Dec 2.
  • Keshvani N, Rizvi S, Segar MW, Miller JW, Coellar JD, Patel KV, Roehm B, Tang WHW, Pandey A. Diuretic efficiency of a single dose of subcutaneous versus oral furosemide after heart failure hospitalization across diuretic resistance strata: A pilot randomized controlled trial. Eur J Heart Fail. 2025 Feb;27(2):347-352. doi: 10.1002/ejhf.3537. Epub 2024 Dec 2.
  • Morton JI, Liew D, Watts GF, Zoungas S, Nicholls SJ, Reid CM, Ademi Z. Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis. Pharmacoeconomics. 2025 Mar;43(3):331-349. doi: 10.1007/s40273-024-01454-z. Epub 2024 Dec 2.
  • Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara Martinez JD, Mullasari AS, Belderrain-Morales N, Najera-Rojas NA, Diaz-Herrera BA, Sarabia-Chao V, Alfaro-Ponce DL, Briseno-De la Cruz JL, Ruiz-Beltran M, Martinez-Rios MA, Pina-Reyna Y, Latapi-Ruiz Esparza X, Grimaldo-Gomez FA, Cortina-De la Rosa E, Romero-Arroyo MO, Sierra-Gonzalez de Cossio A, Gonzalez-Pacheco H, Arias-Mendoza A. A randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia. Am Heart J. 2025 Mar;281:103-111. doi: 10.1016/j.ahj.2024.11.012. Epub 2024 Nov 29.
  • Pollock C, Carrero JJ, Kanda E, Ofori-Asenso R, Chen H, Garcia Sanchez JJ, Pentakota S, Pecoits-Filho R, Fishbane S, Lam CSP, Kashihara N, Wheeler DC. Baseline Characteristics of the DISCOVER CKD Prospective Cohort. Adv Ther. 2025 Mar;42(3):1393-1418. doi: 10.1007/s12325-024-03028-z. Epub 2024 Nov 29.
  • Christensen JC, Anand S, Chertow GM, Lyden K, Sarwal A, Bjordahl T, Boucher R, Mohammed A, Oro EG, Akramimoghaddam F, Katkam N, Takyi A, Bissada G, Chakravartula AR, Lee E, Zheng A, Wei G, Greene T, Beddhu S. The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease. Contemp Clin Trials. 2025 Feb;149:107766. doi: 10.1016/j.cct.2024.107766. Epub 2024 Nov 26.
  • Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2025 Jan;13(1):15-28. doi: 10.1016/S2213-8587(24)00271-7. Epub 2024 Nov 25.
  • Ni Ainle F, Middeldorp S, Hickman A, Clark C, Ageno W, Casais P, Connors JM, Eichinger S, Houghton D, Matsushita T, Meijers JCM, Weyand AC, Douketis J, International Society on Thrombosis and Haemostasis (ISTH) Guidelines and, Guidance Committee. Guidelines and guidance: what is the path forward for the ISTH? J Thromb Haemost. 2025 Feb;23(2):361-367. doi: 10.1016/j.jtha.2024.11.006. Epub 2024 Nov 26.
  • Bikdeli B, Leyva H, Muriel A, Lin Z, Piazza G, Khairani CD, Rosovsky RP, Mehdipour G, O’Donoghue ML, Madridano O, Lopez-Saez JB, Mellado M, Diaz Brasero AM, Grandone E, Spagnolo PA, Lu Y, Bertoletti L, Lopez-Jimenez L, Jesus Nunez M, Blanco-Molina A, Gerhard-Herman M, Goldhaber SZ, Bates SM, Jimenez D, Krumholz HM, Monreal M. Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries. Vasc Med. 2025 Feb;30(1):58-66. doi: 10.1177/1358863X241292023. Epub 2024 Nov 26.
  • Ananda RA, Solomon B, Ray KK. Individual and joint associations of obesity and metabolic health parameters on arterial stiffness: Evidence from the UK Biobank. Diabetes Obes Metab. 2025 Feb;27(2):899-910. doi: 10.1111/dom.16090. Epub 2024 Nov 25.
  • Fogacci F, Ray KK, Nicholls SJ, Cicero AFG. Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning. Metabolism. 2025 Feb;163:156084. doi: 10.1016/j.metabol.2024.156084. Epub 2024 Nov 22.
  • Ayers AT, Ho CN, Kerr D, Cichosz SL, Mathioudakis N, Wang M, Najafi B, Moon SJ, Pandey A, Klonoff DC. Artificial Intelligence to Diagnose Complications of Diabetes. J Diabetes Sci Technol. 2025 Jan;19(1):246-264. doi: 10.1177/19322968241287773. Epub 2024 Nov 22.
  • Ostrominski JW, Hojbjerg Lassen MC, Claggett BL, Miao ZM, Inzucchi SE, Docherty KF, Desai AS, Jhund PS, Kober L, Ponikowski P, Sabatine MS, Lam CSP, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M. Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease. Eur Heart J. 2025 Apr 7;46(14):1321-1331. doi: 10.1093/eurheartj/ehae780.
  • Thomas K, Ganesan C, Liu S, Thomas IC, Montez-Rath ME, Soerensen SJC, Chertow GM, Leppert JT, Pao AC. Facility-Level Variation in Nephrology Care among Veterans after Urinary Stone Diagnosis. Kidney360. 2025 Feb 1;6(2):296-302. doi: 10.34067/KID.0000000639. Epub 2024 Nov 19.
  • Etzrodt V, Huang H, Parikh SM. Advancing anti-inflammatory therapies: leveraging glucocorticoid pathways for novel treatments. Kidney Int. 2025 Feb;107(2):217-221. doi: 10.1016/j.kint.2024.11.005. Epub 2024 Nov 16.
  • Nicholls SJ, Ni W, Rhodes GM, Nissen SE, Navar AM, Michael LF, Haupt A, Krege JH. Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial. JAMA. 2025 Jan 21;333(3):222-231. doi: 10.1001/jama.2024.24017.
  • Shi I, Khan SS, Yeh RW, Ho JE, Dahabreh IJ, Kazi DS. Semaglutide Eligibility Across All Current Indications for US Adults. JAMA Cardiol. 2025 Jan 1;10(1):96-98. doi: 10.1001/jamacardio.2024.4657.
  • Navaneethan SD, Bansal N, Cavanaugh KL, Chang A, Crowley S, Delgado C, Estrella MM, Ghossein C, Ikizler TA, Koncicki H, St Peter W, Tuttle KR, William J. KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2025 Feb;85(2):135-176. doi: 10.1053/j.ajkd.2024.08.003. Epub 2024 Nov 18.
  • Jolly SS, d’Entremont MA, Lee SF, Mian R, Tyrwhitt J, Kedev S, Montalescot G, Cornel JH, Stankovic G, Moreno R, Storey RF, Henry TD, Mehta SR, Bossard M, Kala P, Layland J, Zafirovska B, Devereaux PJ, Eikelboom J, Cairns JA, Shah B, Sheth T, Sharma SK, Tarhuni W, Conen D, Tawadros S, Lavi S, Yusuf S, CLEAR Investigators. Colchicine in Acute Myocardial Infarction. N Engl J Med. 2025 Feb 13;392(7):633-642. doi: 10.1056/NEJMoa2405922. Epub 2024 Nov 17.
  • Jolly SS, d’Entremont MA, Pitt B, Lee SF, Mian R, Tyrwhitt J, Kedev S, Montalescot G, Cornel JH, Stankovic G, Moreno R, Storey RF, Henry TD, Mehta SR, Bossard M, Kala P, Bhindi R, Zafirovska B, Devereaux PJ, Eikelboom J, Cairns JA, Natarajan MK, Schwalm JD, Sharma SK, Tarhuni W, Conen D, Tawadros S, Lavi S, Asani V, Topic D, Cantor WJ, Bertrand OF, Pourdjabbar A, Yusuf S, CLEAR investigators, CLEAR Investigators. Routine Spironolactone in Acute Myocardial Infarction. N Engl J Med. 2025 Feb 13;392(7):643-652. doi: 10.1056/NEJMoa2405923. Epub 2024 Nov 17.
  • Patel KV, Chunawala Z, Verma S, Segar MW, Garcia KR, Ndumele CE, Wang TJ, Januzzi JL Jr, Bayes-Genis A, Butler J, Lam CSP, Ballantyne CM, de Lemos JA, Bertoni AG, Espeland M, Pandey A. Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study. J Am Coll Cardiol. 2025 Feb 11;85(5):489-500. doi: 10.1016/j.jacc.2024.11.004. Epub 2024 Nov 15.
  • Fonarow GC, Peterson ED, Hernandez AF. The Fine Art and Science of Translating Trials Results Into Clinical Practice. JAMA Cardiol. 2025 Jan 1;10(1):48-49. doi: 10.1001/jamacardio.2024.4550.
  • Chimura M, Wang X, Jhund PS, Henderson AD, Claggett BL, Desai AS, Fonseca C, Goncalvesova E, Katova T, Mueller K, Glasauer A, Rohwedder K, Viswanathan P, Nodari S, Lam CSP, Saldarriaga CI, Senni M, Sharma K, Voors AA, Zannad F, Pitt B, Vardeny O, Vaduganathan M, Solomon SD, McMurray JJV. Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025 Jan 1;10(1):59-70. doi: 10.1001/jamacardio.2024.4613.
  • Khan S, Yancy CW, Fonarow GC. Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step. JAMA Cardiol. 2025 Jan 1;10(1):70. doi: 10.1001/jamacardio.2024.4624.
  • Vardeny O, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Matsumoto S, Merkely B, Zieroth S, Yilmaz MB, Lay-Flurrie J, Viswanathan P, Horvat-Broecker A, Scalise A, McMurray JJV, Solomon SD. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiol. 2025 Jan 1;10(1):42-48. doi: 10.1001/jamacardio.2024.4539.
  • Santiago CF, Blekkenhorst LC, Hsu MP, Mirabito Colafella KM, Calkin AC, Nicholls SJ, Doyle KC, Vandenberg JI, Thomas EE, Chapman N, all Summit participants. Cardiovascular Workforce Sustainability Sector Consultation: Recommendations From an Australian Stakeholder Summit. Heart Lung Circ. 2025 Jan;34(1):95-101. doi: 10.1016/j.hlc.2024.10.012. Epub 2024 Nov 15.
  • MacNamara JP, Hearon CM Jr, Manferdelli G, Shah AM, Tayon KG, Pandey A, Sarma S, Levine BD. Heart Failure in Zero Gravity-External Constraint and Cardiac Hemodynamics. JAMA Cardiol. 2025 Jan 1;10(1):98-100. doi: 10.1001/jamacardio.2024.4596.
  • Leith J, An KR, Harik L, Dell’Aquila M, Rossi CS, Cancelli G, Soletti G Jr, Fremes SE, Hare DL, Kulik A, Lamy A, Ruel M, Peper J, Ten Berg JM, Willemsen LM, Zhao Q, Zhu Y, Alexander JH, Wojdyla DM, Gibson CM, Redfors B, Sandner S, Gaudino M. Sequential Grafting of the Left Internal Thoracic Artery to the Left Anterior Descending Artery and Graft Failure. Ann Thorac Surg. 2025 Apr;119(4):835-841. doi: 10.1016/j.athoracsur.2024.11.009. Epub 2024 Nov 14.
  • Udelson JE, Yancy CW, Fonarow GC. Interpreting Health Status Measures in Patients With Heart Failure-What Counts. JAMA Cardiol. 2025 Jan 1;10(1):40-41. doi: 10.1001/jamacardio.2024.4610.
  • Kim JM, Yeh RW, Secemsky EA. What Is the Rush?: Optimizing the Timing of P2Y(12) Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2025 Feb 4;85(4):335-338. doi: 10.1016/j.jacc.2024.10.099. Epub 2024 Nov 15.
  • Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith AB, Dwight J, Rucinski M, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guethmundsdottir IJ, Hrafnkelsdottir ThornJ, Ingimarsdottir IJ, Irs A, Janosi A, Jarai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP, Global Cardiovascular Outcomes Consortium and in collaboration with ACNAP, ACVC,, EACVI, EAPC, EAPCI, EHRA, ESC Committee for Young CV Professionals, ESC Registry, Committee, HFA, ESC Patient Forum and these Working Groups: aorta and peripheral, vascular diseases, atherosclerosis and vascular biology, cardiac cellular, electrophysiology, cardiovascular pharmacotherapy, cardiovascular regenerative, and restorative medicine, cardiovascular surgery, cellular biology of the heart,, e-cardiology, myocardial function, pulmonary circulation and right ventricular, function and thrombosis. Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). Eur Heart J. 2025 Jan 7;46(2):190-214. doi: 10.1093/eurheartj/ehae724.
  • Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ. Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients. J Clin Lipidol. 2025 Jan-Feb;19(1):134-145. doi: 10.1016/j.jacl.2024.10.005. Epub 2024 Nov 13.
  • Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I, SURMOUNT-1 Investigators. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025 Mar 6;392(10):958-971. doi: 10.1056/NEJMoa2410819. Epub 2024 Nov 13.
  • Judge PK, Tuttle KR, Staplin N, Hauske SJ, Zhu D, Sardell R, Cronin L, Green JB, Agrawal N, Arimoto R, Mayne KJ, Sammons E, Brueckmann M, Shah SV, Rossing P, Nangaku M, Landray MJ, Wanner C, Baigent C, Haynes R, Herrington WG. The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial. Nephrol Dial Transplant. 2025 May 30;40(6):1175-1186. doi: 10.1093/ndt/gfae263.
  • Jacobs JA, Ayodele I, Bress AP, Sterling MR, Pandey A, Derington CG, Zheutlin AR, Shah KS, Greene SJ, Alhanti B, Blanco R, Fonarow GC. Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure. Circ Heart Fail. 2025 Jan;18(1):e012357. doi: 10.1161/CIRCHEARTFAILURE.124.012357. Epub 2024 Nov 11.
  • El Beze N, Steg PG. Heart failure and revascularization: which method to choose and should we even do it? Eur Heart J. 2025 Jan 3;46(1):81-83. doi: 10.1093/eurheartj/ehae715.
  • Khairallah P, Lorenz EC, Waterman A, Aggarwal N, Pai A, Winkelmayer WC, Niu J. Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States. Am J Kidney Dis. 2025 Mar;85(3):273-283.e1. doi: 10.1053/j.ajkd.2024.09.005. Epub 2024 Nov 7.
  • Yang M, Henderson AD, Talebi A, Atherton JJ, Chiang CE, Chopra V, Comin-Colet J, Kosiborod MN, Kerr Saraiva JF, Claggett BL, Desai AS, Kolkhof P, Viswanathan P, Lage A, Lam CSP, Senni M, Shah SJ, Rohwedder K, Voors AA, Zannad F, Pitt B, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV. Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF. J Am Coll Cardiol. 2025 Jan 21;85(2):120-136. doi: 10.1016/j.jacc.2024.09.023. Epub 2024 Sep 29.
  • Bistola V, Farmakis D, Tromp J, Tay WT, Ouwerkerk W, Angermann CE, Cleland JGF, Dahlstrom U, Dickstein K, Ertl G, Hassanein M, Liori S, Nikolopoulos P, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Collins SP, Lam CSP, Filippatos G. Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective. JACC Heart Fail. 2025 Feb;13(2):229-247. doi: 10.1016/j.jchf.2024.09.009. Epub 2024 Nov 6.
  • Goto S, Goto S. Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis. Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11;10(8):725-727. doi: 10.1093/ehjcvp/pvae077.
  • Sarwal A, Boucher RE, Hartsell SE, Wei G, Shen J, Chertow GM, Whelton PK, Cheung AK, McEvoy JW, Greene T, Beddhu S. Baseline Diastolic BP and BP-Lowering Effects on Cardiovascular Outcomes and All-Cause Mortality: A Meta-Analysis. J Am Soc Nephrol. 2025 May 1;36(5):911-922. doi: 10.1681/ASN.0000000539. Epub 2024 Nov 8.
  • Ferreira JP, Oliveira AC, Vasques-Novoa F, Leite AR, Mendonca L, Zannad F, Butler J, Leite-Moreira A, Saraiva F, Neves JS. Mineralocorticoid Receptor Antagonist Combined with SGLT2 Inhibitor versus SGLT2 Inhibitor Alone in Chronic Kidney Disease: A Meta-Analysis of Randomized Trials. Am J Nephrol. 2025;56(2):236-242. doi: 10.1159/000541686. Epub 2024 Nov 7.
  • Ho CN, Ayers AT, Beisswenger P, Chalew S, Schmidt AM, Pandey A, Kapahi P, Fleming A, Klonoff DC. Advanced Glycation End Products (AGEs) Webinar Meeting Report. J Diabetes Sci Technol. 2025 Mar;19(2):576-581. doi: 10.1177/19322968241296541. Epub 2024 Nov 7.
  • Bikdeli B, Khairani CD, Bejjani A, Lo YC, Mahajan S, Caraballo C, Jimenez JV, Krishnathasan D, Zarghami M, Rashedi S, Jimenez D, Barco S, Secemsky EA, Klok FA, Hunsaker AR, Aghayev A, Muriel A, Hussain MA, Appah-Sampong A, Lu Y, Lin Z, Mojibian H, Aneja S, Khera R, Konstantinides S, Goldhaber SZ, Wang L, Zhou L, Monreal M, Piazza G, Krumholz HM, PE-EHR+ Investigators. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism. J Thromb Haemost. 2025 Feb;23(2):556-564. doi: 10.1016/j.jtha.2024.10.013. Epub 2024 Nov 4.
  • Fonarow GC, Udelson JE, Yancy CW. Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics. JAMA Cardiol. 2025 Feb 1;10(2):188. doi: 10.1001/jamacardio.2024.3764.
  • Averbuch T, Lee SF, Zagorski B, Pandey A, Petrie MC, Biering-Sorensen T, Xie F, Van Spall HGC. Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure. Eur J Heart Fail. 2025 Feb;27(2):377-387. doi: 10.1002/ejhf.3499. Epub 2024 Nov 5.
  • Soerensen SJC, Lim DS, Montez-Rath ME, Chertow GM, Chung BI, Rehkopf DH, Leppert JT. Pesticides and prostate cancer incidence and mortality: An environment-wide association study. Cancer. 2025 Jan 1;131(1):e35572. doi: 10.1002/cncr.35572. Epub 2024 Nov 4.
  • Mc Causland FR, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Henderson AD, Brinker M, Perkins R, Scheerer MF, Schloemer P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJV, Solomon SD. Finerenone and Kidney Outcomes in Patients With Heart Failure: The FINEARTS-HF Trial. J Am Coll Cardiol. 2025 Jan 21;85(2):159-168. doi: 10.1016/j.jacc.2024.10.091. Epub 2024 Oct 25.
  • Charytan DM, Winkelmayer WC, Granger CB, Middleton JP, Herzog CA, Chertow GM, Eudicone JM, Whitson JD, Tumlin JA, ADAPT Investigators. Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int. 2025 Jan;107(1):169-179. doi: 10.1016/j.kint.2024.10.010. Epub 2024 Oct 26.
  • Gupta A, Yong C, Al-Lamee R. Transcatheter Interventions in Tricuspid Regurgitation: Shifting the Focus Beyond Quantity of Life to Quality of Life. J Am Coll Cardiol. 2025 Jan 28;85(3):297-299. doi: 10.1016/j.jacc.2024.10.085. Epub 2024 Oct 30.
  • Van Mieghem NM, Elmariah S, Spitzer E, Pibarot P, Nazif TM, Bax JJ, Hahn RT, Popma A, Ben-Yehuda O, Kallel F, Redfors B, Chuang ML, Alu MC, Lindeboom W, Kolte D, Zahr FE, Kodali SK, Strote JA, Hermanides RS, Cohen DJ, Tijssen JGP, Leon MB. Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD. J Am Coll Cardiol. 2025 Mar 11;85(9):878-890. doi: 10.1016/j.jacc.2024.10.070. Epub 2024 Oct 28.
  • Arnold SV, Hahn RT, Thourani VH, Makkar R, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O’Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran N, Garcia S, Stewart-Dehner T, Grayburn PA, Sannino A, Snyder C, Zhang Y, Mack MJ, Leon MB, Lurz P, Kodali S, Cohen DJ, TRISCEND II Pivotal Trial Investigators. Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial. J Am Coll Cardiol. 2025 Jan 28;85(3):206-216. doi: 10.1016/j.jacc.2024.10.067. Epub 2024 Oct 30.
  • Yeh RW, Bertrand OF, Mahmud E, Barbato E, Falah B, Issever MO, Redfors B, Popma A, Curtis M, van Royen N, Tanguay JF, Janssens L, Newman WN, Teeuwen K, Choi JW, Dirksen MT, Maehara A, Leon MB. Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial. J Am Coll Cardiol. 2025 Feb 18;85(6):563-574. doi: 10.1016/j.jacc.2024.10.074. Epub 2024 Oct 30.
  • Hahn RT, Makkar R, Thourani VH, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O’Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran NK, Garcia S, Stewart-Dehner T, Thiele H, Kipperman R, Koulogiannis K, Lim DS, Fowler D, Kapadia S, Harb SC, Grayburn PA, Sannino A, Mack MJ, Leon MB, Lurz P, Kodali SK, TRISCEND II Trial Investigators. Transcatheter Valve Replacement in Severe Tricuspid Regurgitation. N Engl J Med. 2025 Jan 9;392(2):115-126. doi: 10.1056/NEJMoa2401918. Epub 2024 Oct 30.
  • Reddy YNV, Butler J, Anstrom KJ, Blaustein RO, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O’Connor C, Patel M, Ponikowski P, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F. Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial. Eur J Heart Fail. 2025 Feb;27(2):209-218. doi: 10.1002/ejhf.3501. Epub 2024 Oct 30.
  • Tang GHL, Hahn RT, Whisenant BK, Hamid N, Naik H, Makkar RR, Tadros P, Price MJ, Singh GD, Fam NP, Kar S, Mehta SR, Bae R, Sekaran NK, Warner T, Makar M, Zorn G, Benza R, Jorde UP, McCarthy PM, Thourani VH, Ren Q, Trusty PM, Sorajja P, Adams DH, TRILUMINATE Pivotal Investigators. Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort. J Am Coll Cardiol. 2025 Jan 28;85(3):235-246. doi: 10.1016/j.jacc.2024.10.086. Epub 2024 Oct 28.
  • Jaber WA, Gonsalves CF, Stortecky S, Horr S, Pappas O, Gandhi RT, Pereira K, Giri J, Khandhar SJ, Ammar KA, Lasorda DM, Stegman B, Busch L, Dexter DJ 2nd, Azene EM, Daga N, Elmasri F, Kunavarapu CR, Rea ME, Rossi JS, Campbell J, Lindquist J, Raskin A, Smith JC, Tamlyn TM, Hernandez GA, Rali P, Schmidt TR, Bruckel JT, Camacho JC, Li J, Selim S, Toma C, Basra SS, Bergmark BA, Khalsa B, Zlotnick DM, Castle J, O’Connor DJ, Gibson CM, PEERLESS Committees and Investigators*. Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial. Circulation. 2025 Feb 4;151(5):260-273. doi: 10.1161/CIRCULATIONAHA.124.072364. Epub 2024 Oct 29.
  • Loganath K, Craig NJ, Everett RJ, Bing R, Tsampasian V, Molek P, Botezatu S, Aslam S, Lewis S, Graham C, White AC, MacGillivray T, Tuck CE, Rayson P, Cranley D, Irvine S, Armstrong R, Milne L, Chin CWL, Hillis GS, Fairbairn T, Greenwood JP, Steeds R, Leslie SJ, Lang CC, Bucciarelli-Ducci C, Joshi NV, Kunadian V, Vassiliou VS, Dungu JN, Hothi SS, Boon N, Prasad SK, Keenan NG, Dawson D, Treibel TA, Motwani M, Miller CA, Mills NL, Rajani R, Ripley DP, McCann GP, Prendergast B, Singh A, Newby DE, Dweck MR, EVOLVED investigators. Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial. JAMA. 2025 Jan 21;333(3):213-221. doi: 10.1001/jama.2024.22730.
  • Bangalore S, Maqsood MH, Bakris GL, Rao SV, Messerli FH. Renal denervation – radiofrequency vs. ultrasound: insights from a mixed treatment comparison meta-analysis of randomized sham controlled trials. J Hypertens. 2025 Feb 1;43(2):325-335. doi: 10.1097/HJH.0000000000003909. Epub 2024 Oct 17.
  • Gragnano F, van Klaveren D, Heg D, Raber L, Krucoff MW, Raposeiras-Roubin S, Ten Berg JM, Leonardi S, Kimura T, Corpataux N, Spirito A, Hermiller JB, Abu-Assi E, Chan Pin Yin D, Azzahhafi J, Montalto C, Galazzi M, Bar S, Kavaliauskaite R, D’Ascenzo F, De Ferrari GM, Watanabe H, Steg PG, Bhatt DL, Calabro P, Mehran R, Urban P, Pocock S, Windecker S, Valgimigli M. Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention. Circulation. 2025 Feb 11;151(6):343-355. doi: 10.1161/CIRCULATIONAHA.124.072009. Epub 2024 Oct 27.
  • Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, Chotai S, Seligman H, Macierzanka K, Davies JR, Keeble TR, O’Kane P, Haworth P, Routledge H, Kotecha T, Clesham G, Williams R, Din J, Nijjer SS, Curzen N, Sinha M, Petraco R, Spratt J, Sen S, Cole GD, Harrell FE Jr, Howard JP, Francis DP, Shun-Shin MJ, Al-Lamee R, ORBITA-2 Investigators. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease. Circulation. 2025 Jan 21;151(3):202-214. doi: 10.1161/CIRCULATIONAHA.124.072281. Epub 2024 Oct 27.
  • Szklarzewicz J, Floege U, Gallego D, Gibson K, Kalantar-Zadeh K, Helm K, Robinson D, Schneider B, Smith P, Tullus K, Poyan-Mehr A, Hendry B, Balkaran BL, Jauregui AK, Wang A, Nason I, Hazra NC, Xu C, Liu J, Zhou ZY, Bensink M. The humanistic burden of immunoglobulin A nephropathy on patients and care-partners in the United States. Qual Life Res. 2025 Feb;34(2):353-363. doi: 10.1007/s11136-024-03813-x. Epub 2024 Oct 26.
  • Goldenberg NA, Schulman S, Kittelson JM, Abshire TC, Casella JF, Dale R, Halperin JL, Hanson J, Kessler CM, Manco-Johnson MJ, McDevitt L, Sidonio RF, Spyropoulos AC, Steg PG, Bonaca MP, Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children, (Kids-DOTT) Trial Investigators and the Antithrombotic Trials Leadership and, Steering (ATLAS) Group. Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years. J Thromb Haemost. 2025 Feb;23(2):651-656. doi: 10.1016/j.jtha.2024.09.038. Epub 2024 Oct 24.
  • Yu C, Natarajan P, Patel AP, Bhatia HS, Khera AV, Neumann JT, Tsimikas S, Wolfe R, Nicholls SJ, Reid CM, Zoungas S, Tonkin AM, McNeil JJ, Lacaze P. Polygenic risk, aspirin, and primary prevention of coronary artery disease. Eur Heart J Cardiovasc Pharmacother. 2025 Feb 8;11(1):84-91. doi: 10.1093/ehjcvp/pvae085.
  • Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Zhu D, Dayanandan R, Arimoto R, Mayne KJ, Ng SYA, Sammons E, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney DZI, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Massey D, Brueckmann M, Landray MJ, Baigent C, Haynes R, EMPA-KIDNEY Collaborative Group, EMPA-KIDNEY Collaborative Group. Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2025 Feb 20;392(8):777-787. doi: 10.1056/NEJMoa2409183. Epub 2024 Oct 25.
  • Zieroth S, Giraldo CIS, Pinto F, Anker SD, Abraham WT, Atherton JJ, Butler J, Chopra V, Coats AJS, Dean V, Filippatos G, Zamorano JL, Zhang Y, Weiskopf RB, Colardelle Y. Applicability of heart failure clinical practice guidelines in low- and middle-income countries. Eur J Heart Fail. 2025 Mar;27(3):435-441. doi: 10.1002/ejhf.3485. Epub 2024 Oct 25.
  • Kong NW, Kim JM, Krawisz AK, Heindel P, Tale A, Song Y, Weinstein JL, Hussain MA, Secemsky EA. Outcomes Following Arteriovenous Fistula Creation in Medicare Beneficiaries With End-Stage Kidney Disease. Am J Cardiol. 2025 Jan 1;234:79-86. doi: 10.1016/j.amjcard.2024.10.006. Epub 2024 Oct 22.
  • Barone-Rochette G, Vanzetto G, Danchin N, Steg PG, Hanon O, Charlon C, David-Tchouda S, Gavazzi G, Simon T, Bosson JL, EVAOLD study investigator. Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia. Am Heart J. 2025 Jan;279:94-103. doi: 10.1016/j.ahj.2024.10.013. Epub 2024 Oct 23.
  • Gragnano F, Angiolillo DJ. Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue. Thromb Haemost. 2025 Jun;125(6):607-609. doi: 10.1055/a-2448-7029. Epub 2024 Oct 24.
  • McCarthy CP, Bruno RM, McEvoy JW, Touyz RM. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy? Eur Heart J Cardiovasc Pharmacother. 2025 Feb 8;11(1):7-9. doi: 10.1093/ehjcvp/pvae084.
  • Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, Ponikowski P, Voors A, Corda S, McMullan C, O’Connor CM, Anstrom KJ, Armstrong PW, VICTORIA Study Group. Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial. ESC Heart Fail. 2025 Apr;12(2):1479-1484. doi: 10.1002/ehf2.15134. Epub 2024 Oct 22.
  • Patel L, Segar MW, Subramanian V, Singh S, Betts T, Lokesh N, Keshvani N, Patel K, Pandey A. Frailty, age, and treatment effect of surgical coronary revascularization in ischemic cardiomyopathy: a post hoc analysis of the STICHES trial. Geroscience. 2025 Apr;47(2):1945-1955. doi: 10.1007/s11357-024-01377-9. Epub 2024 Oct 19.
  • Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A. Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future ‘Knock-Out Trials’ in Heart Failure. Am J Med. 2025 Mar;138(3):495-503.e1. doi: 10.1016/j.amjmed.2024.10.015. Epub 2024 Oct 17.
  • Pokorney SD, Nemeth H, Chiswell K, Albert C, Allyn N, Blanco R, Butler J, Calkins H, Elkind MSV, Fonarow GC, Fontaine JM, Frankel DS, Fermann GJ, Gale R, Kalscheur M, Kirchhof P, Koren A, Miller JB, Rashkin J, Russo AM, Rutan C, Steinberg BA, Piccini JP. Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB study. Am Heart J. 2025 Jan;279:66-75. doi: 10.1016/j.ahj.2024.10.001. Epub 2024 Oct 16.
  • Baber U, Cao D, Collier T, Sartori S, Dangas G, Angiolillo DJ, Vogel B, Kunadian V, Briguori C, Cohen DJ, Dudek D, Gibson CM, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R. Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial. Eur Heart J Cardiovasc Pharmacother. 2025 Feb 8;11(1):66-74. doi: 10.1093/ehjcvp/pvae080.
  • Ganesan C, Shahzad SR, Thomas IC, Montez-Rath ME, Soerensen SJC, Chertow GM, Pao AC, Leppert JT. Variation in Urology Care After Urinary Stone Surgery Among Veterans at High-risk for Recurrence. Urology. 2025 Jan;195:52-58. doi: 10.1016/j.urology.2024.10.012. Epub 2024 Oct 16.
  • Hentati F, Kaushik M, Misra S, Carroll BJ, Earle WB, Secemsky EA. Death certificate documentation is inaccurate for most patients with acute pulmonary embolism. Vasc Med. 2025 Feb;30(1):79-81. doi: 10.1177/1358863X241287691. Epub 2024 Oct 16.
  • Paraskevas KI, AbuRahma AF, Abularrage CJ, Clair DG, Eldrup-Jorgensen J, Kashyap VS, Dardik A, de Borst GJ, Dermody M, Faggioli G, Hicks CW, Kwolek CJ, Lyden SP, Mansilha A, Van Herzeele I, Myrcha P, Leal Lorenzo JI, Jim J, Pini R, Secemsky EA, Spinelli F, Capoccia L, Stone DH, Stoner MC, Zeebregts CJ, Lal BK, Schneider PA, Malas MB, Schermerhorn ML. An International, Expert-Based Delphi Consensus Document on Controversial Issues about TransCarotid Artery Revascularization (TCAR). Ann Vasc Surg. 2025 Jan;110(Pt B):42-53. doi: 10.1016/j.avsg.2024.09.048. Epub 2024 Oct 15.
  • Fonarow GC, Kirtane AJ, Yancy CW. Parsing Signal vs Noise-Secondary Analyses of RCTs. JAMA Cardiol. 2025 Jan 1;10(1):31. doi: 10.1001/jamacardio.2024.3329.
  • Inciardi RM, Chandra A, Pandey A, Metra M. Reframing the role of glucagon-like peptide 1 receptor agonists in cardiovascular medicine. ESC Heart Fail. 2025 Apr;12(2):923-926. doi: 10.1002/ehf2.15123. Epub 2024 Oct 15.
  • Occhipinti G, Ortega-Paz L, Franchi F, Rollini F, Capodanno D, Brugaletta S, Angiolillo DJ. Switching from cangrelor to oral P2Y(12) inhibitors: a focused review on drug-drug interactions. Expert Opin Drug Metab Toxicol. 2025 Jan;21(1):29-40. doi: 10.1080/17425255.2024.2418033. Epub 2024 Oct 20.
  • Arshad MS, Jamil A, Greene SJ, Van Spall HGC, Fonarow GC, Butler J, Khan MS. In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure. Heart Fail Rev. 2025 Jan;30(1):89-101. doi: 10.1007/s10741-024-10446-2. Epub 2024 Oct 15.
  • Worsley ML, Niu J, Erickson KF, Barshes NR, Winkelmayer WC, Gregg LP. Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb;85(2):226-235.e1. doi: 10.1053/j.ajkd.2024.07.017. Epub 2024 Oct 11.
  • O’Toole G, Swan D, Connors JM, Thachil J. Hematological causes of acute ischemic stroke in younger individuals. J Thromb Haemost. 2025 Jan;23(1):11-22. doi: 10.1016/j.jtha.2024.09.025. Epub 2024 Oct 10.
  • Spahillari A, Cohen LP, Lin C, Liu Y, Tringale A, Sheppard KE, Ko C, Khairnar R, Williamson KM, Wasfy JH, Scott NS, Paquette C, Greene SJ, Fonarow GC, Januzzi JL Jr. Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic. JACC Heart Fail. 2025 Apr;13(4):554-568. doi: 10.1016/j.jchf.2024.08.017. Epub 2024 Oct 9.
  • Lu H, Claggett BL, Packer M, Pabon MA, Pfeffer MA, Lewis EF, Lam CSP, Rouleau J, Zile MR, Lefkowitz M, Desai AS, Jhund PS, McMurray JJV, Solomon SD, Vaduganathan M. Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials. JACC Heart Fail. 2025 Jan;13(1):58-71. doi: 10.1016/j.jchf.2024.08.008. Epub 2024 Aug 31.
  • Robson C, Horvath R, Stuart RL, Nicholls SJ, Smith JA, Rogers BA. A national study of infective endocarditis models of care in Australia. Intern Med J. 2025 Mar;55(3):376-383. doi: 10.1111/imj.16537. Epub 2024 Oct 10.
  • Neves JS, Leite AR, Mentz RJ, Holman RR, Zannad F, Butler J, Packer M, Ferreira JP. Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial. Eur J Heart Fail. 2025 Mar;27(3):540-551. doi: 10.1002/ejhf.3478. Epub 2024 Oct 9.
  • Connors JM. Factor XI inhibitors: a new class of anticoagulants. Blood Adv. 2025 Jan 14;9(1):192. doi: 10.1182/bloodadvances.2024013852.
  • Hamid A, Segar MW, Bozkurt B, Santos-Gallego C, Nambi V, Butler J, Hall ME, Fudim M. Machine learning in the prevention of heart failure. Heart Fail Rev. 2025 Jan;30(1):117-129. doi: 10.1007/s10741-024-10448-0. Epub 2024 Oct 7.
  • McGinigle KL, Doros G, Alabi O, Brooke BS, Vouyouka A, Hiramoto J, Charlton-Ouw K, Strong MB, Rosenfield K, Menard MT, Farber A, Giles KA. Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial. J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4.
  • Defilippis EM, Donald E, Cho L, Sauer A, Maning J, Blumer V, Hajduczok A, Youmans Q, Gulati M, Hurt MT, Humphrey A, Reza N, Mentz R, Lala A. Association of Double-Blind Reviews With Increases in Women as First Authors: An Initial Report From the Journal of Cardiac Failure. J Card Fail. 2025 Mar;31(3):592-597. doi: 10.1016/j.cardfail.2024.09.004. Epub 2024 Sep 29.
  • Desai AS, Vaduganathan M, Claggett BL, Kulac IJ, Jhund PS, Cunningham J, Borentain M, Lay-Flurrie J, Viswanathan P, Rohwedder K, Amarante F, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Kosiborod M, McMurray JJV, Solomon SD. Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial. J Am Coll Cardiol. 2025 Jan 21;85(2):106-116. doi: 10.1016/j.jacc.2024.09.004. Epub 2024 Sep 29.
  • Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJV, Solomon SD. Time to Significant Benefit of Finerenone in Patients With Heart Failure. J Am Coll Cardiol. 2025 Jan 21;85(2):199-202. doi: 10.1016/j.jacc.2024.09.018. Epub 2024 Sep 28.
  • Starnecker F, Coughlan JJ, Jensen LO, Bar S, Kufner S, Brugaletta S, Raber L, Maeng M, Ortega-Paz L, Heg D, Laugwitz KL, Sabate M, Windecker S, Kastrati A, Olesen KKW, Cassese S. Ten-year clinical outcomes after drug-eluting stents implantation according to clinical presentation-Insights from the DECADE cooperation. Eur J Clin Invest. 2025 Jan;55(1):e14323. doi: 10.1111/eci.14323. Epub 2024 Oct 1.
  • Docherty KF, Henderson AD, Jhund PS, Claggett BL, Desai AS, Mueller K, Viswanathan P, Scalise A, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial. Circulation. 2025 Jan 7;151(1):45-58. doi: 10.1161/CIRCULATIONAHA.124.072011. Epub 2024 Sep 29.
  • Vaduganathan M, Claggett BL, Kulac IJ, Miao ZM, Desai AS, Jhund PS, Henderson AD, Brinker M, Lay-Flurrie J, Viswanathan P, Scheerer MF, Lage A, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJV, Solomon SD. Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure. Circulation. 2025 Jan 14;151(2):149-158. doi: 10.1161/CIRCULATIONAHA.124.072055. Epub 2024 Sep 28.
  • Ochoa Chaar CI, Malas M, Doros G, Schermerhorn M, Conte MS, Alameddine D, Siracuse JJ, Yadavalli SD, Dake MD, Creager MA, Tan TW, Rosenfield K, Menard MT, Farber A, Hamdan A. The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2025 Feb;81(2):376-385.e3. doi: 10.1016/j.jvs.2024.09.026. Epub 2024 Sep 25.
  • Nordan T, Keshk M, Hackmann A, Givertz MM, Mehra MR, Cunningham MJ, Itoh A. The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device. J Thorac Cardiovasc Surg. 2025 Jun;169(6):1772-1781.e5. doi: 10.1016/j.jtcvs.2024.09.028. Epub 2024 Sep 25.
  • Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Borentian M, Lay-Flurrie J, Viswanathan P, Behmenburg FU, McMurray JJV, Solomon SD. Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025 Feb 1;10(2):176-181. doi: 10.1001/jamacardio.2024.3782.
  • Jalloh MB, Osoro I, Januzzi JL, Shaunik A, Bahit MC, Korjian S, Gibson CM, Van Spall HGC. Barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings. ESC Heart Fail. 2025 Feb;12(1):695-700. doi: 10.1002/ehf2.15076. Epub 2024 Sep 25.
  • Bozkurt B, Ahmad T, Alexander K, Baker WL, Bosak K, Breathett K, Carter S, Drazner MH, Dunlay SM, Fonarow GC, Greene SJ, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Lee CS, Morris AA, Page RL 2nd, Pandey A, Piano MR, Sandhu AT, Stehlik J, Stevenson LW, Teerlink J, Vest AR, Yancy C, Ziaeian B, WRITING COMMITTEE MEMBERS. HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America. J Card Fail. 2025 Jan;31(1):66-116. doi: 10.1016/j.cardfail.2024.07.001. Epub 2024 Sep 24.
  • Farber A, Menard MT, Conte MS, Rosenfield K, Schermerhorn M, Schanzer A, Powell RJ, Chaar CIO, Hicks CW, Doros G, Strong MB, Leers SA, Motaganahalli R, Stangenberg L, Siracuse JJ. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 Feb;81(2):408-416.e2. doi: 10.1016/j.jvs.2024.09.016. Epub 2024 Sep 23.
  • Anker MS, Rashid AM, Butler J, Khan MS. Cardiac wasting in patients with cancer. Basic Res Cardiol. 2025 Feb;120(1):25-34. doi: 10.1007/s00395-024-01079-5. Epub 2024 Sep 23.
  • Castagna F, Andersson C, Mehra MR. Transplantation Outcomes in Hepatitis C Virus-Positive Donor Hearts After Circulatory Death. J Card Fail. 2025 Feb;31(2):477-480. doi: 10.1016/j.cardfail.2024.08.056. Epub 2024 Sep 21.
  • Boehm LM, Potter K, McPeake J, Shaw M, Su H, Jones AC, Renard V, Eaton TL, Boethel C, Butler J, Walden RL, Danesh V. Understanding attendance patterns and determinants in cardiac, pulmonary, and ICU rehabilitation/recovery programs: A systematic review and meta-analysis. Heart Lung. 2025 Jan-Feb;69:51-61. doi: 10.1016/j.hrtlng.2024.09.010. Epub 2024 Sep 21.
  • Butler J, Brown M, Prokocimer P, Humphries AC, Pope S, Wright O, Su J, Elnawasany O, Muresan B. The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review. ESC Heart Fail. 2025 Apr;12(2):980-997. doi: 10.1002/ehf2.15075. Epub 2024 Sep 18.
  • Euper M, Schreieck J, Bladt M, Zdanyte M, Goldschmied A, Sigle M, Angiolillo DJ, Gorog DA, Jacobsen MR, Sorensen R, Rath D, Gawaz M, Geisler T. Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System. Thromb Haemost. 2025 Feb;125(2):130-141. doi: 10.1055/s-0044-1790604. Epub 2024 Sep 18.
  • Wang S, Spincemaille P, Selim M, Hasan D, Thomas AJ, Filippidis A, Wen Y, Wang Y, Soman S. CSF Susceptibility Variation in Patient With Intracranial Hemorrhage: Implications for Quantitative Susceptibility Mapping Reference Selection. J Comput Assist Tomogr. 2025 Mar-Apr 01;49(2):332-341. doi: 10.1097/RCT.0000000000001660. Epub 2024 Sep 4.
  • Guerra PG, Simpson CS, Van Spall HGC, Asgar AW, Billia P, Cadrin-Tourigny J, Chakrabarti S, Cheung CC, Dore A, Fordyce CB, Gouda P, Hassan A, Krahn A, Luc JGY, Mak S, McMurtry S, Norris C, Philippon F, Sapp J, Sheldon R, Silversides C, Steinberg C, Wood DA, Co-chairs:, Writing Panel:. Author Corrections to “Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive” [Can J Cardiol 40 (2024):500-523]. Can J Cardiol. 2025 Feb;41(2):330-331. doi: 10.1016/j.cjca.2024.07.032. Epub 2024 Sep 11.
  • Asgar AW, Tang GHL, Rogers JH, Rottbauer W, Morse MA, Denti P, Mahoney P, Rinaldi MJ, Asch FM, Zamorano JL, Dong M, Huang R, Lindenfeld J, Maisano F, von Bardeleben RS, Kar S, Rodriguez E. Evaluating Mitral TEER in the Management of Moderate Secondary Mitral Regurgitation Among Heart Failure Patients. JACC Heart Fail. 2025 Feb;13(2):213-225. doi: 10.1016/j.jchf.2024.08.001. Epub 2024 Sep 11.
  • Newman J, Bruno E, Allen S, Moore J, Zilinyi R, Khaliq A, Alkhafan F, Vitarello C, Lookstein R, Keeling B, Michael Gibson C, Rosenfield K, Secemsky EA, Rosovsky RP, Darki A. The influence of patient sex on pulmonary embolism evaluation, treatment modality, and outcomes. Vasc Med. 2025 Feb;30(1):67-75. doi: 10.1177/1358863X241281872. Epub 2024 Sep 12.
  • Isath A, Mehra MR. The persistent poor prognosis in cardiogenic shock: Insights from recent trials. Eur J Heart Fail. 2025 Jan;27(1):37-39. doi: 10.1002/ejhf.3462. Epub 2024 Sep 9.
  • Yong Y, Giovannucci J, Pang SN, Hong W, Han D, Berman DS, Dey D, Nicholls SJ, Nerlekar N, Lin A. Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2025 Mar;18(3):294-304. doi: 10.1016/j.jcmg.2024.07.024. Epub 2024 Sep 4.
  • Galli M, Terracina S, Schiera E, Mancone M, Frati L, Angiolillo DJ, Pulcinelli FM. Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital. J Thromb Thrombolysis. 2025 Jan;58(1):71-83. doi: 10.1007/s11239-024-03022-w. Epub 2024 Sep 6.
  • Siddiqi TJ, Cherney D, Siddiqui HF, Jafar TH, Januzzi JL, Khan MS, Levin A, Marx N, Rangaswami J, Testani J, Usman MS, Wanner C, Zannad F, Butler J. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. J Am Soc Nephrol. 2025 Feb 1;36(2):242-255. doi: 10.1681/ASN.0000000000000491. Epub 2024 Sep 4.
  • Lu H, Claggett BL, Packer M, Pfeffer MA, Lam CSP, Zile MR, Desai AS, Jhund P, Lefkowitz M, McMurray JJV, Solomon SD, Vaduganathan M. Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trial. Eur J Heart Fail. 2025 Jan;27(1):85-95. doi: 10.1002/ejhf.3414. Epub 2024 Sep 1.
  • Matsumoto S, Henderson AD, Shen L, Kondo T, Yang M, Campbell RT, Anand IS, de Boer RA, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Packer M, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Vaduganathan M, Zannad F, Zile MR, Jhund PS, Solomon SD, McMurray JJV. Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. Eur J Heart Fail. 2025 Jan;27(1):124-139. doi: 10.1002/ejhf.3383. Epub 2024 Aug 31.
  • Visoiu IS, Jensen B, Rimbas RC, Mihaila-Baldea S, Nicula AI, Vinereanu D. How the trabecular layer impacts on left ventricular function. J Cardiol. 2025 Jan;85(1):17-27. doi: 10.1016/j.jjcc.2024.08.008. Epub 2024 Aug 28.
  • Mahaffey KW, Tuttle KR, Arici M, Baeres FMM, Bakris G, Charytan DM, Cherney DZI, Chernin G, Correa-Rotter R, Gumprecht J, Idorn T, Pugliese G, Rasmussen IKB, Rasmussen S, Rossing P, Sokareva E, Mann JFE, Perkovic V, Pratley R. Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial. Eur Heart J. 2025 Mar 24;46(12):1096-1108. doi: 10.1093/eurheartj/ehae613.
  • Psaltis PJ, Nguyen MT, Singh K, Sinhal A, Wong DTL, Alcock R, Rajendran S, Dautov R, Barlis P, Patel S, Salagaras T, Marathe JA, Bursill CA, Montarello NJ, Nidorf SM, Thompson PL, Butters J, Cuthbert AR, Yelland LN, Ottaway JL, Kataoka Y, Di Giovanni G, Nicholls SJ. Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovasc Res. 2025 Apr 29;121(3):468-478. doi: 10.1093/cvr/cvae191.
  • Frank Peacock W, Snyder J, Brown C, Liu Liu Y, Cooper CK, Januzzi JL. Emergency department clinical performance of ADVIA Centaur n-terminal prohormone of B-type natriuretic peptide assay. Clin Chim Acta. 2025 Jan 1;564:119940. doi: 10.1016/j.cca.2024.119940. Epub 2024 Aug 22.
  • Serpa F, Rivera A, Fernandes JM, Braga MAP, Araujo B, Ferreira Felix I, Ferro EG, Zimetbaum PJ, d’Avila A, Kramer DB. Intracardiac vs transesophageal echocardiography for left atrial appendage occlusion: An updated systematic review and meta-analysis. Heart Rhythm. 2025 Mar;22(3):786-795. doi: 10.1016/j.hrthm.2024.08.027. Epub 2024 Aug 16.
  • Sadeghpour A, Jiang Z, Hummel YM, Frost M, Lam CSP, Shah SJ, Lund LH, Stone GW, Swaminathan M, Weissman NJ, Asch FM. An Automated Machine Learning-Based Quantitative Multiparametric Approach for Mitral Regurgitation Severity Grading. JACC Cardiovasc Imaging. 2025 Jan;18(1):1-12. doi: 10.1016/j.jcmg.2024.06.011. Epub 2024 Aug 14.
  • Mosarla RC, Ahmed H, Rao SD, Kadosh BS, Cruz JA, Goldberg RI, Saraon T, Gelb BE, Mattoo A, Rao SV, Bangalore S. Outcomes with distal transradial access in patients with advanced chronic kidney disease. J Invasive Cardiol. 2025 Jan;37(1). doi: 10.25270/jic/24.00200.
  • Shin ED, Liu J, Moffet H, Gulati M, Virani SS, Karter AJ, Sidney S, Rana JS. Sex Differences in Kidney Function and Atherosclerotic Cardiovascular Disease. Am J Prev Med. 2025 Jan;68(1):204-206. doi: 10.1016/j.amepre.2024.08.005. Epub 2024 Aug 12.
  • Tsukagoshi J, Orrukem M, Shimamura J, Secemsky EA, Nakama T, Yokoyama Y, Takagi H, Kuno T. Editor’s Choice – Short and Midterm Outcomes of Percutaneous Deep Venous Arterialisation for No Option Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2025 Feb;69(2):284-292. doi: 10.1016/j.ejvs.2024.08.001. Epub 2024 Aug 8.
  • Peeters D, Woelders E, Jansen T, Konst R, Crooijmans C, van de Hoef T, Mensink F, Los J, Pellegrini D, Cornel JH, Ong P, van Royen N, Leen A, Elias-Smale S, van Geuns RJ, Damman P. Association Between Coronary Artery Spasm and Atherosclerotic Disease. JACC Cardiovasc Imaging. 2025 Feb;18(2):226-239. doi: 10.1016/j.jcmg.2024.05.024. Epub 2024 Aug 7.
  • Kanbay M, Brinza C, Copur S, Sekreter O, Burlacu A, Tuttle KR, Rossing P, Covic A. SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis. Nephrol Dial Transplant. 2025 Apr 1;40(4):671-678. doi: 10.1093/ndt/gfae179.
  • Wassberg C, Batra G, Hadziosmanovic N, Hagstrom E, White HD, Stewart RAH, Siegbahn A, Wallentin L, Held C. Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy. Eur J Prev Cardiol. 2025 Apr 22;32(6):456-465. doi: 10.1093/eurjpc/zwae252.
  • Gikandi A, Connors JM, Nabzdyk CG, Zenati MA. Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion. 2025 May;40(4):1045-1048. doi: 10.1177/02676591241268395. Epub 2024 Jul 25.
  • Rao SV, Bailey E. Editorial: The need for standardized feedback systems for interventional cardiologists. Cardiovasc Revasc Med. 2025 Jan;70:39-40. doi: 10.1016/j.carrev.2024.07.018. Epub 2024 Jul 20.
  • Pagidipati NJ, Taub PR, Ostfeld RJ, Kirkpatrick CF. Dietary patterns to promote cardiometabolic health. Nat Rev Cardiol. 2025 Jan;22(1):38-46. doi: 10.1038/s41569-024-01061-7. Epub 2024 Jul 17.
  • Shimbo D, Shah RU, Abdalla M, Agarwal R, Ahmad FS, Anaya G, Attia ZI, Bull S, Chang AR, Commodore-Mensah Y, Ferdinand K, Kawamoto K, Khera R, Leopold J, Luo J, Makhni S, Mortazavi BJ, Oh YS, Savage LC, Spatz ES, Stergiou G, Turakhia MP, Whelton PK, Yancy CW, Iturriaga E. Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung, and Blood Institute (NHLBI) Workshop Report. Hypertension. 2025 Jan;82(1):36-45. doi: 10.1161/HYPERTENSIONAHA.124.22095. Epub 2024 Jul 16.
  • Hill Gallant KM, Sprague SM, Rosenbaum DP, Spiegel DM, Kozuka K, Edelstein S, Chertow GM. Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure. J Ren Nutr. 2025 Jan;35(1):25-34. doi: 10.1053/j.jrn.2024.07.003. Epub 2024 Jul 9.
  • Navar AM, Shah NP, Shrader P, Thomas LE, Ahmad Z, Allred C, Chamberlain AM, Chrischilles EA, Dhalwani N, Effron MB, Hayek S, Jones LK, Kalich B, Shapiro MD, Wojcik C, Peterson ED. Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry. Am Heart J. 2025 Jan;279:107-117. doi: 10.1016/j.ahj.2024.06.012. Epub 2024 Jul 6.
  • Apperloo EM, Cherney DZI, Kuhlman AB, Mann JFE, Rasmussen S, Rossing P, Tuttle KR, Vrhnjak B, Heerspink HJL. Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6. Nephrol Dial Transplant. 2025 Feb 4;40(2):352-359. doi: 10.1093/ndt/gfae150.
  • Samarasekera N, Ferguson K, Parry-Jones AR, Rodrigues M, Loan J, Moullaali TJ, Hughes J, Shoveller L, Wardlaw J, McColl B, Allan SM, Selim M, Norrie J, Smith C, Al-Shahi Salman R. Perihaematomal Oedema Evolution over 2 Weeks after Spontaneous Intracerebral Haemorrhage and Association with Outcome: A Prospective Cohort Study. Cerebrovasc Dis. 2025;54(3):298-307. doi: 10.1159/000540099. Epub 2024 Jul 17.
  • Secchi TL, Pille A, da Silva MMD, Martins SCO, Bagur R, Sposato LA, Ayan D. Neurologists Preferences on Basic and Advanced Cardiac Imaging Utilization in Ischemic Stroke Patients. Cerebrovasc Dis. 2025;54(3):350-355. doi: 10.1159/000539998. Epub 2024 Jun 22.
  • Sposato LA, Ayan D, Ahmed M, Fridman S, Mandzia JL, Lodol FF, Elrayes M, Pandey S, Bagur R. Extended Computed Tomography Angiography for the Successful Diagnosis of Cardioaortic Thrombus in Acute Ischemic Stroke and TIA: Study Protocol for a Randomized Controlled Trial. Cerebrovasc Dis. 2025;54(3):415-424. doi: 10.1159/000540034. Epub 2024 Jun 26.
  • Nouhravesh N, Garg J, Rockhold FW, De Pasquale CG, O’Meara E, Lewis GD, Butler J, Harrington J, Ezekowitz JA, Ponikowski P, Troughton RW, Wong YW, Blackman N, Numan S, Adamczyk R, Hernandez AF, Mentz RJ. Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. Eur J Heart Fail. 2025 May;27(5):872-880. doi: 10.1002/ejhf.3348. Epub 2024 Jun 19.
  • Simitsis P, Nohria A, Kelleher J, Boulet J, Wanderley MRB Jr, Natarajan P, Libby P, Mehra MR. Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation. J Card Fail. 2025 Feb;31(2):400-410. doi: 10.1016/j.cardfail.2024.05.011. Epub 2024 Jun 15.
  • Singh LJ, Floyd RG, Reynolds MR, Pike NM, Huenergarde MC. What does the Developmental Neuropsychological Assessment-II (NEPSY-II) measure in children ages 7 to 12? A structural and psychometric analysis. Child Neuropsychol. 2025 Feb;31(2):197-228. doi: 10.1080/09297049.2024.2357376. Epub 2024 Jun 14.
  • Abramovitz Fouks A, Yaghi S, Selim MH, Gokcal E, Das AS, Rotschild O, Silverman SB, Singhal AB, Kapur S, Greenberg SM, Gurol ME. Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation. Stroke Vasc Neurol. 2025 Feb 25;10(1):120-128. doi: 10.1136/svn-2024-003143.
  • Heerspink HJL, Agarwal R, Bakris GL, Cherney DZI, Lam CSP, Neuen BL, Sarafidis PA, Tuttle KR, Wanner C, Brinker MD, Dizayee S, Kolkhof P, Schloemer P, Vesterinen P, Perkovic V, FIND-CKD investigators. Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial. Nephrol Dial Transplant. 2025 Feb 4;40(2):308-319. doi: 10.1093/ndt/gfae132.
  • Heindel P, Fitzgibbon JJ, Secemsky EA, Belkin M, Ozaki CK, Hussain MA. Evaluating the effectiveness of systemic heparin during arteriovenous fistula creation by emulating a target trial. Am J Epidemiol. 2025 Mar 4;194(3):651-658. doi: 10.1093/aje/kwae098.
  • Jotwani V, Thiessen-Philbrook H, Arking DE, Yang SY, McArthur E, Garg AX, Katz R, Tranah GJ, Ix JH, Cummings S, Waikar SS, Sarnak MJ, Shlipak MG, Parikh SM, Parikh CR. Association of Blood Mitochondrial DNA Copy Number With Risk of Acute Kidney Injury After Cardiac Surgery. Am J Kidney Dis. 2025 Jan;85(1):130-133. doi: 10.1053/j.ajkd.2024.03.013. Epub 2024 Apr 17.
  • Lioutas VA, Katsanos AH, Shoamanesh A, Vahidy F, Heistand EC, Foster LD, Yeatts SD, Selim M, iDEF investigators. Cognitive Outcome after Acute Spontaneous Intracerebral Hemorrhage: Analysis of the iDEF Randomized Trial. Cerebrovasc Dis. 2025;54(2):156-164. doi: 10.1159/000538415. Epub 2024 Apr 5.
  • Marchina S, Yeatts SD, Foster LD, Janis S, Shoamanesh A, Khatri P, Bernstein K, Perlmutter A, Stever C, Heistand EC, Broderick JP, Greenberg SM, Leira EC, Rosand J, Lioutas VA, Salman RAS, Tirschwell D, Marti-Fabregas J, Selim M. Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. Cerebrovasc Dis. 2025;54(2):270-277. doi: 10.1159/000538195. Epub 2024 Mar 16.
  • Fiolet ATL, Keusters W, Blokzijl J, Nidorf SM, Eikelboom JW, Budgeon CA, Tijssen JGP, Romer T, Westendorp I, Cornel JH, Thompson PL, Frederix GWJ, Mosterd A, de Wit GA. Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands. Eur Heart J Qual Care Clin Outcomes. 2025 Jan 16;11(1):89-96. doi: 10.1093/ehjqcco/qcae021.
  • Nagori A, Segar MW, Keshvani N, Patel L, Patel KV, Chandra A, Willett D, Pandey A. Prevalence and Predictors of Subclinical Cardiomyopathy in Patients With Type 2 Diabetes in a Health System. J Diabetes Sci Technol. 2025 May;19(3):699-704. doi: 10.1177/19322968231212219. Epub 2023 Dec 8.

NEWS

ABOUT US

PUBLICATIONS

CAREERS

CONTACT US

SERVICES

CENTERS OF EXCELLENCE

CLINICAL RESEARCH

Copyright - Baim Institute ®